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Ever since it was reported that synaptic vesicle (SV) retrieval follows two kinetic phases, the 
molecular mechanisms corresponding to these kinetic modes have been controversially 
discussed. This work aimed at elucidating the molecular details of SV recycling in small 
central synapses. We have generated tools to inhibit clathrin-mediated endocytosis (CME) in 
primary hippocampal neurons and analyzed their effects on SV retrieval using the optical 
tracers FM1-43 and synaptopHluorin. We found that the majority of SVs was recycled via an 
AP-2/clathrin- and dynamin-dependent pathway. Fast and slow components of SV retrieval 
were equally affected by CME inhibition. While CME as such is generally well understood, 
the question how select SV proteins are targeted for endocytosis has remained elusive. 
Genetic and biochemical studies have implicated the SV membrane protein synaptotagmin 1 
(syt1) in connecting the exo- and endocytic limbs of the SV cycle. We have identified stonin 2 
as syt1-specific endocytic sorting adaptor, which serves as linker between syt1 and the 
clathrin machinery by directly interacting with syt1 and AP-2 in vitro and in vivo. The 
interaction between stonin 2 and syt1, and the endocytic function of stonin 2 are directly 
dependent on residues KYE783-785 within the stonin 2 µ-homology domain (µHD). Our data 
indicate a synergistic effect between the syt1 C2 domains with respect to stonin 2 interaction, 
however, when C2 domains are offered separately, stonin 2 associates primarily with the C2A 
domain. We found that the C2B domain as well as the direct association of syt1 and AP-2 are 
dispensable for AP-2/stonin 2-dependent syt1 internalization in fibroblasts. We hypothesize 
that stonin 2 may serve as a linker between syt1 and AP-2/clathrin by directly recognizing 
syt1 C2 domains.  
In addition, we were able to identify the G protein-coupled receptor kinase interacting protein 
GIT1 as novel stonin 2 binding partner. Stonin 2 directly associates with the ADP-
ribosylation factor GTPase activating protein (ARF-GAP) domain of GIT1, indicating a 
potential regulatory function of stonin 2 for the enzymatic activity of GIT1. GIT1 is involved 
in various processes such as cell motility by cytoskeletal rearrangements, trafficking between 
plasma membrane and endosomal compartments, or synapse formation. The functional 
relevance of the stonin 2 – GIT1 interaction for one or more of these processes remains to be 
unraveled.        
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1 Introduction 
1.1 Synaptic Transmission 
One of the most remarkable aspects of the adult nervous system is the human brain. It 
controls memory, vision, learning, thought, consciousness and other activities by means of 
electrochemical impulses. The adult brain has around one hundred billion neurons and an 
even larger number of glial cells (Wade, 2002). Each neuron in the brain establishes in the 
order of 1000 synaptic contacts resulting in an unimaginable circuitry (Figure 1-1). The 
resulting complexity vastly surpasses, for example, the complexity of the human genome. 
Synaptic contacts are established by chemical synapses, which are able to convert an 
electrical signal arriving at the presynaptic nerve terminal into a chemical signal that is 
propagated between the two communicating neurons, and finally back into an electrical signal 












Figure 1-1: Illustration of a synaptic 
contact in the brain (by Graham 
Johnson) 
The brain contains billions of neurons, 
whose network of chemical messages form 
the basis for all thought, movement, and 
behavior. Using the brain slices and electron 
micrographs as references, Johnson 
illustrated the convoluted labyrinth of 
neurons in the background to the clusters of 
organelles inside the neural cells. Because 
the original data were so complex, Johnson 
cut the number of neuron interactions 
depicted to only 30% of the original data. 
Credit: Graham Johnson, Graham Johnson 
Medical Media, Boulder, Colorado. 
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1.2 Morphology of Chemical Synapses 
A chemical synapse is composed of a presynaptic terminal and a postsynaptic contact site. 
While the presynaptic cell is always a neuron, the postsynaptic cell can be a nerve cell or 
another type of responding cell, such as a muscle cell. Contacts between neurons and muscle 
cells are called neuromuscular junctions. An action potential is propagated on the axon, 
arrives at the presynaptic terminal, which causes opening of calcium channels and influx of 
calcium into the terminal. The rise of calcium concentration is sensed and triggers fusion of 
synaptic vesicles with the presynaptic active zone and the release of neurotransmitter into the 
synaptic cleft, a process termed exocytosis. Neurotransmitter diffuses to the postsynaptic cell, 
which presents neurotransmitter receptors on its surface at a region called the postsynaptic 
density. The presynaptic active zone and the postsynaptic density are precisely aligned and 
the extracellular space between the two membranes is as narrow as 30 nm (Landis et al., 
1988). Binding of neurotransmitter to postsynaptic receptors elicits a response in the target 
cell, which differs depending on the type of contact. Exocytosed synaptic vesicles are 
recycled by a mechanism termed endocytosis, refilled with neurotransmitter, and made 
available for a next round of transmitter release (see 1.3). The mechanism of synaptic 




Depending on the type of synapse the actual morphology differs (Walmsley et al., 1998), 
however, the principal characteristics as depicted in Figure 1-2 are common for all synaptic 
contacts. Model synapses include the Drosophila larval neuromuscular junction, the frog 
neuromuscular junction, and, as models for synapses of the central nervous system (CNS), 
hippocampal synapses, the calyx of Held, and Goldfish retinal bipolar nerve terminals 
 
 
Figure 1-2: Schematic representation 
of a chemical synapse 
Action potentials arrive via the axon at 
the presynaptic terminal (1), cause 
synaptic vesicles to fuse with the active 
zone, and to release neurotransmitter 
into the synaptic cleft (2) (3). 
Neurotransmitter diffuses to the 
postsynaptic cell and binds to the 
corresponding receptor (4). The 
postsynaptic neuron generates an action 
potential of its own (5). Taken from 
www.brain.riken.go.jp/english. 
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(Figure 1-3). The Drosophila neuromuscular junction (NMJ) has attracted widespread 
attention as an excellent model system for studying the cellular and molecular mechanisms of 
neurotransmission. In Drosophila the advantages of small invertebrate systems, where 
individual cells can be examined with single cell resolution, are combined with the powerful 
techniques of patch-clamp analysis and molecular genetics (reviewed in Keshishian et al., 
1996). While the Drosophila NMJ presynaptic terminal contains around 84,000 synaptic 
vesicles organized in many release sites (Delgado et al., 2000) (Figure 1-3, panel A), the 
presynaptic terminal of the frog NMJ holds up to 500,000 synaptic vesicles (Figure 1-3, 
panel B). It has already been used in the 1970’s for extensive ultra-structural studies by 
electron microscopy (EM) (Ceccarelli, 1973; Heuser and Reese, 1973). Another synaptic 
system used preferentially for ultra-structural studies by EM is the lamprey giant 
reticulospinal synapse. Its size allows for injection of interfering molecules including 
antibodies, protein domains, or pharmacological reagents. The effects of such injections are 
then studied by electron microscopy (reviewed in Brodin and Shupliakov, 2006). In contrast 
to the NMJ and the reticulospinal synapse, hippocampal synapses in the central nervous 
system are rather small. One hippocampal bouton with a diameter smaller than 1 µm holds 
only between 100 and 200 synaptic vesicles (Schikorski and Stevens, 1997; Shepherd and 
Harris, 1998). However, neurons of the mammalian hippocampus have several axonal 
branches that connect with multiple postsynaptic neurons through hundreds of small synapses 
(Figure 1-3, panel C). The advantage of this system is the possibility for genetic 
manipulations if combined with mouse genetics. However, due to the size of the synapses 
electrophysiological studies using the patch-clamp technique are difficult to perform. The 
calyx of Held is one of two giant synapses of the auditory pathway in the brain-stem named 
after Held (1893). This synapse arises from a single presynaptic axon and forms a single large 
calyceal terminal on to the soma of a target neuron (Figure 1-3, panel D). The calyx synapse 
might be regarded as a giant bouton with around 500 release sites (Fernandez-Alfonso and 
Ryan, 2006), which release neurotransmitter into a laterally extensive synaptic cleft 
communicating with a single postsynaptic cell. Since the presynaptic terminal of this synapse 
is rather large (> 10 µm in diameter) it is very well suited for electrophysiological studies 
such as capacitance measurements (reviewed by Schneggenburger and Forsythe, 2006). The 
bipolar cells of the retina and hair cells of the inner ear have synapses characterized by the 
presence of ribbons (reviewed by Prescott and Zenisek, 2005; Nouvian et al., 2006), electron-
dense protrusions that are decorated with synaptic vesicles. These synapses are thus named 
ribbon synapses and contain around 12,000 synaptic vesicles at each of around 20 to 50 
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release sites per presynaptic terminal (Lenzi et al., 1999; Schnee et al., 2005). A clear 
advantage of this system is its size, which allows for injection of interfering peptides and 




Figure 1-3: Selection of model synapses used to study synaptic transmission and SV cycling 
(A) Drosophila neuromuscular junction. Arrows indicate active zones; m: mitochondrion, v: synaptic 
vesicles: 1: axon. (B) Frog Neuromuscular junction. Arrows indicate active zones. (C) Hippocampal 
boutons. Arrowheads indicate the two edges of the active zone in this image; the black arrows point to two 
docked vesicles; a non-docked vesicle near the active zone is shown by the white arrow.  (D) Calyx of Held 
of the mammalian auditory pathway in the brain-stem. (E) Goldfish retinal bipolar cell. (a) FM1-43 dye 
uptake and fluorescence imaging. (b) Electron micrographs of the synapses or presynaptic terminals. For 
more detail to the individual synapse types see the text. Modified from Rizzoli and Betz, 2005. 
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According to their mode of operation, synaptic contacts can be divided into tonic and phasic 
synapses (Lnenicka, 1991). Whereas the initial release probability of phasic synapses is high, 
but depresses upon sustained stimulation, the release probability of tonic synapses is initially 
low, but facilitates with repeated stimulation (Atwood and Wojtowicz, 1986). The initial 
neurotransmitter release is 100 to 1000 fold greater for phasic than for tonic synapses 
(Msghina et al., 1998). This does not correlate with the number of readily releasable and 
docked vesicles in the synaptic terminal (see explanation to synaptic vesicle pools chapter 
1.2.4.1), but is dependent on release probability, since it has been reported that tonic synapses 
possess around twice as many docked vesicles per synapse than phasic terminals (Millar et al., 
2002).      
 
1.2.4 The Presynaptic Terminal 
The presynaptic terminal converts electric impulses into chemical signals. Messengers for 
chemical signals are neurotransmitters, which are stored in synaptic vesicles (SVs). SVs are 
clustered - probably by cytoplasmic scaffolds - juxtaposed to the so-called active zone 
(Couteaux and Pecot-Dechavassine, 1970), where exocytosis of SVs takes place. The 
periactive zone, where endocytosis of SV membrane is supposed to take place is located 
adjacent to the active zone. Since SV exocytosis is calcium-triggered, essential components 
for presynaptic terminals are voltage-gated calcium channels (Dunlap et al., 1995). 
Furthermore, synapses are enriched in energy-generating mitochondria (Shepherd and Harris, 
1998). Energy is required for instance for re-acidification and re-filling of SVs with 
neurotransmitter. In addition, there have been speculations that the mobilization of reserve 
pool vesicles (see explanation to synaptic vesicle pools in chapter 1.2.4.1) requires ATP (Ly 
and Verstreken, 2006). Most neurotransmitters used in the nervous system are cleared from 
the synaptic cleft through diffusion and re-uptake into the nerve terminal and by adjacent glial 
cells. Therefore presynaptic terminals are equipped with neurotransmitter transporters 
(Nelson, 1998).  
 
1.2.4.1 Synaptic Vesicles 
Almost 40 years ago Katz showed already that neurotransmitters are released in defined 
packets or quanta (Katz, 1969). Nowadays, it is well established that neurotransmitters are 
stored and released from so called synaptic vesicles (SVs), the smallest membrane-bound 
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organelles known. Synaptic vesicle clusters of varying sizes - depending on the type of 
synapse - are located to presynaptic boutons. Hippocampal synapses possess between 100 and 
200 vesicles per active zone (Schikorski and Stevens, 1997). The SV cluster is composed of 
morphologically apparently identical, however, functionally different SV pools (Schikorski 
and Stevens, 2001). Depending on the publication there is a rather bewildering list of names 
for these pools. Here, we use the definition of vesicle pools provided by Rizzoli and Betz 
(2005). The pool of vesicles that is drawn from by the next action potential is commonly 
referred to as readily-releasable pool (RRP). RRP vesicles are located close to the plasma 
membrane in a docked and primed state, however, it should be noted that not all docked 
vesicles appear to be readily releasable (Xu-Friedman et al., 2001; Rizzoli and Betz, 2004). 
During sustained stimulation the readily releasable pool is replenished from the recycling 
pool. The total recycling pool size defines the number of vesicles that are actually taking part 
in the synaptic vesicle cycle under given stimulation conditions. It has been observed that 
previously exocytosed SVs are preferably used for a next round of neurotransmitter release. 
There is a number of SVs that are not immediately used for neurotransmitter release. This SV 






The exact function of the reserve  pool is not known so far. It might replenish the recycling 
pool under very strong stimulation conditions. The different pool sizes vary between types of 
synapses. Around 1% to 2% constitute the RRP, 10% to 20% the recycling pool, and 80% to 
90% the reserve pool (Rizzoli and Betz, 2005). Rosenmund and Stevens (1996) defined the 
readily releasable pool in hippocampal synapses as those vesicles released during a hypertonic 
sucrose challenge (300 to 500 mM sucrose). Longer trains of action potentials or 
 
Figure 1-4: Schematic representation of 
synaptic vesicle pools 
The classic three pool model. Shown is a 
presynaptic endplate. Vesicles of the readily 
releasable pool (RRP) are in close proximity 
or docked to the presynaptic active zone and 
are likely to be released during the next action 
potential. The readily releasable pool will be 
replenished by the recycling pool. A third 
group of vesicles is apparently not fusion 
competent and comprises the reserve pool. 
Taken from Rizzoli and Betz, 2005. 
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depolarization with high potassium concentrations in presence of FM dyes (see Figure 1-11) 
label the entire recycling pool (Ryan et al., 1996, Murthy et al., 1997). 
It has to be mentioned that the different SV pools are not spatially separated as depicted in the 
schematic representation in Figure 1-4, but may be mixed at random, at least in some types of 
synapses (Harata et al., 2001 a,b).  
 
Looking at individual SVs one finds membrane-bound organelles filled with neurotransmitter 
of around 40 nm in diameter. The group of Reinhard Jahn (Max-Planck-Institute for 
Biophysical Chemistry, Göttingen) has put great effort into quantification of synaptic vesicle 
components. By application of biochemical and biophysical methods they were able to 
provide a comprehensive quantitative description of synaptic vesicles as model trafficking 
organelles (Reinhard Jahn, talk at Synapse 2006, Paris). They estimated the molecular weight 
of a synaptic vesicle to be ~ 18 MDa. Each SV contains around 7000 phospholipids, 5600 
cholesterol molecules and around 250 membrane and membrane associated proteins. The 
protein to phospholipids ratio is approximately 1.9 and each vesicle contains around 630 
transmembrane domains. Major SV protein families are SNAREs, with synaptobrevin being 
the most abundant SV protein (around 70 copies per SV), synaptophysin, synaptotagmins, 
Rab3A, synapsins, neurotransmitter transporters, and proton pumps (V-ATPases). Additional 
SV proteins in lower copy numbers are SV2s, synaptogyrin, SCAMPs and cysteine string 





Figure 1-5: Schematic representation 
of a synaptic vesicle 
Depicted are the major proteins of 
synaptic vesicles. Isoprenyl groups that 
attach rab proteins and palmitoyl chains 
that bind cysteine string proteins (CSPs) 
to SVs are depicted as thin orange lines. 
Amino-termini of the proteins are 
marked with N, carboxy-termini with C. 
P indicates positions of phosphorylation 
sites. Yellow dots represent calcium 
molecules, and Ys indicate 
glycosylation. Modified from Südhof et 
al., 1995)  
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SV proteins fulfill different functions that accompany the SV exo/endocytic cycle: (i) vesicle 
exocytosis (synaptobrevin/vesicle associated membrane protein VAMP, and synaptotagmin 
1), (ii) endocytosis (synaptotagmin 1), (iii) synaptic vesicle re-acidification upon vesicle 
retrieval (V-ATPase), (iv) neurotransmitter loading (neurotransmitter transporters),               
(v) coupling to the actin cytoskeleton (synapsins), and trafficking (Rab proteins). 
Synaptobrevin/VAMP belongs to the family of soluble NSF attachment protein receptors 
(SNAREs). Neuronal SNAREs are synaptobrevin/VAMP, located to SVs, syntaxin and 
SNAP25, found at the plasma membrane. SNARE proteins represent the basic membrane 
fusion machinery. These form a tight 4-helix bundle between the vesicle and the plasma 
membrane SNAREs and by that force the two membranes together (reviewed in Jahn and 
Scheller, 2006). In neurons, SV fusion with the plasma membrane is coupled to calcium 
influx. The presumed calcium sensor is synaptotagmin 1 (reviewed in Augustine, 2001; 
Chapman, 2002; Koh and Bellen, 2003; Bai and Chapman, 2004; Yoshihara and Montana, 
2004), which couples a rise of calcium concentration with SV exocytosis and neurotransmitter 
release. In addition to its function in exocytosis, a number of studies connect synaptotagmin 1 
with SV endocytosis and recycling. Zhang et al. (1994) demonstrated that synaptotagmin 1 
harbors the potential to bind to the clathrin adaptor AP-2. The interaction site for AP-2 within 
synaptotagmin 1 has been mapped to a stretch of polybasic amino acids (Chapman et al., 
1998; Haucke et al., 2000), which were sufficient for endocytosis when oligomerized (Grass 
et al., 2004). Poskanzer et al. (2006) have shown that mutations in the AP-2 binding site of 
synaptotagmin 1 resulted in the formation of larger synaptic vesicles. Jorgensen et al. (1995) 
have observed a SV depletion and endocytic defect in synaptotagmin 1 mutants of the 
nematode Caenorhabditis elegans. In addition, blocking the function of synaptotagmin by 
antibody injection blocks SV endocytosis (Llinas et al., 2004). Photoinactivation of 
synaptotagmin 1, through fluorescein-assisted light inactivation specifically during 
endocytosis in Drosophila neurons showed that synaptotagmin 1 is essential for this process 
(Poskanzer et al., 2003). Nicholson-Tomishima and Ryan (2004) showed a defect in SV 
endocytosis in synapses from synaptotagmin 1 KO mice. These combined data indicate an 
important role for synaptotagmin 1 in SV endocytosis.  
Neuronal synaptotagmin 1 is a member of a large protein family comprising at least 16 
isoforms, sharing a common domain structure (Südhof, 2002; Fukuda, 2003a,b). 
Synaptotagmin 1 was shown to be structurally and functionally conserved from Drosophila to 
humans (Perin et al., 1991b), harboring an amino-terminal, intra-vesicular tail that is 
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glycosylated, a single transmembrane region, and a hinge region that separates the 






C2 domains are conserved motifs of around 135 amino acid residues and are the major 
protein-protein interaction and effector domains of synaptotagmin 1. The name C2 is derived 
from conserved or constant sequence 2 among isoforms of protein kinase C (Nalefski and 
Falke, 1996). Both C2 domains are capable of binding to calcium. Nuclear magnetic 
resonance studies indicate that the C2A domain binds 3 (Ubach et al., 1998) and the C2B 
domain 2 calcium ions (Fernandez et al., 2001). In addition, synaptotagmin 1 interacts with 
phospholipids and SNARE proteins (Sutton et al., 1999, Bai and Chapman 2004). It is well 
established that in response to calcium, C2A binds tightly and rapidly to membranes 
harboring anionic phospholipids, such as phosphatidylserine (PS) (Davletov and Südhof, 
1993; Chapman and Davis, 1998). C2B exhibits binding activity for liposomes containing 
acidic phospholipids when it is tethered next to the C2A domain by a flexible linker (Bai et 
al., 2002). C2B also exhibits considerable binding affinity for liposomes containing 
phosphatidylinositol (4,5)-bisphosphate (PIP2), even in the absence of calcium (Schiavo et al., 
1996). Synaptotagmin 1 can oligomerize via two different mechanisms: (i) in a calcium-
dependent manner via the cytoplasmic domain (Damer and Creutz, 1996; Chapman et al., 
1996; Osborne et al., 1999), and (ii) in a calcium-independent fashion via its amino-terminal 
region (Brose et al., 1992; Bai et al., 2000).  
 
 
Figure 1-6: Domain structure of 
synaptotagmins 
(A) Synaptotagmin 1 is localized to 
synaptic vesicles. It contains a short 
amino-terminal, intra-vesicular tail, a 
transmembrane domain, a linker 
region, and two calcium-binding C2 
domains on the cytoplasmic side. 
Taken from Bai and Chapman, 2004. 
(B) Depicted is the C2B domain with 
known protein-protein interaction 
motifs. Taken from Llinas et al., 
2004. 
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Figure 1-7 shows a summary of all potential binding partners of synaptotagmin 1 and their 




Synaptic vesicle cycling is spatially regulated by protein scaffolds. The SV cycle can be 
divided into two major limbs: exo- and endocytosis. These functional limbs are confined to 
distinct areas of the active zone: the core active zone, where regulated exocytosis takes place, 
and the peri-active zone, where clathrin-mediated endocytosis occurs. At the ultra-structural 
level, the core active zone is composed of an electron-dense, biochemically insoluble 
material, called the presynaptic grid, presynaptic particle web, or cytomatrix assembled at the 
active zone (CAZ). During recent years, multiple molecular components – both CAZ-specific 
ones and those that are recruited through interaction with CAZ scaffolding proteins – have 
 
Figure 1-7: Regions of synaptotagmin 1 that interact with other molecules 
Proteins and lipids that have been implicated in synaptotagmin 1 interaction: botulinum neurotoxin B 
(BoNT/B) (Nishiki et al., 1996), stoned A/B (Phillips et al., 2000; Fergestad and Broadie, 2001; Walther et 
al., 2001) [comment: there are indications that the actual interaction domain of stonin is not the C2B but 
rather the C2A domain, see this thesis work], PtdIns4-PtdIns6 (IP4-6) (Fukuda et al., 1995), β-SNAP (Schiavo 
et al., 1995), neurexins (Hata et al., 1993; Perin, 1996), syntaxin (Chapman et al., 1995; Li et al., 1995), 
SNAP-25 (Schiavo et al., 1997; Gerona et al., 2000), tubulin (Honda et al., 2002), Na+-channels (Sampo et 
al., 2000), N and P/Q-type calcium channels (Kim and Catteral, 1997; Sheng et al., 1997), Phosphatidylserine 
(PS) (Davletov and Südhof, 1993; Chapman and Jahn, 1994) (note b: C2B only binds tightly to PS-containing 
membranes in the C2AB context), PIP2 and PIP3 (Schiavo et al., 1996) (note 
a: according to Zhang et al., 
1998b, C2A binds only at high mol% PIP2), SV2 (Schivell et al., 1996), calcium-dependent oligomerization 
(Chapman et al., 1996; Damer and Creutz, 1996), calcium-independent oligomerization (Bai et al., 2000; 
Fukuda et al., 2001), calmodulin (Perin, 1996), and the Rab effector RIM (Coppola et al., 2001; Schoch et al., 
2002). Taken from Tucker and Chapman, 2002.  
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been identified and characterized. Functionally, the CAZ is thought to define the site of 
regulated neurotransmitter release. It localizes presynaptic membrane proteins including 
voltage-gated calcium channels and cell adhesion molecules, to organize steps of the SV cycle 
including tethering and priming of SVs. In addition, it links the exocytic machinery with 
elements of the endocytic zone and with the surrounding actin cytoskeleton (Figure 1-8).  
 
To date, five protein families whose members are highly enriched at active zones have been 
characterized: Munc13, the mammalian UNC-13 proteins (Brose et al., 1995) and Rab3 
interacting molecules (RIMs, Wang et al., 1997) are multi-domain proteins that interact with 
each other and with many other synaptic components. Piccolo and Bassoon (Cases-Langhoff 
et al., 1996; tom Dieck et al., 1998) are homologous, very large multi-domain scaffolding 
molecules of the CAZ. Most of their interaction partners have still to be discovered. They 
 
Figure 1-8: Molecular organization of the cytomatrix at the active zone (CAZ) 
The scheme depicts observed physical interactions between active zone-specific scaffolding proteins (black), 
associated proteins with putative structural functions (yellow), effector proteins (blue-green), actin cytoskeletal 
and associated elements (green), small modulatory molecules (gray), proteins involved in SV exocytosis (blue) 
and endocytosis (red) as well as presynaptic membrane proteins (pink). Some of the interactions for Piccolo and 
RIM were discovered in pancreatic β-cells and will have to be confirmed for the CAZ. Note, the diagram 
neither reflects the relative sizes of the proteins nor their exact topographic localization within the presynaptic 
bouton. The arrow indicates that neurexins (α-forms) are involved in the localization of calcium channels. 
Taken from Haucke and Gundelfinger.  
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both bind ELKS/CAST belonging to the ERC family of proteins (ELKS/RIM/CAST, Wang et 
al., 2002). Finally, α-liprins bind to RIMs (Schoch et al., 2002) and ERCs (Ko et al., 2003b). 
The active zone protein network is thought to be responsible for the temporal coordination of 
synaptic vesicle docking, priming, and fusion, and for the spatial restriction of these processes 
to the active zone subdomain of the presynaptic plasma membrane (Schoch and Gundelfinger, 
2006). 
Since GIT1 was identified as putative interaction partner of stonin 2 in this work, we want to 
point out that GIT proteins play a potential role in organization of the CAZ by their 
interaction with piccolo (Kim et al., 2003) and liprin-α (Ko et al., 2003a). In addition, GIT1 
has been shown to locate to the postsynaptic density, where it forms a complex with liprin-α, 
GRIP and AMPA receptors. Interfering with this complex formation leads to a selective and 
marked reduction in the dendritic and surface clustering of AMPA receptors in cultured 
neurons suggesting that the GIT1-liprin-alpha interaction is required for AMPA receptor 
targeting (Ko et al., 2003a). 
 
1.3 The Synaptic Vesicle Cycle 
The major task of a synapse is the transmission of electrical signals from a presynaptic to a 
postsynaptic cell. Most presynaptic functions involve SVs, which undergo an activity-driven 
trafficking cycle during neurotransmission in the nerve terminal. Upon action potential arrival 
calcium channels allow for calcium influx and neurotransmitter (NT) loaded vesicles fuse 
with the plasma membrane to release neurotransmitter. Upon exocytosis SV membrane is 
retrieved by endocytosis and SVs are refilled with NT to be available for a next round of 
exo/endocytosis. Accordingly to Südhof (2004) six major steps in this cycle can be defined: 
(1) NT transport into SVs, (2) joining of the SV cluster, (3) docking to the active zone, (4) SV 
priming for exocytosis, (5) calcium-triggered fusion pore opening, and (6) endocytosis of SV 
membrane (Figure 1-9), which will be discussed in chapter 1.4. A major player in this cycle 
is calcium, which finally triggers SV exocytosis and NT release. Bollmann et al. (2000) found 
that calcium concentrations between 1 and 20 µM result in NT release. The calcium 
concentration is sensed by a calcium sensor that contains 5 Ca2+ binding sites with an affinity 
of 5 to 25 µM (Bollmann et al., 2000; Schneggenburger and Neher, 2000). Synaptotagmin 1 is 
the most likely candidate for this (reviewed in Augustine, 2001; Chapman, 2002; Koh and 
Bellen, 2003; Bai and Chapman, 2004; Yoshihara and Montana, 2004).  




The exact molecular mechanisms for docking and priming of the synaptic vesicles are still 
largely unknown. Nonetheless, Munc13s and their interaction with RIMs were found to be 
essential for vesicle docking (Augustin et al., 1999; Varoqueaux et al., 2002; Andrews-
Zwilling et al., 2006). The actual fusion step is mediated by SNARE proteins (reviewed in 
(Jahn and Scheller, 2006). The neuronal SNARE complex contains synaptobrevin (also called 
vesicle-associated membrane protein VAMP) on synaptic vesicles, and syntaxin and SNAP-
25 on the presynaptic plasma membrane. The release of neurotransmitter may be achieved by 
full fusion and collapse of the synaptic vesicle membrane into the plasma membrane of the 
active zone, or opening and closing of a fusion pore, a mechanism generally referred to as 
kiss-and-run (reviewed by Galli and Haucke, 2004). However, the existence of a kiss-and-run 
mechanism is controversially discussed. After full fusion synaptic vesicle proteins and 
membranes are then retrieved at least in part by clathrin-mediated endocytosis from the peri-
active zone, an area adjacent to the active zone. Regenerated synaptic vesicles are then again 
available for docking, priming, and neurotransmitter release (Schweizer and Ryan, 2006).  
 
 
Figure 1-9: The synaptic 
vesicle cycle (by Thomas 
Südhof, 2004) 
Synaptic vesicles (SVs) are 
filled with neurotransmitter 
(NT) by an active process (step 
1) and are packed into an SV 
cluster (step 2). SVs dock to 
the active zone (step 3) and are 
primed for exocytosis (step 4). 
Upon action potential arrival 
calcium-triggered fusion pore 
opening follows (step 5) and 
SVs are recycled via different 
routes (steps 6 to 9). Steps in 
exocytosis are indicated by red 
arrows and steps in 
endocytosis and recycling by 
yellow arrows. Taken from 
Südhof, 2004. 
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1.4 Pathways of Synaptic Vesicle Endocytosis 
The pathways of synaptic vesicle endocytosis are a matter of controversial discussions. The 
idea of vesicle retrieval was put forward by Bittner and Kennedy (1970) who studied 
transmitter release at the crayfish neuromuscular junction. They estimated linear axonal 
outgrowth of 77 to 154 cm per hour during continuous stimulation at 20 Hz assuming full 
vesicle fusion without retrieval. More than 30 years ago Barker et al. (1972) suggested on the 
basis of biochemical experiments on synaptosomes that after exocytosis, vesicles undergo 
endocytosis and are refilled rapidly, while a subset of vesicles remains associated with the 
active zone and recycles locally. Early EM studies on the frog neuromuscular junction by 
Heuser and Reese (1973) showed that synaptic vesicle recycling at the peri-active zone 
coincides with the appearance of cisternae and clathrin coated pits. Ceccarelli et al. (1973) 
demonstrated at the same time that vesicles may endocytose and recycle rapidly without the 
appearance of clathrin-coated intermediates. Ever since myriads of studies have been carried 
out to dissect endocytic modes at the presynapse. Thus, two general modes of endocytosis 
have been proposed: (i) the kiss-and-run type mechanism (Fesce et al., 1994) where vesicles 
only fuse transiently with the plasma membrane forming a narrow fusion pore and are 
retrieved as intact entities from the active zone (reviewed in Jarousse and Kelly, 2001b; 
Morgan et al., 2002; Palfrey and Artalejo, 2003; Rutter and Tsuboi, 2004; Harata et al., 2006), 
and (ii) a clathrin-dependent mechanism of endocytosis operating after full fusion of SVs 
(reviewed in Cremona and De Camilli, 1997; Brodin et al., 2000; Slepnev and De Camilli, 
2000; Morgan et al., 2002; Murthy and De Camilli, 2003; Royle and Lagnado, 2003; Galli 
and Haucke, 2004; Perrais and Merrifield, 2005; Augustine et al., 2006). The two modes of 
exo/endocytosis of vesicles in neurosecretion are reviewed in depth by Harata et al. (2006). A 
number of genetic (Koenig and Ikeda, 1989; Gonzales-Gaitan and Jäckle, 1997; Zhang et al., 
1998a; Cremona et al., 1999; Di Paolo et al., 2002; Kim et al., 2002) and morphological 
studies (Shupliakov et al., 1997; Gad et al., 1998) have substantiated the participation of the 
clathrin pathway in SV retrieval, which operates after full fusion. Vesicles can either be 
retrieved directly from the plasma membrane of the peri-active zone as described by Takei et 
al. (1996), or by bulk endocytosis of large membrane infoldings in combination with clathrin-
mediated endocytosis (CME) according to the classical scheme proposed by Heuser and 
Reese (1973) (Figure 1-10).  
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Out of the commonly studied synaptic systems described in chapter 1.2, the mammalian 
central nervous system synapses of the hippocampus seem to constitute an exception due to 
their small size. While for example the retinal bipolar nerve terminal of the goldfish holds      
~ 12,000 SVs per active zone, hippocampal synapses only work with 100 to 200 vesicles per 
bouton, which only spans about 100 µm. Therefore, an efficient recycling system is essential 
in order to sustain high rates of transmitter release over longer periods of stimulation. Several 
groups have provided evidence for the full fusion mode of synaptic transmission in CNS 
synapses (Sankarananayanan and Ryan, 2000 and 2001; Li and Murthy, 2001; Zenisek et al., 
2002; Gandhi and Stevens, 2003; Richards et al., 2005). A large number of molecules have 
been identified as effectors and modulators of clathrin-dependent synaptic vesicle endocytosis 
(see chapter 1.5). By contrast, little is known about the molecular characteristics of the 
alternative kiss-and-run pathway. Kiss-and-run vesicle exocytosis has clearly been observed 
during  secretion of peptide hormones and neurotransmitters from large dense-core secretory 
granules (Tsuboi and Rutter, 2003; An and Zenisek, 2004; Rutter and Tsuboi, 2004; Tsuboi et 
al., 2004). However, secretory granules, such as dense core vesicles, differ from synaptic 
 
Figure 1-10: Modes of synaptic vesicle retrieval 
(1) The kiss-and-run mechanism of synaptic vesicle exo/endocytosis. Vesicles 
open a fusion pore only transiently and are retrieved intact from the active zone. 
(2) – (4) Fully collapsed vesicles are retrieved via clathrin-dependent endocytosis 
at the peri-active zone. Clathrin-coated vesicles are depicted in green with spikes. 
Vesicles could be retrieved directly from the plasma membrane, are refilled with 
neurotransmitter, and join the synaptic vesicle pool immediately (2), or travel 
through an endosomal compartment probably for repair (3). Bulk endocytosis of 
larger membrane infoldings in combination with clathrin-mediated endocytosis 
has also been reported (4). Taken from Harata et al., 2006.  
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vesicles with respect to size, content, and most importantly biogenesis. Whereas synaptic 
vesicles can be recycled locally at the synapse, secretory granules are generated de novo from 
the trans-Golgi network. Kiss-and-run type exocytosis allows for local recycling of vesicles 
and therefore represents a great advantage over full fusion and collapse into the plasma 
membrane for large dense-core vesicles. Due to the size of secretory cells, such as mast cells, 
adrenal chromaffin, or PC12 cells, and the properties of dense-core secretory granules, vesicle 
exo/endocytosis can be analyzed by capacitance and amperometric measurements (Wightman 
et al., 1991; Chow et al., 1992). These studies pointed at transient fusion pore openings 
without full collapse of large dense-core vesicles (Alvarez de Toledo et al., 1993; Artalejo et 
al., 1995 and 2002). Taraska et al. (2003) provided evidence for secretory vesicles retaining 
their shape after exocytosis by the use of fluorescent proteins. Experiments using anti-clathrin 
antibodies in chromaffin cells indicated that clathrin is not involved in this alternative 
pathway (Artalejo et al., 1995; Daly et al., 2000), whereas, dynamin appeared to be required 
(Holroyd et al., 2002). 
Several characteristics can be attributed to the kiss-and-run type mechanism of vesicle 
recycling: (i) the shape of the vesicle is maintained during the exo/endocytic cycle, (ii) vesicle 
content is released via a narrow fusion pore, (iii) it represents a fast mode of vesicle retrieval, 
and (iv) it is independent of the clathrin machinery. The contribution of dynamin to a kiss-
and-run type mechanism is controversially discussed.  
In neurons it has been shown, that synaptic vesicle endocytosis follows two kinetic 
components: a fast and a slow phase of vesicle retrieval (von Gersdorff and Matthews, 1994; 
Beutner et al., 2001; Sun et al., 2003; Gandhi and Stevens, 2003). It has been a long lasting 
debate whether these kinetically different endocytic modes also correspond to molecularly 
different mechanisms of synaptic vesicle retrieval (Neves and Lagnado, 1999). SV 
endocytosis in large synapses, such as the retinal bipolar terminal of the goldfish, can be 
studied by capacitance measurements. However, typical central nervous system (CNS) 
synapses are small and contain comparably few vesicles. Optical assays can be used to 
monitor endocytosis and vesicle recycling for these bouton-like synapses. For this purpose 
fluorescent probes, i.e., FM dyes, have been developed by Betz and colleagues (Cochilla et 
al., 1999). In addition, several synaptic vesicle proteins have been labeled with green 
fluorescent protein (GFP) to follow trafficking of synaptic vesicles in real time (Miesenböck 
et al., 1998; Merrifield et al., 1999; Holroyd et al., 2002; Wienisch and Klingauf, 2006). 
Generally, CNS synapses do not allow for electrical capacitance measurements (Gillespie, 
1979; Neher and Marty, 1982) with some exceptions (Hallermann et al., 2003). Presynaptic 
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imaging techniques have been reviewed by Ryan (2001). Commonly used methods to study 

























Figure 1-11: Biophysical techniques for studying exo/endocytosis in neurons 
Top: membrane capacitance measurements (Gillespie, 1979; Neher and Marty, 1982) can be used to monitor net 
surface area of the whole cell. Middle: assays of presynaptic function using FM1-43 dye are done in 3 steps 
(Cochilla et al., 1999). Action potential stimuli (1) either in presence of FM1-43 or before application by a time 
∆t (2) dye uptake by endocytosis of vesicle membrane, which follows exocytosis. The newly captured vesicle 
containing dye is then recirculated into the releasable synaptic vesicle pool and is available for discharging the 
dye during a next round of stimulation (3). The timescale of endocytosis can be determined by measuring total 
dye uptake as a function of delay time ∆t. Bottom: The synaptic vesicle protein VAMP is lumenally labeled with 
a pH-sensitive GFP (synapto-pHluorin; Miesenböck et al., 1998). pHluorin is quenched at the rather acidic pH 
(5.6) of the synaptic vesicle lumen. Exocytosis relieves the proton-dependent quenching of pHluorin 
fluorescence and causes an increase in fluorescence. The fluorescence decay reflects the time course of 
endocytosis. Taken from Ryan and Reuter, 2001. 
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Jockusch et al. (2005) approached the question regarding molecular mechanisms of SV 
endocytosis by the introduction of dominant-negative protein domains targeting the clathrin 
machinery in the retinal bipolar terminal of the goldfish. Effects on endocytosis were 
analyzed by capacitance measurements, which showed that only the slow phase of SV 
internalization was affected by CME dominant-negative domains. This argues for two 
molecularly distinct endocytic pathways in this synaptic terminal. Fast and slow vesicle 
retrieval was also observed for small central synapses of the hippocampus (Klingauf et al., 
1998; Pyle et al., 2000; Sankaranarayanan and Ryan, 2002; Gandhi and Stevens, 2003). 
However, no studies deciphering the molecular mechanisms of these kinetically different 
endocytic modes in small central synapses were published so far. In this thesis work we aimed 
at elucidating this question by inhibiting CME using dominant-interfering domains in small 
central synapses of the hippocampus. SV recycling was analyzed by optical methods using the 
optical tracers FM1-43 and synaptopHluorin.   
 
1.5 Clathrin-Mediated Endocytosis 
The idea of coated vesicles goes back to 1961 when Gray first reported a special type of 
vesicle with a central sphere surrounded by a shell of ‘closely packed layer of small vesicular 
bodies’. Similar structures found by others were for example referred to as annular or ring 
vesicles (De Robertis et al., 1963), or dense-rimmed vesicles (Brightman and Palay, 1963). 
The term ‘coated vesicles’ as we use it today was defined by Roth and Porter (1964). Soon 
these coated vesicles were related to cellular uptake of various compounds (Roth and Porter, 
1964). In addition to clathrin coated vesicles there are two other types of coated trafficking 
vesicles inside a cell, the COPI and COPII vesicles, which are important for anterograde and 
retrograde trafficking between the ER and the Golgi apparatus. There are detailed reviews 
about the different coats available by Kirchhausen (2000b) and McMahon and Mills (2004). 
Clathrin-mediated endocytosis (CME) provides a pathway for internalization of extracellular 
hormones and signaling factors, of transmembrane receptors for the purpose of nutrition and 
communicating extracellular signals to intracellular targets (Conner and Schmid, 2003; 
Kirchhausen et al., 2005; Le Roy and Wrana, 2005). In secretory cells, such as neurons or 
neuroendocrine cells, CME is used to recycle vesicle membrane after full collapse into the 
plasma membrane (see chapter 1.4).  
Moreover, activity-dependent trafficking of postsynaptic receptors during long-term 
depression (LTD) is mediated by CME. In general, the molecular machinery required for 
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compensatory endocytosis appears to be very similar to that used for constitutive and ligand-
stimulated endocytosis (reviewed in Cremona and De Camilli, 1997; Brodin et al., 2000; 
Slepnev and De Camilli, 2000; Galli and Haucke, 2004; Morgan et al., 2002; Murthy and De 
Camilli, 2003; Royle and Lagnado, 2003; Perrais and Merrifield, 2005; Augustine et al., 
2006). The process of CME can be divided into several steps: 1) coat nucleation and 
assembly, 2) coated pit maturation, 3) fission, and 4) uncoating (Figure 1-12). These events 
are coordinated by a dynamic network of protein-protein as well as protein-lipid interactions 
of coat and cytosolic proteins. 
 
The process of CME is accomplished by a spatially and temporally regulated interplay of a 
plethora of proteins, which can be divided into (i) the coat proteins clathrin and the classical 
heterotetrameric clathrin adaptors (AP proteins), (ii) alternative adaptors or clathrin associated 
sorting proteins (CLASPs), and (iii) accessory proteins. Coat assembly starts with the 
recruitment and oligomerization of the heterotetrameric adaptor complex AP-2, and is 
followed by the recruitment of clathrin. Three clathrin heavy and three light chains form 
stable oligomeric complexes, the three-legged triskelia, which are the unit elements of the 
clathrin lattice (Smith & Pearse, 1999; Kirchhausen, 2000a). During the initial stages of 
coated pit formation, clathrin and the AP-2 adaptor complex interact with a variety of 
 
Figure 1-12: Sequential stages in clathrin-mediated endocytosis at the presynaptic terminal 
Top: electron micrographs of clathrin-coated pit intermediates trapped at different stages by experimental 
manipulations in the lamprey reticulospinal synapse. Bottom: schematic representation of the endocytosis stages. 
a) microinjection of antibodies against endophilin followed by stimulation. b, c) microinjection of the SH3 
domain of amphiphysin (b) or peptide PP15, which corresponds to its cognate binding site in dynamin (c) 
followed by stimulation. d) microinjection of the SH3 domain of endophilin followed by stimulation. e, f) 
dynamin-coated tubules induced by the incubation of broken synaptosomes with cytosol and GTPγS. g) 
microinjection of the peptide PP-19, which blocks SH3-mediated interactions of endophilin. Figure taken from 
Slepnev & De Camilli, 2000. 
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accessory proteins (see chapter 1.5.6) that themselves are not an intrinsic part of the coat. 
These include dynamin, endophilin, amphiphysin, synaptojanin, eps15, syndapin, intersectin, 
auxilin, and hsc70 (reviewed in Slepnev & De Camilli, 2000). These accessory proteins assist 




The protein forming the lattice-like vesicle coat was first purified from pig brain and named 
clathrin by Pearse (1975, 1976). A clathrin coat is a three-dimensional array of triskelia made 
of three clathrin heavy chains (190 kDa) and three clathrin light chains (25-29 kDa). The first 
three-dimensional reconstruction of a clathrin coat was achieved by the group of Pearse 
(Vigers et al., 1986). Combined protein crystallography (ter Haar et al., 1998) and cryo-
electronmicroscopy (Fotin et al., 2004) provided high-resolution images of clathrin cages 









Figure 1-13: The architecture 
of clathrin 
(A) Clathrin barrel with a single 
triskelia highlighted in blue. (B) 
An 8 Ǻ reconstruction of a 
clathrin barrel with the light 
chains highlighted in yellow. (C) 
Schematic representation of a 
clathrin triseklion, which 
highlights the various domains 
using different colors (see the 
box). The clathrin-heavy-chain-
repeat (CHCR) modules that are 
involved in each domain are 
listed. (D) Single clathrin heavy 
chain molecule colored as in (C). 
Figure modified from Edeling et 
al., 2006.  
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The clathrin heavy chain comprises five functionally distinct regions: the globular amino-
terminal domain (β-propeller), a relatively curved region termed the knee, which divides the 
polypeptide into a distal and a proximal leg, and a carboxy-terminal end (hub) that mediates 
trimerization (see Figure 1-13). Adaptors and accessory proteins interact with the clathrin 
heavy chain β-propeller via peptide-in-groove interactions (ter Haar et al., 2000): the clathrin-
box motif LΦLΦ[DE] (Φ: bulky hydrophobic residue, such as leucine, isoleucine, 
methionine, phenylalanine, valine) first identified by Dell’Angelica et al. (1998), a variant 
clathrin box or DLL motif [SD]LL (Morgan et al., 2000), and a ‘type II clathrin box’ (Drake 
and Traub, 2001) also termed the W-box motif PWDLW (Miele et al., 2004).  
The function of the clathrin light chain is not well understood so far. It is assumed to 
modulate clathrin assembly. In addition, it has been shown to bind to Huntingtin-interacting 
protein 1 (HIP1) and HIP1-related protein (HIP1R) (Chen and Brodsky, 2005; Legendre-
Guillemin et al., 2005). Clathrin lattices are found at the plasma membrane, the trans Golgi 
network, and some endosomes (Bonifacino and Lippincott-Schwartz, 2003). The formation of 
clathrin coated vesicles is reviewed in Kirchhausen (2000a,b), Brodsky et al. (2001), Mousavi 
et al. (2004), and Conner and Schmid (2003). A typical lattice at the plasma membrane of 






Figure 1-14:  Deep-etch view of a typical clathrin lattice found on the 
inside of a tissue cultured cell 
Taken from Heuser et al., 1987 
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1.5.5 Adaptors 
Since clathrin does not bind to lipid bilayers or cargo proteins itself, clathrin coated vesicle 
formation requires the participation of adaptor proteins linking clathrin with membranes and 
cargo. At least 20 clathrin adaptors have been identified all sharing a common design 
principle (reviewed in Owen et al., 2004; Robinson, 2004; Sorkin, 2004). They are composed 
of structurally compact folded domains with which they bind to proteins or phospholipids, 
and rather unstructured linkers used to bind to the β-propeller region of the clathrin heavy 
chain or to other adaptors. Adaptors involved in clathrin-mediated endocytosis from the 
plasma membrane include, the classical heterotetrameric AP-2 complex (Ahle and 
Ungewickell, 1989), autosomal recessive hypercholesterolemia (ARH) protein (Mishra et al., 
2002b), β-arrestins 1 and 2 (Goodman et al., 1996), AP180/clathrin assembly lymphoid 
myeloid leukemia protein (CALM) (Murphy et al., 1991; Morris et al., 1993), disabled (Dab2) 
(Mishra et al., 2002a), epsins 1, 2, and 3 (Chen et al., 1998; Drake et al., 2000), the 
Huntingtin-interacting proteins (HIP) and HIP1-related protein (HIP1R) (Legendre-Guillemin 
et al., 2002), and sorting nexin 9 (Snx9) (Lundmark and Carlsson, 2003). A schematic 
overview of the endocytic adaptor interaction web is depicted in Figure 1-17. 
 
1.5.5.1 AP-2 
The first adaptor proteins, AP-1, AP-2, and AP180, were identified almost 30 years ago. They 
were referred to as ‘assembly polypeptides’ (APs) because they promoted the assembly of 
purified clathrin into lattices in vitro (Keen et al., 1979; Ahle and Ungewickell, 1986). To 
date, two more clathrin adaptor complexes, AP-3 (Dell’Angelica et al., 1997; Panek et al., 
1997, Simpson et al., 1997) and AP-4 (Dell’Angelica et al., 1999, Hirst et al., 1999) have 
been identified. The neuronal adaptor protein AP180 and its ubiquitous isoform CALM are 
monomeric proteins binding clathrin (Ye and Lafer, 1995; Tebar et al., 1999), AP-2, eps15, 
and PIP2-containing membranes via short peptide motifs or their amino-terminal ANTH 
domain, respectively (ANTH: AP180 N-terminal homology) (Ford et al., 2001). AP-2 is the 
predominant clathrin adaptor at the plasma membrane and mediates most clathrin-mediated 
endocytosis processes. The related AP-1, AP-3 and AP-4 have been shown to localize to 
endosomes and the TGN (Robinson and Bonifacino, 2001; Peden et al., 2004). Since this 
thesis work focuses on endocytosis, I would like to dedicate this section to AP-2. AP-2 is a 
heterotetrameric protein composed of α-adaptin (100 – 110 kD), β2-adaptin (105 kD), a µ2 
chain (50 kD), and a small subunit σ2 (17 kD), which together form a core and two 
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appendages or ears (Collins et al., 2002) (Figure 1-15). It is part of the clathrin coat, serves to 
link clathrin to the plasma membrane, to sort cargo proteins, and to orchestrate alternate 
adaptors and accessory factors. Membrane recruitment may involve interactions with 
phosphoinositides, which can bind to α-adaptin (Gaidarov & Keen, 1999), µ2 (Collins et al., 
2002; Rohde et al., 2002), and with cargo membrane proteins including synaptotagmin 
(Zhang et al. 1994; Haucke & De Camilli, 1999).  
 
 
AP-2 recognizes short peptide motifs contained in the cytoplasmic portion of cargo proteins. 
YxxΦ motifs (Φ: bulky hydrophobic amino acid; x: any amino acid), for instance found in the 
 
Figure 1-15: Schematic representation of the clathrin adaptor complex AP-2 
AP-2 is a heterotetrameric protein complex consisting of two large subunits (α, β2), a medium 
subunit (µ2), and a small subunit (σ2). The complex can be divided into the core complex, a hinge 
region, and the appendage or ear domains of the large subunits. The appendage domains are 
homologous and form a so called platform and a sandwich subdomain. The ear domains and core 
structures were solved by X-ray crystallography. The flexible linkers joining the appendages to the 
trunk domains have been modeled in an extended conformation. Modified from Owen, 2004. 
24  Introduction 
 
transferrin, epidermal growth factor, or neonatal Fc receptors (Wernick et al., 2005), are 
recognized by the carboxy-terminal part of the µ2 subunit (Owen and Evans, 1998). Another 
tyrosine-based sorting signal, located to the cytoplasmic side of the LDL receptor, FxNPxY 
has been shown to bind to µ2 in vitro (Boll et al., 2002), although interactions with the 
specialized sorting adaptors ARH and Dab2 may predominate in vivo. The two types of 
tyrosine-based motifs seem to bind to different sites on the µ2-subunit (Warren et al., 1998; 
Boll et al., 2002). Additional cargo recognition motifs recognized by AP-2 are the acidic 
cluster dileucine motifs with the consensus sequence [DE]xxxL[IL] (Letourneur and 
Klausner, 1992). The exact binding site is unclear, however, there are indications for binding 
sites in the β2-trunk domain (Rapoport et al., 1998), the µ2-subunit (Rodionov et al., 1998), 
the α/σ2 hemicomplex (Janvier et al., 2003), or the β2-appendage domain of AP-2 (Schmidt et 
al., 2006). µ2-adaptin also harbors a structurally unresolved binding site for basic 
internalization motifs in a variety of membrane proteins including postsynaptic AMPA (α-
amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) and GABAA (γ-aminobutyric acid 
type A) receptors, the α1B-adrenergic receptor (Diviani et al., 2003), and members of the 
synaptotagmin family (Chapman et al., 1998; Haucke et al., 2000; Grass et al., 2004). Sorting 
Signals for trafficking between the plasma membrane, endosomes, and lysosomes are 
reviewed in detail in Bonifacino and Traub (2003) and Traub (2005). Cargo recognition 
signals are summarized in Table 1-1. 






















In addition to cargo proteins AP-2 interacts with a variety of clathrin adaptor and accessory 
proteins. Such interactions are mainly mediated via the α- and β-ear domains and short 
peptide motifs in the accessory proteins. The appendage domains are homologous in structure 
and consist of a platform and a sandwich subdomain (Figure 1-15). ARH and β-arrestins bind 
via an α-helical [DE]nX1–2FXX[FL]XXXR motif to the β-appendage platform domain 
(Edeling et al., 2006). Single or tandemly arrayed combinations of DP[FW] (Brett et al., 
2002; Owen et al., 1999), FXDXF (Brett et al., 2002), or WXX[FW]X[DE] (Jha et al., 2004; 
Ritter et al., 2003; Walther et al., 2004) interaction motifs are found in various accessory 
proteins, and each of these motifs binds to the α-appendage. DP[FW] and FXDXF motifs bind 
to the platform domain, WXX[FW]X[DE] to the sandwich domain of the α-appendage 
domain as depicted in Figure 1-16 (Mishra et al., 2004). Binding of short peptide motifs to 
the appendage domains is reviewed in detail by Traub (2005) and Edeling et al. (2006).  
 
Table 1-1: Clathrin-dependent sorting signals (Taken 
from Traub, 2005) 
 
a:  consensus sequence given in single 
letter amino acid code according to the 
PROSITE syntax 
b     UIM: ubiquitin interaction motif 
c     ENaC: epithelial sodium channel 
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1.5.5.2 Alternative Adaptors 
Tyrosine-based and dileucine motifs have been identified in several signaling receptors. In a 
number of studies the interaction of signaling receptors with AP-2 was reported (Sorkin et al., 
1996; Yao et al., 2002; Diviani et al., 2003; Wu et al., 2003). However, mutational analysis 
revealed that neither these motifs nor AP interactions played an important role in the CME of 
some of these receptors. In addition, RNAi experiments showed that silencing clathrin indeed 
eliminated uptake of EGF and LDL receptor, however, knock down of AP-2 did not. This 
prompted the search for additional adaptor proteins distinct from AP-2. Such connector 
proteins that promote the selective trafficking of a specific category of cargo were named as 
clathrin-associated sorting proteins (CLASPs) by Traub (2005). CLASPs include not only 
endocytic sorting proteins but also adaptors that mediate sorting at Golgi or endosomal 
membranes (reviewed in Traub, 2005). In this work we will concentrate on endocytic 
CLASPs, which include the following proteins (according to Traub, 2005): AP180/CALM, 
ARH, β-arrestins, Disabled-2 (Dab2), eps15, epsin, HIP1/HIP1R, numb, and stonin 2. Except 
for eps15, numb, and stonin 2 all CLASPs bind to both clathrin and AP-2, and all of them 
exhibit interactions with AP-2. Figure 1-17 presents a schematic overview of the endocytic 
adaptor interaction web. β-arrestins have been shown to couple G protein-coupled receptors 
(GPCRs) to the clathrin endocytic machinery (Claing et al., 2002; Santini et al., 2002; 
 
Figure 1-16: Peptide motif binding sites in the α-appendage domain 
DPF/DPW (PDB accession file 1KYF) as well as FXDXF motifs (PDB accession file 1KY7) bind to the 
platform domain. The WxxF motif interacts with the sandwich domain of the α-ear (PDB accession file 1W80). 
Taken from Edeling et al., 2006. [*: the Kd between the synaptojanin WVxF motif and the sandwich domain 
was measured to be 0.7 µM by Praefcke et al., 2004] 
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reviewed in Marchese et al., 2003; and Lefkowitz and Whalen, 2004). This is achieved by the 
ability of β-arrestins to bind to phosphorylated GPCRs, PIP2 (Gaidarov et al., 1999), and to 
both clathrin and AP-2. ARH, Dab2, and numb belong to a family of phosphotyrosine-
binding (PTB) domain containing proteins. The PTB domain binds to PIP2 and to non-
phosphorylated FXNPXY motifs (Dho et al., 1999; Santolini et al., 2000; Morris and Cooper, 
2001; Mishra et al., 2002a,b) found in LDL receptor family members.  
 
 
Epsin, AP180/CALM, and HIP1/HIP1R can be assigned to one group since these proteins 
carry amino-terminal PIP2 binding sites, the ENTH/ANTH domain (Ford et al., 2001; 
Legendre-Guillemin et al., 2004). The assignment of specific cargo molecules to this group is 
unclear. Nonetheless, HIP1 seems to be involved in AMPA receptor endosomal trafficking, 
since neurons from HIP1-/- mice are defective in AMPA receptor endocytosis (Metzler et al., 
2003). Furthermore, there are indications that AP180 is involved in SNARE sorting in C. 
elegans (Nonet et al., 1999). Epsin, just like eps15, is involved in the recognition of ubiquitin-
 
Figure 1-17: The endocytic adaptor interaction web 
Schematic representation of the protein-protein interactions possible between clathrin, AP-2, and alternate 
adaptors. Sorting signals or putative cargo types recognized by the different adaptors are boxed in black. 
Phosphoinositide(4,5)bisphosphate binding sites are indicated by the spherical grey attachments. AP-2 is 
modeled on the known molecular architecture of the core and appendages, but the different proteins are not to 
scale. pGPCR: phosphorylated G protein-coupled receptor; AMPA-R: α-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid receptor. Taken from Traub, 2003. 
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based sorting signals by a protein domain termed the ubiquitin-interacting motif (UIM) 
(Hofmann and Falquet, 2001). The coupling of monoubiquitin to lysine side chains of protein 
cargo can serve as transport signal to multivesicular bodies and for lysosomal degradation (for 
reviews see Bonifacino and Traub, 2003; Hicke and Dunn, 2003). Proteins that are 
endocytosed upon monoubiquitination are for instance the EGF receptor, Delta, Notch, or the 
epithelial sodium channel ENaC (Wendland, 2002; Hicke and Dunn, 2003).  
 
1.5.5.3 Stonin 2 
Stonin 2 can be regarded as an alternative endocytic adaptor, because it specifically mediates 
clathrin/AP-2-dependent endocytosis of synaptotagmin 1 (Diril et al., 2006). Since a major 
part of this thesis work was dedicated to unravel stonin 2 function and interaction with 
synaptotagmin 1, we would like to provide some more detailed information on this alternative 
adaptor. Stoned proteins were first identified in Drosophila melanogaster. The Drosophila 
stoned locus encodes for a dicistronic mRNA of 8.4 kb from which two distinct proteins are 
translated: stoned A and stoned B (Andrews et al., 1996). It was identified by a screen for 
temperature-sensitive mutants that were paralyzed at the non-permissive temperature 
(Grigliatti et al., 1973). Most of the mutant alleles were embryonically lethal suggesting an 
essential role for the locus, but two viable mutants were identified: stnts1 and stnts2. In a 
separate screen by Homyk and colleagues (Homyk, 1977; Homyk and Sheppard, 1977) a third 
behavioral mutant, stnc, was identified. These viable stoned mutants showed severe 
neurological defects (Kelly, 1983). Spontaneous neurotransmitter release was enhanced 
whereas evoked release was erratic and impaired in mutant flies (Stimson et al., 1998; 
Fergestad et al., 1999). Electron microscopy revealed a depletion of synaptic vesicles and an 
accumulation of membrane-recycling intermediates such as multivesicular bodies (MVBs) at 
the synapse (Fergestad et al., 1999). Furthermore the synaptic vesicle protein synaptotagmin 
was found to be mislocalized and degraded (Fergestad et al., 1999). Other synaptic vesicle 
proteins like synaptobrevin and cysteine string protein were less affected (Fergestad et al., 
1999). FM1-43 dye uptake experiments revealed a decreased rate of plasma membrane 
endocytosis (Fergestad and Broadie, 2001). The phenotypes of stoned mutants are in part very 
similar to those observed for mutants in the synaptotagmin gene and implicate an important 
role for the stoned locus in the synaptic vesicle cycle. Stoned B contains a carboxy-terminal 
region with high homology to the medium subunit µ2 of the adapter complex AP-2 (Andrews 
et al., 1996). Stoned B shows also homology with unc-41 (Fergestad et al., 1999), a gene 
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identified in Caenorhabditis elegans that has been postulated to play a role in synaptic vesicle 
recycling (Cremona and De Camilli, 1997). The amino-terminal domain harbors seven NPF 
motifs, which might be recognized and bound by endocytic proteins with EH domains like 
eps15, eps15R (Benmerah et al., 1996; Salcini et al., 1997) and intersectin (Fergestad et al., 
1999). The Drosophila stoned proteins are specifically expressed in the presynaptic terminal 
of neuromuscular junctions from early stages of synaptogenesis (Fergestad et al., 1999). They 
co-localize with AP-2, dynamin, and cysteine string protein (Fergestad and Broadie, 2001). 
Both, stoned A and stoned B, are able to bind to synaptotagmin, stoned A through its amino-
terminal 250 residues, stoned B through its µ-homology domain (Stimson et al., 1998; 
Phillips et al., 2000) and might have a specific role in localizing synaptotagmin to the 
synaptic terminal by direct protein-protein interactions. It is therefore likely that some of the 
reported phenotypes of stoned mutants are caused by the loss of synaptotagmin from 
presynaptic boutons. This conclusion is supported by the fact that overexpression of 
transgenic synaptotagmin 1 can rescue the embryonic lethality of stoned mutants in the hands 
of Fergestad and Broadie (2001). Considering the accumulation of MVBs in stoned mutants 
Fergestad and colleagues (1999) hypothesized that stoned proteins may normally function at a 
choice point segregating recycled synaptotagmin into maturing synaptic vesicles and away 
from the MVB degradative pathway. 
Two orthologs of stoned B, termed stonin 1 and stonin 2 have been described in humans and 
in mice (Martina et al., 2001; Walther et al., 2001), however, no orthologs exist in 
Saccharomyces cerevisiae. Stoned A has no homology to any other known protein, although 
it contains five DPF motifs that could potentially interact with the α-adaptin subunit of AP-2. 
Martina et al. (2001) found that stonin 2, but not stonin 1, interacts directly with the eps15-
homology domains of eps15, eps15R, and intersectin 1 via two NPF motifs located in the 
amino-terminal proline-rich region. Stonin 2 is a brain-specific protein which co-enriches 
with other endocytic proteins such as AP-2 in a crude synaptic vesicle fraction, within CCVs, 
and at nerve terminals (Walther et al., 2001). Like the Drosophila stoned B gene product 
stonin 2 contains a µ-homology domain and interacts directly with AP-2 and synaptotagmin 1 
(Walther et al., 2001). The direct AP-2 interaction is mediated via three WVxF motifs located 
to the amino-terminus of stonin 2 (Walther et al. 2004). Stonin 2 co-localizes with 
synaptotagmin in synaptic vesicle clusters in cultured hippocampal neurons and its µ-
homology domain is required for its translocation to the plasmalemma by synaptotagmin 
(Walther et al., 2004). Altogether, stonin 2 has been implicated in clathrin-mediated 
endocytosis of the synaptic vesicle protein synaptotagmin 1 in fibroblasts as well as in 
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cultured hippocampal neurons (Diril et al., 2006). However its precise mode of interaction 
with synaptotagmin and the molecular determinants involved have remained elusive. 
 
1.5.6 Accessory Proteins 
Apart from adaptor proteins that take care of specific cargo selection several more proteins 
are associated with clathrin coats and are involved in spatial and temporal regulation of 
membrane deformation, clathrin coat assembly and disassembly. These proteins are generally 
termed ‘clathrin accessory proteins’ and include regulatory enzymes, such as small and large 
GTPases (Arf proteins, dynamin), lipid and protein modifying kinases (phosphatidylinositol 
4-phosphate 5-kinase PIPKIγ, adaptor associated kinase AAK, cycline G associated kinase 
GAK), phosphatases (synaptojanin, calcineurin), proteins that allow for membrane bending 
and recruitment of other adaptor or accessory proteins (amphiphysin, endophilin, epsin), 
proteins that provide a link to the actin cytoskeleton (eps15, syndapin, ankyrin), and proteins 
involved in vesicle scission (dynamin), and uncoating (auxilin, synaptojanin, hsc70) (for 
reviews see Slepnev and De Camilli (2000), Lafer (2002), Conner and Schmid (2003), and 
McMahon and Mills (2004)). The molecules that make the largest numbers of contacts within 
this clathrin protein interaction web are clathrin, AP-2, and PIP2. The crucial lynchpin seems 
to be AP-2, which may serve to coordinate the steps from cargo recruitment and assembly all 
the way to uncoating (Owen et al., 1999). Many accessory proteins have the ability to bind to 
PIP2, probably to concentrate all factors at the membrane (Cremona et al., 1999; Haucke 
2005). Many of the interactions in the web are regulated by protein (Cousin et al., 2001; 
Cousin and Robinson, 2001) and lipid (Cremona and De Camilli, 2001; Haucke et al., 2005) 
phosphorylation and dephosphorylation. Accessory factors can be conceptually organized into 
four classes: (1) cargo selection, coat initiation and maturation, (2) coupling to the actin 
cytoskeleton, (3) coated vesicle scission, and (4) uncoating (according to Lafer, 2002). The 
temporal order of accessory protein action during CME is depicted in Figure 1-18. 
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Cargo selection is mainly achieved by classical and alternative clathrin adaptors as described 
in the previous chapters. Coat initiation is a process that is not entirely understood, however 
lipids, especially phosphoinositides, seem to play a major role in this process. Endocytic 
proteins such as AP-2 (Gaidarov and Keen, 1999; Rohde et al., 2002), AP180/CALM, epsin 
(Ford et al., 2002), Dab2, and HIP1/1R, as well as dynamin (Vallis et al., 1999) bind directly 
to PIP2. Domains that interact with inositol lipids are reviewed in Balla (2005), and Le Roy 
and Wrana (2005), general membrane binding domains in Hurley (2006). The interaction 
between AP-2 and PIP2 is essential for recognition of sorting signals (Höning et al., 2005) and 
stable association with the plasma membrane. PIP2 is generated by phosphatidylinositol 4-
phosphate 5-kinases type I (PIPKI) (Doughman et al., 2003). Three PIPKI isoforms (α, β, γ) 
exist in mammals, of which PIPKIγ is most highly expressed in neurons (Wenk et al., 2001). 
PIPKI is activated by the small GTPase ADP ribosylation factor 6 (Arf6) (Aikawa and 
Martin, 2003; Krauss et al., 2003), which is also implicated in recruiting AP-2 to endocytic 
sites (Paleotti et al., 2005). Altogether, initiation of coated pit formation is crucially dependent 
on PIP2 and enzymes involved in the generation thereof (reviewed in Haucke, 2005). Coated 
pit maturation involves bending of membranes. Several mechanisms have been proposed for 
membrane deformation: (1) changes in lipid composition, (2) influence of integral membrane 
 
Figure 1-18: Temporally and spatially regulated interactions of clathrin accessory proteins 
The time lines shown are approximate and serve to illustrate the temporal relationships between the dynamic 
interactions governing CME. Neither the exact hierarchy of these protein interactions nor their exact role in 
CME is understood. Several accessory proteins involved in endocytosis, including amphiphysin, endophilin, 
epsin and dynamin, can induce membrane curvature by asymmetrically inserting a portion of their mass into 
the outer lipid monolayer (see insets), and might function both early and late in CCV formation. PIPK-γ, 
phosphatidylinositol-4-phosphate 5-kinase gamma; HSC70, heat shock cognate 70. Taken from Conner and 
Schmidt, 2003.  
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proteins that have intrinsic curvature or have curvature upon oligomerization, (3) changes in 
cytoskeletal polymerization and pulling of tubules by motor proteins, (4) direct and indirect 
scaffolding of the bilayer, or (5) active amphipathic helix insertion into one leaflet of the 
bilayer (reviewed in McMahon and Gallop, 2005; Zimmerberg and Kozlov, 2006). While the 
actual vesicle shape might be stabilized by the clathrin coat (Hinrichsen et al., 2006), clathrin 
action is aided by the insertion of amphipathic helices of accessory proteins into one leaflet of 
the lipid bilayer. Proteins considered to accomplish this task are BAR domain containing 
proteins, such as amphiphysin and endophilin (Gallop and McMahon, 2005; Itoh and De 
Camilli, 2006; Ren et al., 2006), and ENTH/ANTH domain containing proteins such as epsin, 
HIP1/1R, or AP180/CALM (Ford et al., 2002; Legendre-Guillemin et al., 2004; Itoh and De 
Camilli, 2006). It has been shown recently that endophilin lacks a lysophosphatidic acid acyl 
transferase activity (Gallop et al., 2005), which was suggested by Schmidt and co-workers 
(1999). Eps15 seems to be an important factor not only for cargo recognition by its UIM, but 
also for coated pit maturation, since it is found associated with the growing edges of clathrin 
coated pits (Tebar et al., 1996). In addition, it might provide a link to the actin cytoskeleton, 
since yeast eps15 binds to and activates the arp2/3 complex which nucleates actin 
polymerization (Duncan et al., 2001; Toshima et al., 2005). Linking CME to actin 
polymerization plays an important role probably during later steps of endocytosis such as 
vesicle scission and motility (reviewed in Kaksonen et al., 2006). In addition to eps15, 
ankyrin might serve this function since it is part of the actin machinery and binds to clathrin 
(Michaely et al., 1999). Furthermore the F-BAR family of proteins including syndapins 
(Kessels and Qualmann, 2004), and dynamin (Ochoa et al., 2000; Schafer, 2004; Itoh et al., 
2005) have been suggested to connect the clathrin machinery to the actin cytoskeleton. 
Dynamin, a large GTPase, is the crucial factor in vesicle scission not only for clathrin-
mediated endocytosis but also for most other membrane budding events (Praefcke and 
McMahon, 2004). It functions as a mechano-enzyme that constricts the vesicle neck by 
twisting upon GTP hydrolysis probably in combination with a mechanism that produces 
membrane tension (Roux et al., 2006). Intersectin, amphiphysin, and endophilin are 
implicated in dynamin recruitment and are supposed to be important co-factors in dynamin 
function (Rappoport et al., 2004). After scission vesicles are rapidly uncoated to be able to 
fuse with target membranes. Proteins associated with vesicle uncoating are auxilin (Morgan 
et al., 2001; Newmyer et al., 2003; Augustine et al., 2006; Massol et al., 2006), the 
phosphoinositide 5-phosphatase synaptojanin (Verstreken et al., 2003), and the uncoating 
ATPase hsc70 (de Waegh et al., 1989; Morgan et al.2001; Newmyer et al., 2003).  
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Accessory proteins interact with each other, AP-2, and clathrin essentially as described above. 
Short linear peptide motifs bind to protein domains, for instance the DPW/F motif to the 
platform domain of AP-2 α-ear (Brett et al., 2002; McPherson and Ritter, 2005). Common 
protein-protein interaction modules in the clathrin-dependent endocytic machinery include the 
AP-2α- and β-ear interactions described above, the clathrin box motifs with the terminal 
domain β-propeller of the clathrin heavy chain, src homology 3 (SH3) with proline-rich 
domains (PRD), and NPF motifs with eps15-homology (EH) domains. In addition, protein – 
lipid interactions are generally carried out by BAR and ENTH/ANTH domains. These types 
of interactions and the fact that AP-2, clathrin, PIP2, and accessory proteins are involved in a 
complex interaction network account for modular structures of accessory proteins, which is 
depicted for a selection of accessory proteins in Figure 1-19. Table 1-2 summarizes the 
clathrin assembly protein – protein interaction motifs.  
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  Table 1-2: Comparison of the clathrin assembly protein – protein interaction motifs (Taken from Traub, 
2005) 
 









Figure 1-19: Domain structure of clathrin accessory factors at the synapse 
AP, adaptor protein; CALM, clathrin assembly lymphoid myeloid leukemia protein; CC, coiled coil; Dbl, 
Disabled; DPF, Asp-Pro-Phe; DPW, Asp-Pro-Trp; EH, EPS15 homology; EHSH, EH domain and SH3-domain-
containing protein; ENTH, epsin amino-terminal homology; EPS, epidermal growth factor receptor pathway 
substrate; ESE, EH domain and SH3 domain regulator of endocytosis; GED, GTPase-enhancing domain; J, DNAJ 
domain; NPF, Asp-Pro-Phe motifs; PH, pleckstrin homology domain; PRD, proline-rich domains; Sac1, 
suppressor of actin 1; SH3, Src homology 3; SH3P4, SH3-domain-containing protein 4). Taken from Slepnev and 
De Camilli, 2000. 
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2 Aims of the Studies 
The major aims of this work were (1) to study the role of clathrin/AP-2- and dynamin-
mediated endocytosis in hippocampal neurons in vivo, (2) to molecularly dissect the 
interaction of the AP-2 binding sorting adaptor stonin 2 with the synaptic vesicle membrane 
protein synaptotagmin 1, and (3) to identify novel stonin 2 interaction partners. 
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3 Materials and Methods 
3.1 Materials 
3.1.4 Chemicals and Consumables 
Chemicals were purchased from the following companies: BioRad (Munich), GE Healthcare 
(Munich), GibcoBRL (Eggenstein), Merck (Darmstadt), Molecular Probes (Leiden, The 
Netherlands), Pierce (Perbio, Bonn), Roth (Karlsruhe), Serva (Heidelberg), and Sigma 
(Deisenhofen). 
Consumables were obtained from Amersham (Braunschweig), Greiner (Solingen), Millipore 
(Eschborn), Sarstedt (Nümbrecht), Schott (Mainz), Whatman (Maidstone, England). 
 
3.1.5 Enzymes and Reaction Kits 
Restriction enzymes, T4 DNA Polymerase, VENT polymerase, calf intestinal phosphatase 
(CIP) and Klenow-fragment were purchased from New England Biolabs (NEB, Schwalbach). 
We obtained T4 DNA ligase from Roche (Mannheim), and Taq Polymerase from Genaxxon 
BioScience (Biberach). We used the Wizard Plus SV miniprep Kit from Promega 
(Mannheim) for miniscale plasmid preparation. Larger quantities and higher purity plasmid 
preparation was performed with the Plasmid midi prep kit from Qiagen (Hilden). The 
E.Z.N.A Cycle pure and gel extraction kit from PeqLab (Erlangen) was used to purify DNA 
from polymerase chain reactions, restriction enzyme digests, or from agarose gels. For gel 
extraction we used alternatively the QIAEXII gel extraction Kit from Qiagen. For protein 




Antibodies were purchased from Affinity Bioreagents (Dianova, Hamburg), BD Biosciences 
(Heidelberg), BD Transduction Laboratories (TDL, Heidelberg), Berkeley Antibody 
Company (BAbCo, Covance Research Products CRP, Denver, PA, USA), Dianova 
(Hamburg), Molecular Probes (MoBiTec, Göttingen), Santa Cruz (Heidelberg), Sigma 
(Deisenhofen), and Synaptic Systems (Göttingen). For immunoblotting (IB), 
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immunofluorescence (IF), immunoprecipitation (IP) and antibody internalization assays (AI) 
the following antibodies have been used: 
 
Primary antibodies 
 AP-2α:  mouse monoclonal antibody (clone AP6), purified from hybridomas (4 
mg/ml), IF 1:100 
 
 AP-2α: mouse monoclonal antibody (TDL), IB 1:500 
 AP-2β2:  mouse monoclonal antibody (BD Biosciences), IB 1:1000 
 AP-2µ2: mouse monoclonal antibody (BD Biosciences), IB 1:400 
 CD4: mouse monoclonal antibody clone Q4120 (Sigma), AI 
 CD8:  mouse monoclonal antibody clone UCHT4 (Sigma) 
 CD25: mouse monoclonal antibody (kind gift from the Robert Koch Institut, Berlin) 
 
 CHC:  mouse monoclonal antibody clone X22 (Affinity Bioreagents), IF 1:500 
 CHC: mouse monoclonal antibody clone TD1 was kindly provided by Pietro De 
Camilli (Yale University, New Haven, USA), IB 1:10 (hybridoma culture 
supernatant) 
 
 Dynamin: the polyclonal anti-dynamin 1 antibody DG1 was a generous gift from P. De 
Camilli (Yale University, New Haven, USA), IB  
 
 Eps15: mouse monoclonal antibody (BD Biosciences), IB 1:200 
 FLAG-tag: mouse monoclonal antibody clone M2 (Sigma), AI/IB/IF 1:1000, IP 
 FLAG-tag:  rabbit polyclonal antibody (Sigma): AI/IF 1:100 
 HA-tag: rabbit polyclonal antibody (Y11, Santa Cruz), IB 1:500, IF 1:100 
 HA-tag: mouse monoclonal antibody (F7, Santa Cruz), IF 1:100 
 HA-tag: mouse monoclonal antibody (HA11, BAbCo), IB 1:1000, IF 1:1000, IP 
 Hsc70: mouse monoclonal antibody (Affinity Bioreagents), IB 1:1000 
 Intersectin: rabbit polyclonal antibody kindly provided by Peter McPherson (McGill 
University, Montreal, Kanada) 
 
 c-myc-tag: mouse monoclonal antibody purified from hybridoma clone, IP 
 Stonin 2: rabbit polyclonal anti-serum (2324.3), self made, IB 1:100, IF 1:500, IP  
 Syt1: mouse monoclonal antibody clone 41.1 (Synaptic Systems), IB 1:4000, IF 
1:1000 
 
 Syt1:  rabbit polyclonal antibody (89.07) raised against the lumenal domain of 
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Secondary antibodies for immunoblotting were either horseradish peroxidase (HRP)- or 
alkaline phosphatase (AP)-labeled. We used Alexa dye- or Cy5-conjugated secondary 
antibodies for immunofluorescence staining. Unlabeled antibodies were used for blocking 
surface staining in antibody internalization assays and for signal amplification in Western 
blots using iodinated protein A.  
 
Enzyme-conjugated, fluorescence-labeled antibodies and unlabeled antibodies 
 GαMHRP: polyclonal HRP-conjugated goat anti-mouse serum (Dianova), IB 1:5000 
 GαRHRP: polyclonal HRP-conjugated goat anti-rabbit serum (Dianova), IB 1:5000 
 GαMAP: polyclonal AP-conjugated goat anti-mouse serum (Dianova), IB 1:5000 
 GαRAP: polyclonal AP-conjugated goat anti-rabbit serum (Dianova), IB 1:5000 
 GαM350: Alexa FluorTM350 goat anti-mouse IgG (Molecular Probes), IF 1:50 
 GαM488: Alexa FluorTM488 goat anti-mouse IgG (Molecular Probes), IF 1:200 
 GαM594: Alexa FluorTM594 goat anti-mouse IgG (Molecular Probes), IF 1:200 
 GαR488: Alexa FluorTM488 goat anti-rabbit IgG (Molecular Probes), IF 1:200 
 GαR594: Alexa FluorTM594 goat anti-rabbit IgG (Molecular Probes), IF 1:200 
 GαRCy5: Cy5-conjugated goat anti-rabbit IgG (Molecular Probes), IF 1:50 
 GαM:  goat anti-mouse serum, blocking 1:5 
 GαR: goat anti-rabbit serum, blocking 1:5 
 RαM: rabbit anti-mouse serum, IB 1:2000 
 
3.1.7 Synthetic Oligonucleotides 
Synthetic oligonucleotides for polymerase chain reactions, oligo annealing, or RNA 
interference (RNAi) were purchased from MWG Biotech (Martinsried). A list of primers used 
for amplification and modification of DNA as well as sequencing can be found in the 
appendix (A).  
 
3.1.8 Synthetic Peptides 
Synthetic peptides derived from synaptotagmin were used in binding competition 
experiments. In this work we used the rat synaptotagmin (NCBI accession number: 
XM_343205) C2B domain basic stretch sequence 320GKRLKKKKTTIKK332 and the human 
stonin 2 sequence comprising the putative synaptotagmin 1 binding site 
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781TAKYEHAFNSIVWRINR797. As control we used a synaptophysin-derived peptide. All 
peptides were aminated at the carboxy-terminus. Synthetic peptides were purchased from Dr. 
Henklein (Institute for Biochemistry, Charité, Berlin). 
 
3.1.9 Plasmids 
We used a number of commercially available plasmids for bacterial, yeast, insect, and 
mammalian expression. In addition, some plasmids containing tag sequences for mammalian 
and yeast expression were custom made.  
 
pET28: The vector is designed for bacterial expression of amino- and carboxy-terminally 
His6-tagged fusion proteins and was purchased from Novagen (Darmstadt). Usage 
of appropriate restriction sites allows for fusion of an additional T7-tag. The 
amino-terminal His6-tag can be cleaved by thrombin. The vector harbors a 
kanamycin resistance.  
 
pGEX: Vectors of the pGEX series (GE Healthcare, Munich), allow the bacterial 
expression of glutathione-S-transferase (GST) fusion proteins. Depending on the 
choice of the vector a number of proteases can be used to remove the GST-tag 
(4T: thrombin, 5X: Factor Xa, 6P: Prescission). The vector harbors an ampicillin 
resistance.  
 
pMalc2x:  This vector was designed by New England Biolabs (NEB, Schwalbach) for the 
expression of maltose-binding protein (MBP)-fusion proteins. It contains an 
ampicillin resistance. The MBP-tag can be removed by Factor Xa cleavage.  
 
pcDNA3:  The vector was provided by Invitrogen and is used for expression of proteins from 
a CMV promoter in mammalian cells. It includes a T7 promoter site that can be 
used for bacterial in vitro transcription/translation systems. The vector harbors a 
neomycin and an ampicillin resistance. 
 
pEGFP:  This vector belongs to the ‘living color’ series of vectors from BD Biosciences 
(Clontech, ), which allow for the expression of enhanced green fluorescence 
protein (EGFP)-fusion proteins in mammalian cells. N-type vectors generate an 
EGFP fusion at the carboxy-terminal end of the protein. C-type vectors fuse EGFP 
to the amino-terminus. The vector contains a kanamycin resistance 
 
pGADT7: This vector expresses proteins fused to the amino acids 768-881 of the GAL4 
activation domain. In yeast fusion proteins are expressed at high levels from the 
constitutive ADH1 promoter. The fusion protein is targeted to the yeast nucleus by 
the SV40 nuclear localization signal. It contains a T7 promoter and a 
hemagglutinin (HA)-tag. It replicates autonomously in E.coli and S.cerevisiae. The 
vector carries ampicillin resistance for selection in E.coli and the LEU2 nutritional 
marker for selection in yeast. The vector was purchased with the Matchmaker 
Yeast-2-Hybrid Screening system from BD Biosciences (Clontech, Heidelberg). 
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pGBKT7: The pGBKT7 vector expresses proteins fused to amino acids 1–147 of the GAL4 
DNA binding domain (DNA-BD). In yeast, fusion proteins are expressed at high 
levels from the constitutive ADH1 promoter (PADH1); transcription is terminated 
by the T7 and ADH1 transcription termination signals (TT7 & ADH1). pGBKT7 
also contains the T7 promoter, a c-Myc epitope tag, and a MCS. pGBKT7 rep-
licates autonomously in both E.coli and S. cerevisiae from the pUC and 2 µ ori, 
respectively. The vector carries the Kanr for selection in E.coli and the TRP1 
nutritional marker for selection in yeast (BD Biosciences, Clontech, Heidelberg). 
 
pcHA2:  This vector was generated by Yasuo Nemoto (Yale University, New Haven, USA) 
to allow for expression of hemagglutinin (HA)-tagged proteins in mammalian 
cells. The HA-tag sequence (ATG GCG TAC GAC GTC CCA GAC TAC GCG 
 MAYPYDVPDYA) was cloned into the Kpn1 and BamH1 restriction sites of 
the pcDNA3 vector. In addition, the multiple cloning site from BamH1 to Xho1 of 
the pBluescript IISK+ vector was inserted. The vector harbors an ampicillin 
resistance for selection in E.coli and a neomycin resistance for generation of stable 
cell line.  
 
pcFLAG:  This vector was generated as described for the pcHA2 vector, but instead of the 
HA-tag a FLAG-tag (ATG GAC TAC AAG GAC GAC GAT GAC AAG  
MDYKDDDDK) was inserted into the Kpn1 and BamH1 restriction sites of the 
pcDNA3 vector.  
 
pSFV1: This vector was designed by Life Technologies (Karlsruhe) for the heterologous 
protein expression in mammalian cells using the Semliki Forest Virus (SFV). The 
pSFV1 vector was constructed from a full-length clone of SFV with a deletion in 
the coding region for the viral structural proteins. The multiple cloning site 
contains a BamHI – SmaI – XmaI polylinker cassette. The helper plasmid pSFV-
Helper2 is needed for the packaging of  recombinant SFV viral particles in BHK-
21 cells. 
 
pETM30: This vector was kindly provided by the EMBL protein expression and purification 
facility (Heidelberg) and was designed to allow for bacterial expression of His6-
GST-tagged fusion proteins. It harbors a kanamycin resistance.  
 
pET43.1: This vector was designed for high level expression of proteins fused with the 491 
amino acid NusA.TagTM protein. It can be purchased from Novagen (Darmstadt). 
The vector harbors an ampicillin resistance.  
 
pThioHis: This vector can be purchased from Invitrogen (Karlsruhe) and was designed for 
the bacterial expression of hardly soluble fusion proteins. It allows for expression 
of a His6-tagged thioredoxin fusion protein. The selection in E.coli is mediated via 
an ampicillin resistance.  
 
pcDNA5/FRT/TO:  
 This vector is a doxycycline-inducible expression vector designed for use with the 
Flp-InTM T-Rex System available from Invitrogen (Karlsruhe). When co-
transfected with the pOG44 Flp recombinase expression plasmid into a Flp-InTM 
T-RExTM mammalian host cell line, the pcDNA5/FRT/TO vector containing the 
gene of interest is integrated in a Flp recombinase-dependent manner into the 
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genome. The vector contains a hygromycin resistance gene for selection of stable 
cell lines and an ampicillin resistance for selection in E.coli. 
  
pFPMT121: 
 This vector was kindly provided by Sven Krappmann (Universität Göttingen) and 
was designed for heterologous protein expression in the methylotrophic yeast 
Hansenula polymorpha. For secretion of the gene of interest the S.cerevisiae 
mating factor α pre/pro-signal sequence was cloned into the vector. Additionally, 
we cloned a His6-tag downstream of the Mfα-sequence for convenient purification. 
Ampicillin resistance is used as bacterial selection marker, URA3 as nutritional 
marker for yeast.  
 
pBI-Tet: This vector is a response plasmid that can be used to express two genes of interest 
from one bidirectional tet-responsive promoter in Clontech’s Tet-OnTM and Tet-
OffTM gene expression systems and cell lines. This system was first described by 
Gossen & Bujard (1992) and Gossen et al. (1995). We used this vector in 
combination with a plasmid expressing the synthetic rtTA-M2 gene (pUHrT 62-1) 
generated by Udo Baron and Maz Hasan, kindly provided by Tanja 
Wucherpfennig (Max-Planck-Institut für biophysikalische Chemie, Göttingen). 
The pBI-Tet vector harbors an ampicillin resistance.  
 
 
3.1.9.1 Amphiphysin Constructs 
We aimed at inhibiting clathrin-mediated endocytosis by overexpression of dominant-
negative amphiphysin domains. We chose to use the amphiphysin B/C domain (amino acids 
250 – 578 of rat amphiphysin 1, NCBI accession number NM_022217) containing a clathrin 
/AP-2 – binding site (CLAP) to target clathrin and its adaptor protein AP-2. For targeting 
dynamin we have chosen the SH3 domain (amino acids 545 – 695 of human amphiphysin 1, 
NCBI accession number U07616). Mutants of both domains served as negative controls (B/C 




Figure 3-1: Schematic 
representation of dominant-
negative amphiphysin constructs 
 
 
Amphiphysin protein fragments were cloned into pcHA2 and into the Semliki Forest virus 
vector pSFV1 carrying an internal ribosomal entry site with ECFP cDNA downstream of the 
amphiphysin sequence allowing for bicistronic expression of HA-tagged dominant negative 
domains and ECFP as transfection marker. Semliki Forest Virus particles were generated and 
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kindly provided by Ralf Nehring and Dirk Reuter, Department for membrane biophysics, 
Max-Planck-Institute for Biophysical Chemistry, Göttingen. 
 
3.1.9.2 Stonin Constructs 
We used mouse stonin 1 and human stonin 2 (Figure 3-2) to generate stonin constructs.  
 





Figure 3-2: Schematic representation of the domain structure and binding motifs in stonin 2 
The WVxF motifs interact with the α-appendage of AP-2, NPF motifs with intersectin and eps15; 
there is no known function for the stonin homology domain (SHD), and the µ-homology domain 
(µHD) is known to interact with synaptotagmin. 
 
Figure 3-3: Amino acid sequence of human stonin 2 
WVxF motifs are high lighted in red, NPF motifs in turquoise, the SHD in blue and the 
µHD in green. The KYE motif is given in italics and underlined, the loop region is 
underlined. 
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First we generated stonin 1 and 2 constructs for yeast-2-hybrid screening (Figure 3-4) as full-
length, amino-terminal, and carboxy-terminal fragments. cDNA fragments were cloned into 
the pGBKT7 vector allowing for myc-tagged expression of a GAL4 DNA-binding domain 
fusion protein.  
 
For the purpose of protein production in E.coli several human stonin 2 constructs were 
generated (Table 3-1). 
 
Table 3-1: Stonin 2 constructs generated with the purpose of protein production in E.coli 
Constructs marked with * were generated by Kristin Walter, ** by Jasmin Podufall, and *** by M. Kasim Diril 
construct vector Stonin 2 fragment (amino 
acids) 
pGEX-HsStn2,NT-1* pGEX4T 1-555  
pGEX-HsStn2,NT-2 pGEX4T 1-414 (WVxF  AVxF) 
pGEX-HsStn2,NT-3 pGEX4T 1-309 (WVxF  AVxF) 
 
 
Figure 3-4: Overview over stonin yeast-2-hybrid screening constructs  
Several stonin 1 and 2 fragments have been chosen to be cloned into pGBKT7 for the purpose of yeast-2-
hybrid screening. Numbers indicate amino acid residues.   
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pGEX-HsStn2,NPF pGEX4T 308-351 
pGEX-HsStn2,NPF+ pGEX4T 308-414 
pGEX-HsStn2,NT-4** pGEX4T 110-414 
pGEX-HsStn2,NT-5** pGEX4T 186-414 




pGEX-HsStn2,µHD pGEX4T 563-874 
pGEX-HsStn2,SHD-µHD pGEX4T 414-874 
pGEX-HsStn2,CT* pGEX4T 557-898 
pGEX-HsStn2,CT-1 pGEX4T 445-898 
pGEX-HsStn2,CT-2 pGEX4T 448-898 
pGEX-HsStn2,CT-3 pGEX4T 453-898 
pGEX-HsStn2,CT-4 pGEX4T 7  -898 
pGEX-HsStn2,CT-5 pGEX4T 7  -898 
pGEX-HsStn2,CT-6 pGEX4T 7  -898 
pMal-HsStn2,CT-1 pMal-c2x 445-898 
pMal-HsStn2,CT-2 pMal-c2x 448-898 
pMal-HsStn2,CT-3 pMal-c2x 453-898 
pThio-HsStn2,CT-1 pThio-His6 445-898 
pThio-HsStn2,CT-2 pThio-His6 448-898 
pThio-HsStn2,CT-3 pThio-His6 453-898 
pETM30-HsStn2,CT-1 pETM30 445-898 
pETM30-HsStn2,CT-2 pETM30 448-898 
pETM30-HsStn2,CT-3 pETM30 453-898 
pET43-HsStn2,CT-1 pET43.1 445-898 
pET43-HsStn2,CT-2 pET43.1 448-898 
pET43-HsStn2,CT-3 pET43.1 453-898 
pGEX-Stn2,KYEpep pGEX4T 770-799 
pGEX-SHD,µHD pGEX4T 416-874 
 
Several stonin 2 mutants were generated and cloned into the pcHA2 vector for mammalian 
expression (Table 3-2). 
 
Table 3-2: pcHA2-Stonin 2 constructs 
Constructs marked with * were generated by M. Kasim Diril 
Construct Mutation Amino acids 




stonin 2 (δNPF) NPF313-315NAV,  
NPF329-331NAV  
1-898 
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stonin 2 (δKYE) KYE783-785AAA 1-898 







stonin 2 (YF) Y784F 1-898 
stonin 2 (YA) Y784A 1-898 
stonin 2 (YR) Y784E 1-898 
stonin 2 (F788E) F788E 1-898 
stonin 2 (DID) RIN794-796DID 1-898 
stonin 2 (∆loop)* ∆736-765 1-735,766-898 
stonin 2 (S695A) S695A 1-898 
stonin 2 (E702A) E702A 1-898 
stonin 2 (DE) DE820,822AA 1-898 
stonin 2 (EDE) EDE702,820,822AAA 1-898 
 
3.1.9.3 Synaptotagmin Constructs 
Synaptotagmin 1 is localized to synaptic vesicles, possesses a short lumenal tail at its amino-
terminal end and two cytoplasmically exposed calcium binding C2 domains in the cytosolic 












Figure 3-5: Schematic representation of rat synaptotagmin 1 
(A) synaptotagmin 1 is located to synaptic vesicles. It possesses a short lumenal, amino-terminal domain, and a 
cytosolic part that contains two calcium binding C2 domains, C2A and C2B. TMD: transmembrane domain. 
(B) Amino acid sequence of rat synaptotagmin 1 (NCBI accession number: XM_343205). Sequence marked in 
blue corresponds to the TMD, red to the C2A, green to the C2B domain. We highlighted basic residues that 
potentially participate in stonin 2 binding. Underlined residues represent putative WxxL protein-protein 
interaction motifs.  
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The following synaptotagmin 1 constructs have been generated with the purpose of 
heterologous gene expression in E.coli and expression in mammalian cells for co-
immunoprecipitation, synaptotagmin endocytosis, and membrane recruitment studies (Table 
3-3).  
 
Table 3-3: Synaptotagmin constructs 
The construct marked with * was generated by Anand Radakrishnan, Max-Planck-Institute for Biophysical 
Chemistry, Göttingen. Mutations in the C2A domain are marked in red, those in the C2B in green. Mutations in 
the putative WxxL protein-protein interaction motifs are underlined. Charge reversal mutations are marked in 
blue. 
construct mutations amino acids vector 
pGEX-C2A  140-265 pGEX4T 
pET28-C2A  140-265 pET28 
pGEX-C2B  271-421 pGEX4T 
pET28-C2B  271-421 pGEX4T 
pET28-C2AB(97)*  97-421 pET28 
pET28-C2AB  140-421 pET28 
pGEX-C2AB  140-421 pGEX 
pGEX-C2Am1 KK189,190AA 140-265 pGEX4T 
pGEX-C2Am2 KK191,192AA 140-265 pGEX4T 
pGEX-C2Am3 K189-192A 140-265 pGEX4T 
pGEX-C2Am4 W259A (WRDLARDL) 140-265 pGEX4T 
pGEX-C2Bm1 KK326,327AA 271-421 pGEX4T 
pGEX-C2Bm2 K324-327A 271-421 pGEX4T 
pGEX-C2Bm3 KR321,322AA; K324-327A 271-421 pGEX4T 
pGEX-C2Bm4 KR321,322AA; K324-327A; K313A 271-421 pGEX4T 
pGEX-C2Bm5 W404A (WHTLAHTL) 271-421 pGEX4T 
pGEX-C2ABm1 KR321,322AA; K324-327A 140-421 pGEX4T 
pGEX-C2ABm2 K189-192A 140-421 pGEX4T 
pGEX-C2ABm3 KK189,190AA; KR321,322AA; 
K324-327A 
140-421 pGEX4T 
pGEX-C2ABm4 K189-192A; KR321,322AA; K324-
327A 
140-421 pGEX4T 
pGEX-C2ABm5 K189-192A; KK326,327AA 140-421 pGEX4T 
pGEX-C2ABm6 K189-192A; K324-327A 140-421 pGEX4T 
pGEX-C2Apept.  187-199 pGEX4T 
pGEX-C2Apept.m3 K189-192A 187-199 pGEX4T 
pGEX-C2Bpept.  320-332 pGEX4T 
pGEX-C2Bpept.m3 KR321,322AA; K324-327A 320-332 pGEX4T 
pcFLAG-FL  1-421 pcFLAG 
pcFLAG-∆C2B  1-265 pcFLAG 
pcFLAG-∆C2A  1-139,271-421 pcFLAG 
pcFLAG-∆C2AB  1-139 pcFLAG 
pcFLAG-∆C2Bm1 KK189,190AA 1-265 pcFLAG 
pcFLAG-∆C2Bm2 KK191,192AA 1-265 pcFLAG 
pcFLAG-∆C2Bm3 K189-192A 1-265 pcFLAG 
pcFLAG-∆C2Bm4 K191H, K213E, K244S 1-265 pcFLAG 
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pcFLAG-∆C2Bm5 K189-192A, K213E, K244S 1-265 pcFLAG 
pcFLAG-∆C2Bm6 W259A (WRDL  ARDL) 1-265 pcFLAG 
pcFLAG-∆C2Bm7 K189-192A, W259A (WRDL  
ARDL) 
1-265 pcFLAG 
pcFLAG-∆C2Bm3E K189-192E 1-265 pcFLAG 
pcFLAG-∆C2Bm5E K189-192E, K213E, K244E 1-265 pcFLAG 
pcFLAG-FLm1 KR321,322AA; K324-327A 1-421 pcFLAG 
pcFLAG-FLm2 K189-192A 1-421 pcFLAG 















K191H, K213E, K244S   
pcFLAG-FLm7 
 
K191H, K213E, K244S; 
KR321,322AA; K324-327A; K313A 
1-421 pcFLAG 
pcFLAG-FLm8 K189-192A, K213E, K244S 1-421 pcFLAG 
pcFLAG-FLm9 K189-192A, K213E, K244S; 
KR321,322AA; K324-327A; K313A 
1-421 pcFLAG 
pcFLAG-FLm1E KR321,322EE; K324-327E 1-421 pcFLAG 
pcFLAG-FLm8E K189-192E, K213E, K244E 1-421 pcFLAG 
pcFLAG-FLm9E K189-192E, K213E, K244E; 
KR321,322EE; K324-327E; K313E? 
1-421 pcFLAG 
pcFLAG-FLm10 W404A (WHTLAHTL) 1-421 pcFLAG 
 
3.1.10 Media, Buffers, and Solutions 
Commonly used media, buffers, and solutions were prepared according to (Sambrook et al., 
1996). We used deionized water supplied by a Millipore apparatus and autoclaved solutions if 
necessary (121°C/20 min/1 bar). Thermolabile components were filter-sterilized (0.22 µm) 
and added after autoclaving. The pH was adjusted using HCl or NaOH if not stated 
differently.  
 
Ampicillin stock solution  
  50 mg/ml sterile filtered     
  stored at -20°C 
 
10 x Blotting buffer 
  480 mM Tris 
  390 mM Glycine 
  1% SDS 
 
Blotto 
  4% non-fat dry milk in TBS 
2 x Bradford reagent 
  70 mg Coomassie (G250) 
  100 ml 85% phosphoric acid 
  10% (v/v) ethanol 
  in 500 ml ddH2O 
  filtered  
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Chloramphenicol stock solution 
  34 mg/ml in ethanol 
  sterile filtered 
  stored at -20°C 
Coomassie staining solution for SDS 
PAGE 
  0.1% (w/v) Coomassie (G250) 
  10% (v/v) acetic acid 
  25% (v/v) methanol 
  filtered 
 
Destaining solution for SDS PAGE 
(Coomassie) 
  10% (v/v) acetic acid 
  25% (v/v) methanol 
EDTA stock solution 
  0.5 M in ddH2O 
  adjust pH to 8.0 to dissolve EDTA 
 
Ethidium bromide stock solution 
  10 mg/ml in ddH2O 
Fixative 
  4% (w/v) para-formaldehyde 
  4% (w/v) sucrose 
  in 120 mM sodium phosphate buffer pH   
7.4 
 
Goat serum dilution buffer 
  30% goat serum  
  in high salt PBS + Triton X-100 
High Salt PBS 
  20 mM sodium phosphate buffer pH 7.4 
  500 mM sodium chloride 
  +/- 0.3% (w/v) Triton X-100 
 
 
Homogenization buffer (rat brain 
extract) 
  320 mM sucrose 
  4 mM HEPES pH 7.4 
 
 
Kanamycin stock solution 
  10 mg/ml in ddH2O 
  sterile filtered and stored at -20°C 
 
Luria-Bertani broth (LB medium) 
  1% (w/v) tryptone 
  0.5% (w/v) yeast extract 
  0.5% (w/v) sodium chloride 
  (supplemented with 1.4% agar  
  for agar  plates) 
  adjusted to pH 7.2 
 
6 x Loading dye for DNA  
  0.25% (w/v) bromphenol blue 
  0.25% (w/v) xylene cyanol 
  30% glycerol 
10 x PBS 
  1.37 M sodium chloride 
  0.027 M potassium chloride 
  0.043 M Na2HPO4 
  0.014 M NaH2PO4 
  pH 7.4 
 
PMSF stock solution 
  100 mM in DMSO 
 
Ponceau S staining 
  0.2% (w/v) Ponceau S 
  1% (v/v) acetic acid 
 
5 x pull down buffer 
  500 mM potassium chloride 
  10 mM magnesium chloride 
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6 x SDS PAGE sample buffer 
  375 mM Tris pH 6.8 
  60% (v/v) glycerol 
  30% (v/v) 2-mercaptoethanol 
  18% (w/v) SDS 
  heat and stir 
  add bromphenol blue 
   
4 x SDS PAGE stacking buffer 
  0.4% (w/v) SDS 
  0.5 M Tris pH 6.8 
4 x SDS PAGE separating buffer 
  0.4% (w/v) SDS 
  1.5 M Tris pH 8.8 
10 x SDS PAGE running buffer 
  30 g Tris pH 8.8 
  144 g glycine 
  10 g SDS 
   adjust to 1L with ddH2O 
 
SOB medium 
  2% (w/v) tryptone 
  0.5% (w/v) yeast extract 
  0.06% (w/v) sodium chloride 
  0.05% (w/v) potassium chloride 
Sodium phosphate buffers (1 M each) 
pH  Na2HPO4 (ml) NaH2PO4 (ml) 
6.0  12.0  88.0 
6.4  25.5  74.5 
6.8  46.3  53.7 
7.0  57.7  42.3 
7.2  68.4  31.6 
7.4  77.4  22.6 
7.6  84.5  15.5 
7.8  89.6  10.4 
         
10 x TBE (Tris-Borate-EDTA) 
  108 g Tris base  
  55 g boric acid 
  9.3 g Na4EDTA 
   
10 x TBS (Tris buffered saline) 
  200 mM Tris pH 7.6 
  1.4 M NaCl 
10 x TE (Tris-EDTA) 
  0.1 M Tris pH 7.5 
  10 mM EDTA 
  
2 x YT medium 
  1.6% (v/w) tryptone 
  1% (w/v) yeast extract 
  0.5% (w/v) sodium chloride 
 
 
3.1.11 Bacterial and Yeast Strains 
The E.coli strain TOP10 from Invitrogen (Karlsruhe) was used for transformation of ligations 
and for amplification and preparation of plasmid DNA (genotype of TOP10: F- mcrA ∆(mrr-
hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 araD139 galU galK ∆(ara-leu)7697 rpsL 
(StrR) endA1 nupG). We used the BL21(DE3)pLysS strain from Invitrogen and the ER2566 
from NEB (Schwalbach) strains for recombinant protein expression in E.coli (genotype 
BL21(DE3)pLysS: F- ompT hsdSB (rB-, mB-) gal dcm (DE3) pLysS (CamR); genotype 
ER2566: F- lamda- fhuA2 [lon] ompT lacZ:: T7 gene1 gal sulA11 D(mcrC-mrr)114::IS10 
R(mcr-73::miniTn10--TetS)2 R(zgb-210::Tn10) (TetS) endA1 [dcm]). This E.coli strains lack 
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both the lon protease and the ompT outer membrane protease which can degrade protein 
during purification (Grodberg and Dunn, 1988). pLysS, a plasmid carrying a chloramphenicol 
resistance, encodes for T7 lysozyme, which suppresses basal expression of recombinant genes 
by inhibiting basal levels of T7 RNA polymerase. BL21(DE3) and ER2566 carry an 
Isopropyl-β-thio-1-D-galactopyranoside (IPTG) inducible gene for the T7 polymerase in their 
genome allowing the inducible expression of genes driven by a T7 promoter. For generation 
of bacmids for recombinant protein expression using the Baculovirus system we used the 
MAX Efficiency® DH10BacTM E.coli strain from Invitrogen (genotype: F- mcrA ∆(mrr-
hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 endA1 recA1 ∆(ara, leu)7697 araD139 galU galK, 
nupG rpsL λ-).  
 
The yeast species Saccharomyces cerevisiae was used in the yeast-2-hybrid screens. Strains 
AH109 (genotype: MATa, trp 1-901, leu2-3, 112, ura3-52, his3-200, gal4∆, gal80∆, 
LYS2::GAL1UAS-GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-
MEL1TATA-LacZ MEL1), and Y187 (MATα, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 
112, gal4∆, gal80∆, met-, URA3::GAL1UAS-GAL1TATA-LacZ MEL1) were used in the 
BD MatchmakerTM system from BD Biosciences Clontech (Heidelberg). Transformation 
markers for both strains are trp1 and leu2. Reporters are HIS3, ADE2, MEL1, and lacZ for 
AH109, and MEL1 and lacZ for Y187. Both strains are Ade-, His-, Leu-, and Trp- and cannot 
grow on minimal media lacking these nutrients. AH109 and Y187 are mating compatible.  
 
For heterologous gene expression in yeast we chose to use the methylotrophic yeast 
Hansenula polymorpha (synonym: Pichia angusta). Methylotrophs, which also include 
Pichia pastoris, can grow on methanol as a sole carbon and energy source. We used the 
uracil-auxotrophic mutant strain RB11, which is an odc1 (= ura3, coding for orotidine-5’-
phosphate pyrophosphorylase) derivative of the particular H. polymorpha isolate CBS4732 
(synonymous to ATCC34438, NRRL-Y-5445, CCY38-22-2). CBS4732 was isolated from 
soil in Brazil (De Morais and Maia, 1959). Merckelbach et al. (1993) cloned and sequenced 
the URA3 gene, which is now used as transformation marker. Detailed information about 
Hansenula polymorpha and its applications can be found in ‘Hansenula polymorpha: Biology 
and Applications (edited by Gellison, 2002) 
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3.1.12 Devices and Equipment 
Autoclaves  Systec model V-65     Systec, Wettenberg 
  tuttnauer Systec model 5075 ELV    Systec, Wettenberg 
 
Centrifuges  Beckman J2-21     Beckman Coulter, Krefeld 
      Rotors:   JA-10, JA-17 
  Beckman Avanti J-26XP    Beckman Coulter, Krefeld 
      Rotors: JS-5.3, JA-25.50 
 Heraeus Biofuge pico    ThermoElectron, Langenselbold 
  Heraeus Biofuge fresco    ThermoElectron, Langenselbold 
  Hareaus multifuge 3 L-R    ThermoElectron, Langenselbold 
  Eppendorf model 5417-R    Eppendorf, Hamburg 
  Eppendorf model 5702R    Eppendorf, Hamburg 
  Sorvall RC 5C Plus     ThermoElectron, Langenselbold 
      Rotors: SA-600, GSA 
  Ultracentrifuge optima TLX   Beckman Coulter, Krefeld 
      Rotors: TLA100.2, TLA100.3,  
     TLA110 
 
Electroporator  Multiporator     Eppendorf, Hamburg 
 
Fluorometer  GENios      Tecan, Männedorf, Switzerland 
 
Gel dryer  model 583     BioRad, Munich 
 
Incubators  for microbiological organisms   Memmert, Schwabach 
  Heraeus for tissue culture    ThermoElectron, Langenselbold 
 
Laminar flow  Heraeus HERAguard (horizontal)   ThermoElectron, Langenselbold 
  Heraeus HERAsafe    ThermoElectron, Langenselbold 
 
Magnetic stirrer  RCT basic     IKA-Werke, Staufen 
 
Micropipettes  P2, P10, P20, P200, P1000   Gilson, Bad Camberg 
 
Microscopes  Axiovert 200M Fluorescence   Carl Zeiss, Göttingen  
  microscope 
  Objectives:  
    Plan NEOFLUAR 10x/0.3 
    Plan NEOFLUAR 20x/0.50 
    Plan NEOFLUAR 40x/1.3 oil 
    Plan APOCHROMAT 63x/1.4 oil 
  Binocular microscope B061   Olympus, Hamburg 
  Inverted light microscope Wilovert S  Helmut Hund GmbH, Wetzlar 
    Objectives:  SPL Ph20/0.35-LD 
     A Ph10/0.25; A4/0.10 
 
pH meter  SevenEasy (electrode InLab 410)   Mettler-Toledo, Giessen 
 
Phosphoimager  Cyclone Autoradiography    PerkinElmer,Rodgau-Jügesheim 
  System (Packard Biosciences) 
 
Photometer  Biophotometer     Eppendorf, Hamburg 
 
Power supply   Standard Power Pack P25    Whatman Biometra, Göttingen 
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Semi-dry blotter  Fastblot B44     Whatman Biometra, Göttingen 
 
Shaker  model 3005     GFL, Burgwedel 
 
Shaking incubators  TH30       Edmund Bühler, Hechingen 
innova 44      New Brunswick Scientific,  
          Nürtingen 
  Laboshake     Gerhardt, Königswinter 
 
Sonification  Microtip System Sonoplus   Bandelin, Berlin 
  Ultrasonic bath Sonorex    Bandelin, Berlin 
 
Thermocycler  T3      Whatman Biometra, Göttingen 
 
Thermomixer  Thermomixer 5437    Eppendorf, Hamburg 
 
UV table   photographic documentation system  Herolab, Wiesloch 
 
Vortex, Mixer  type Reax 1     Heidolph, Schwabach 
 




3.1.13 Commonly used Software and World Wide Web Interfaces 
Adobe 6.0 Professional  Adobe Systems, San Jose, CA, USA 
Adobe Photoshop 7.0.1  Adobe Systems 
BLAST (Basic local alignment 
search tool) 





Software for multiple sequence 
alignments 
 
 EMBL-EBI, European Bioinformatics Institute 
available on www.ebi.ac.uk/clutalw/ 
CN3D 4.1 
Software for analysis of biological 
macromolecular structures 
 
 available on 
www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.sh
tml 
ExPASy Proteomics Server (Expert 
Protein Analysis System) 
 
 Swiss Institute of Bioinformatics (SIB) 
www.expasy.org 
GraphPad PRISM®  GraphPad Software, San Diego, CA, USA 
Microsoft Office Applications  Microsoft, Unterschleißheim 
NCBI Homepage 
database for DNA, proteins, 
literature, etc  
 
 National Center for Biotechnology Information 
(NCBI) Web Site  
www.ncbi.nlm.nih.gov 
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PDB (Protein Data Bank) 
3D structures of biological 
macromolecules 
 




DNA analysis software  
 
 AcaClone Software 
available on www.acaclone.com 
PubMed 
is a service of the US National 
Library of Medicine that includes 
over 16 million citations from 





Slidebook 4.0.8 Digital Microscopy 
Software 
 
 Intelligent Imaging Innovations (Göttingen) 
 
3.2 Molecular Biology Methods 
General molecular biology methods were performed according to the protocols by Sambrook 
et al. (1996). 
 
3.2.4 Isolation of Plasmid DNA from E.coli 
The Wizard Plus SV miniprep Kit from Promega (Mannheim) was used according to 
manufacturer’s instructions for obtaining plasmids suitable for sequencing. Plasmid DNA of 
higher quality, for instance for transfection of mammalian cells, was obtained by applying the 
midiprep kit from Quiagen (Hilden).  
We used a rapid plasmid purification protocol (Birnboim, 1983) for screening plasmid 
constructs after ligation by restriction enzyme digestion (see chapter 3.2.6). 2 ml E.coli 
overnight culture in LB medium supplemented with appropriate antibiotics were harvested by 
centrifugation and resuspended in 150 µl resuspension buffer (50 mM Tris pH 8.0, 10 mM 
EDTA, 10 µg/ml RNase A). After addition of 150 µl lysis buffer (200 mM NaOH, 1% SDS) 
the suspension was gently mixed and incubated for 5 min at RT. Then we added 150 µl ice-
cold neutralization buffer (3.0 M potassium acetate pH 5.5) and centrifuged at top speed in an 
Eppendorf table top cooling centrifuge for 10 min at 4°C. The supernatant was precipitated 
with 800 µl ice-cold isopropanol. Precipitated nucleic acids were harvested by centrifugation 
as mentioned above. The pellet was washed with 500 µl 70% ethanol and air dried before 
resuspension in 25 µl ultra-pure water.  
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3.2.5 Isolation of Plasmid DNA from Yeast 
The isolation of plasmid DNA from yeast was essentially performed according to the Yeast 
Protocols Handbook (PT3024-1) from BD Biosciences Clontech (modified from Ling et al., 
1995). Fresh yeast colonies (2 to 4 day old) were used to inoculate 0.5 ml of appropriate 
medium (see chapter 3.3.4.2) and incubated in a shaking incubator (230-250 rpm) at 30°C 
overnight. Cells were harvested by centrifugation in an Eppendorf table top centrifuge at 
maximum speed (14,000 rpm) for 5 minutes. Supernatant was discarded and yeast cells 
resuspended in residual liquid (~ 50 µl). 10 µl lyticase from Arthrobacter luteus (Sigma, 
Deisenhofen) were added and the cell suspension was vigorously mixed by vortexing and 
pipetting up and down. After incubation at 37°C and 200 to 250 rpm for 30 to 60 minutes 10 
µl of 20% SDS were added to each tube and samples were mixed vigorously. To ensure 
complete lysis of the cells the samples were put through a freeze/thaw cycle (-20°C) and 
vortexed. The volume was brought up to 200 µl with TE buffer (pH 7.0) and 200 µl of 
phenol:chloroform:isoamylalcohol (25:24:1) were added. Samples were vortexed at highest 
speed for 5 minutes and centrifuged at maximum speed (14,000 rpm) for 10 min. The aqueous 
(upper) phase was transferred to a fresh tube. 8 µl of 10 M ammonium acetate and 500 µl 95-
100% ethanol were added before placing the samples at -70°C for 1 hour. After centrifugation 
at 14,000 rpm for 10 min the supernatant was discarded, the pellet was dried and resuspended 
in 20 µl of ddH2O.  
 
3.2.6 DNA Restriction Analysis 
We used restriction enzyme digestion for the generation and verification of plasmid 
constructs. Restriction enzymes were purchased from New England Biolabs (Schwalbach) 
with recommended buffers. For the generation of plasmid constructs 3 µg vector DNA were 
digested in a total volume of 100 µl with 40 units of restriction enzyme for 3 hours at 37°C. 
We performed double digests if applicable. If this was not the case plasmid DNA was purified 
using the Cycle Pure Kit from PeqLab (Erlangen) after digestion with the first enzyme. We 
purified vector DNA after completed digest also on Cycle Pure columns if no significant 
insert was excised. Otherwise, vector or insert DNA was purified via agarose gel 
electrophoresis. PCR products were purified by agarose gel electrophoresis before digestion. 
After excision of the DNA from the gel using the Gel Extraction Kit from PeqLab the 
restriction enzyme digest was performed in a volume of 100 µl and 60 units restriction 
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enzyme. The digest was incubated at 37°C between 3 hours and overnight. Digested PCR 
products were purified using a Cycle Pure Column before ligation.  
For verification of vector constructs after ligation 4 µl of a rapid plasmid prep (see chapter 
3.2.4) were digested with 6 units restriction enzyme in a volume of 20 µl for at least 20 min at 
37°C. The result was monitored by agarose gel electrophoresis.   
 
3.2.7 Dephosphorylation of Linear DNA 
To prevent vector reannealing and ligation of vector backbone in ligation reactions linearized 
plasmid DNA was 5’-dephosphorylated prior to ligation. We used 0.5 units calf intestinal 
phosphatase (CIP) NEB (Schwalbach) for 3 µg vector. The dephosphorylation reaction was 
performed for 15 min at 37°C directly after restriction enzyme digestion (see chapter 3.2.6). 
CIP cannot be heat inactivated. Therefore, we purified the vector DNA either by agarose gel 
electrophoresis or by applying the DNA to a PeqLab Cycle Pure Column immediately after 
incubation.  
 
3.2.8 DNA Ligation 
Prior to ligation we checked the quality and quantity of digested vector and insert DNA by 
loading 2 µl on an agarose gel. We used the 1 kb ladder from MBI Fermentas (St. Leon-Rot) 
to quantify the DNA (2000 base pair band equals 121 ng if 8 µl were loaded). We used 
between 100 to 150 ng vector DNA and a threefold molar excess of insert DNA in a total 
volume of 10 µl. The T4 DNA ligase together with the appropriate reaction buffer was 
purchased from Roche (Mannheim). We generally used 1 unit ligase per ligation reaction. The 
ligation was performed in a thermocycler at 16°C for 4 hours or at 12°C overnight. The 
ligation reaction was transformed into chemically competent E.coli (Top10), which were 
plated on LB agar plates supplemented with appropriate antibiotics.  
 




For the generation of plasmid constructs harboring inserts smaller than 80 base pairs we 
purchased oligo nucleotides from MWG Biotech (Martinsried), which were annealed and 
10 x Annealing buffer 
100 mM Tris pH 7.4 
1 M sodium chloride 
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phosphorylated before ligation into appropriate vectors. For inserts larger than 40 base pairs 
we used four oligos (2 sense and 2 anti-sense). A typical annealing reaction: 
 
    5 µl   10 x Annealing buffer 
    5 µl   100 µM oligo 1 (sense) 
    5 µl   100 µM oligo 2 (anti-sense) 
    35 µl  ddH2O 
 
We annealed the oligos in a thermocycler using a program that heated the reaction to 95°C for 
15 minutes and gradually reduced the temperature in 5°C steps (each step 5 minutes) to 
Tm+2°C. Then we reduced the temperature in 1°C steps down to Tm-2°C and further reduced 
the temperature in 5°C steps down to room temperature. The duplexes were phosphorylated 
using T4 Polynucleotide kinase (PNK) from New England Biolabs (Schwalbach) in the 
following reaction for 30 minutes at 37°C: 
 
  2 µl   annealed duplex (20 pmol) 
    0.3 µl  100 µM ATP 
    1 µl   PNK  
    2 µl   10 x PNK buffer 
    14.7 µl  ddH2O 
  
The reaction was diluted 1:10 by the addition of 180 µl ddH2O after incubation                     
( 0.1 pmol/µl). We used 2 µl of the phosphorylated duplex (0.2 pmol) and approximately 
100 ng digested and dephosphorylated vector for the ligation reaction (see chapter 3.2.8). 
 
3.2.10 Polymerase Chain Reaction 
PCR was used for amplification of DNA with simultaneous addition of restriction sites, for 
PCR site-directed mutagenesis, and for screening of generated plasmid constructs after 
ligation. For the amplification of DNA with the purpose of plasmid generation we used 
VentR® polymerase from NEB (Schwalbach), a high fidelity DNA polymerase with integral 
3’5’ proofreading exonuclease activity. A standard Vent PCR was performed in 100 µl total 
volume in ThermoPol buffer (20 mM Tris-HCl pH 8.8, 10 mM (NH4)2SO4, 10 mM KCl,        
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  1 x   ThermoPol buffer 
    200 µM  dNTPs 
    1 µM   5’-primer 
    1 µM   3’-primer 
    100 ng  template 
    1 unit  Vent polymerase 
 
The amplification was carried out in a T3 thermocycler from Whatman Biometra (Göttingen). 
A typical polymerase chain reaction for DNA amplification with the purpose of generating 
plasmid constructs: 
 
 1x   95°C  1 min    initial denaturation 
_________________________________________________________________________ 
    
   95°C  30 sec    denaturation 
 5 x   Tm – 2°C 30 sec    annealing 
   72°C  60 sec per 1000 bp  elongation 
_________________________________________________________________________ 
    
   95°C  30 sec    denaturation 
 20 x  65°C  30 sec    annealing 
   72°C  60 sec per 1000 bp  elongation 
_________________________________________________________________________ 
 
1 x   72°C   5 min    final elongation 
  
3.2.11 Agarose Gel Electrophoresis 
Agarose gel electrophoresis was used to separate DNA fragments after PCR or restriction 
enzyme digestion. We used Agarose NEEO Ultra-Quality ROTI®GAROSE from Roth 
(Karlsruhe) at 0.7% to 3% in TBE buffer. Samples were supplemented with 6 x loading dye 
(0.25% bromphenol blue, 0.25% xylene cyanol, 30% glycerol in water). Gels were run in self 
made gel chambers at 95 V for approximately 1 hour in TBE buffer. The Gene RulerTM 1 kb 
or 50 bp DNA ladder from Fermentas (St. Leon-Rot) were used as size standards. Gels were 
stained in a 1 µg/ml ethidium bromide staining solution in TBE buffer for 10 to 15 minutes 
before images were taken with the photographic documentation system from Herolab 
(Wiesloch).  
 
3.2.12 Sequencing of Plasmid DNA 
Sequencing was performed to verify generated plasmid constructs. We used the Sequencing 
facility from MWG (Martinsried). For this purpose we purified plasmid DNA using the 
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Wizard Miniprep Kit from Promega and sent 1 to 2 µg air dried plasmid DNA to MWG. 
Sequencing primers were either sent together with the DNA or chosen from a list of 
commonly used primers.   
Sequencing results were aligned with the target sequence using the ‘Align two sequencing’ 
application (bl2seq) on the NCBI Blast homepage (http://www.ncbi.nlm.nih.gov/BLAST/).  
 
3.3 Microbiological Methods 
3.3.4 Culturing Microorganisms 
3.3.4.1 Escherichia coli 
E.coli were used for amplification of plasmid DNA and were grown in Luria Bertani broth 
(LB medium, 2.1.7 Media, Buffers, and Solutions) for this purpose. For heterologous gene 
expression and protein purification bacteria were grown in rich 2xYT medium. Media were 
sterilized by autoclaving at 121°C for 15 min at 1 bar. For selection a variety of antibiotics 
was added to the medium after autoclaving and cooling when necessary: 100 µg/ml ampicillin 
(stock: 50 mg/ml in water), 50 µg/ml kanamycin (stock: 10 mg/ml in water), 25 µg/ml 
chloramphenicol (stock: 25 mg/ml in absolute ethanol). Chloramphenicol was also used at 
170 µg/ml to increase the copy number of low copy number plasmids, such as pET or pGEX 
vectors and improve midiprep yields. Generally, E.coli were grown at 37°C in a shaking 
incubator at 200 to 250 rpm or on medium plates containing 1.4% agar. The temperature was 
adjusted for protein production.  
 
3.3.4.2 Saccharomyces cerevisiae 
S. cerevisiae was generally grown at 30°C either in a shaking incubator at 200 rpm in liquid 
culture or on agar plates. YPD medium was used as rich medium and prepared as follows. 2% 
Difco peptone and 1% yeast extract were autoclaved. 2% glucose were added from a sterile 
filtered 40% stock solution after autoclaving and cooling to ~55°C. For adenine auxotrophic 
strains, i.e., AH109, we used YPDA medium, i.e., YPD medium supplemented with 0.003% 
adenine hemisulfate, which was added from a 0.2% stock before autoclaving.  
For selection we used minimal medium (SC medium) lacking amino acids or nucleotides 
(drop out). The basic medium contained 0.3% yeast nitrogen base, 1% ammonium sulfate,   
0.4 mM myoinositol, 0.4% amino acid-5 mix, and optionally 2% agar. The pH was adjusted 
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to 5.8 with sodium hydroxide. After autoclaving and cooling 2% glucose and optionally 
additional amino acids and nucleotides were added from 10 x stocks. We prepared the amino 
acid-5 mixture as follows: 2 g of adenine, arginine, asparagine, aspartic acid, cysteine, 
glutamic acid, glutamine, glycine, isoleucine, lysine, methionine, phenylalanine, proline, 
serine, threonine, tyrosine, valine, and 0.2 g of para-aminobenzoic acid were mixed, ground 
with mortar and pestle, and stored in the dark. 10 x amino acid and nucleotide stock solutions 
were prepared at required combinations using 200 mg/l histidine HCl monohydrate,          
1000 mg/L leucine, 200 mg/L tryptophan, 200 mg/L uracil, and 200 mg/L adenine 
hemisulfate. To prepare a triple drop out (TDO) medium lacking for example tryptophan, 
leucine, and histidine, we added the sterile 10 x stock solution ‘adenine + uracil’ after 
autoclaving the basic SC medium.  
 
3.3.4.3 Hansenula polymorpha 
Hansenula polymorpha uracil-auxotrophic strain RB11 was grown either on agar plates or in 
liquid culture at 37°C. We used YPD medium (2% Bacto-Peptone, 1% Yeast extract, 2% 
glucose) for the untransformed strain and YNB medium (0.15% yeast nitrogen base, 0.5% 
ammonium sulfate, 0.2 mM myo-inositol, 2% glucose) for selection of transformed clones. 
For the purpose of protein production the carbon source in YNB medium was exchanged from 
2% glucose to 3% glycerol.  
 
3.3.5 Preparation of Competent Cells and Transformation 
3.3.5.1 Chemically competent Escherichia coli 
We used heat shock transformation as standard transformation procedure for bacteria. To 
obtain chemically competent E.coli 50 ml LB medium were inoculated from a fresh culture on 
an agar plate and incubated at 37°C and 250 rpm until the OD600 reached 0.4. Cells were 
harvested in sterile centrifuge tube for 10 min at 4000 rpm and 4°C. The cell pellet was 
resuspended in 10 ml sterile 4°C 0.1 M calcium chloride solution and incubated on ice for at 
least 15 minutes. After harvesting the cells again by centrifugation the pellet was resuspended 
in 2 ml 0.1 M calcium chloride solution. Glycerol was added to a final concentration of 10% 
and 80 µl aliquots were either used immediately for heat shock transformation or shock frozen 
in liquid nitrogen and stored at -80°C. For transformation bacteria aliquots were rapidly 
thawed by hand warming and immediately put on ice. 10 to 100 ng plasmid DNA or ligation 
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reaction were added to the cell suspension and gently mixed. After 30 minutes of incubation 
on ice cells were heat shocked at 42°C for 90 seconds and immediately put on ice thereafter 
for 5 minutes. For plasmids harboring an antibiotic resistance gene for bacteriocidal 
antibiotics, such as kanamycin, 300 µl LB medium was added and cells were incubated at 
37°C for at least 30 min to allow for resistance gene expression before plating on selective 
medium. For bacteriostatic antibiotics, such as ampicillin, bacteria were plated immediately 
after 5 min of incubation on ice on selective LB agar plates.  
 
3.3.5.2 Electrotransformation of Escherichia coli 
We used electrotransformation for introducing plasmids purified from yeast into E.coli with 
the purpose of plasmid preparation and sequencing in the yeast-2-hybrid screening approach. 
One liter 2xYT medium supplemented with 0.5% glucose was inoculated with 5 ml TOP10 
overnight culture and grown until mid-log phase (OD600 = 0.6). Bacteria were cooled on ice 
for about 30 minutes before the cells were sedimented for 20 min at 4000 x g in ice-cold 
centrifuge tubes at 4°C. The pellet was washed once with 500 ml ice-cold Milli-Q water, and 
once with 40 ml ice-cold 10% (v/v) glycerol. Cells were finally resuspended in 2 ml ice-cold 
10% (v/v) glycerol and 80 µl aliquots were quick frozen in liquid nitrogen and stored at           
-80°C. For electro-transformation cells were thawed on ice and pipetted into a pre-chilled      
2 mm electroporation cuvette. Five µl plasmid DNA purified from yeast (see chapter 3.2.5) 
were added and electroporated at 1.6 kV and 25 µF after gentle mixing. Immediately after 
electroporation 1 ml 37°C LB medium was added and bacteria were incubated at 37°C for    
30 min before plating on selective media.  
 
3.3.5.3 Lithium Acetate Transformation of Saccharomyces cerevisiae 
We have used the lithium acetate transformation procedure first described by Ito et al. (1983) 
to introduce DNA into yeast as suggested by the Yeast Protocols Handbook provided by 
Clontech (www.clontech.com, protocol # PT3024-1). The method applied contained 
modifications introduced by Schiestl & Gietz (1989), Hill et al. (1991), and Gietz et al. 
(1992). One ml medium (generally YPD, YPDA for AH109, SC drop out medium for host 
strains previously transformed with another autonomously replicating plasmid) was 
inoculated with several colonies (2-3 mm in diameter) and vortexed for 5 minutes. The cell 
suspension was transferred into a flask containing 50 ml medium and incubated at 30°C for 
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16 to 18 hours at 250 rpm. The OD600 should have reached > 1.5 (stationary phase) by then. 
The overnight culture was diluted in 300 ml YPD to reach an OD600 between 0.2 and 0.3      
(~ 30 ml overnight culture in 300 ml fresh medium). The diluted culture was then incubated at 
30°C and 230 rpm for 3 hours (OD600 ~ 0.4 - 0.6). Cells were sedimented in 50 ml tubes at 
1000 x g for 5 min at room temperature. Pellets were washed in sterile TE buffer and pooled 
(total volume ~ 25 – 50 ml). After centrifugation as described above cells were resuspended 
in 1.5 ml freshly prepared, sterile 100 mM lithium acetate in TE (prepared from 10 x stocks; 
10 x TE: 0.1 M Tris-HCl, 10 mM EDTA, pH 7.5; 10 x lithium acetate: 1 M lithium acetate, 
pH adjusted to 7.5 with dilute acetic acid). 100 ng plasmid DNA and 100 µg salmon sperm 
carrier DNA were mixed in a separate reaction tube. 100 µl of competent yeast cells were 
added and mixed by vortexing. 600 µl sterile 40% PEG3350/lithium acetate solution (freshly 
prepared from 50% PEG3350 stock and 10x TE and lithium acetate stocks) and mixed by 
vortexing for 10 seconds. After incubation at 30°C and 200 rpm for 30 minutes 70 µl DMSO 
were added and suspension was mixed gently by inversion. Cells were heat shocked at 42°C 
for 15 minutes in a water bath and chilled on ice for 2 minutes. Cells were harvested by short 
centrifugation (5 seconds at 14,000 rpm in Eppendorf table top centrifuge) and resuspended in 
0.5 ml sterile TE buffer before plating on selective media. Plates were incubated at 30°C until 
colonies appeared (generally, 2-4 days). Successful transformation was verified by PCR of 
plasmids purified from transformed yeast (see chapter 3.2.5) and immunoblotting for 
expressed heterologous protein in yeast protein extracts (see chapter 3.4.8).  
 
3.3.5.4 Electrotransformation of Hansenula polymorpha and Selection 





Heterologous DNA can be introduced into H. polymorpha by electrotransformation. Plasmids 
are initially episomal and show low mitotic stability under selective and non-selective 
conditions. However, vectors can be stably integrated into the H. polymorpha genome in high 
copy tandem repeats (Gellissen et al., 1992; Gatzke et al., 1995). Few rounds of alternating 
cultivation under selective and non-selective conditions selects for stable transformants.  
For electrotransformation 200 ml pre-warmed YPD medium were inoculated with 2 ml of 
RB11 overnight culture. Cells were incubated in a shaking incubator at 250 rpm and 37°C 
STM electroporation buffer 
10 mM Tris HCl pH 7.5 
270 mM sucrose 
1 mM MgCl2 
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until the optical density at 663 nm (OD663) reach 1.4 (approximately 8 hours after 
inoculation). Cells were harvested in sterile centrifuge tubes by centrifugation at 1000 x g for 
10 min. Cells were resuspended in sterile 50 mM potassium phosphate buffer pH 7.4 
supplemented with 25 mM DTT and incubated at 225 rpm and 37°C for 15 min. Cells were 
washed in 200 ml sterile STM electroporation buffer and afterwards in 100 ml STM buffer 
before the cell pellet was resuspended in 1 ml STM buffer. 10 µg DNA were added to 60 µl 
aliquots which were electrotransformed in 2 mm electroporation cuvettes at 1800 V ( 
electric field pulse: 9.0 kV/cm) and 5 ms. Electroporated cells were transferred to sterile       
1.5 ml tubes and incubated for 1 hour  with 1 ml room temperature YPD medium in the 
shaking incubator. Cells were harvested by centrifugation in an Eppendorf table top centrifuge 
at 3000 rpm for 5 min, washed once with 1 ml YNB medium and plated on YNB agar plates. 
Plates were incubated at 37°C until colonies were visible. For selection of stable 
transformants colonies were harvested and alternately grown in YPD and YNB medium (non-
selective and selective) for at least 5 rounds. Presence of heterologous DNA was confirmed 
by preparation of genomic DNA of the transformants and PCR. Ultimate evidence for 
genomic integration and determination of copy number could be provided by southern 
blotting, which was omitted in this case.  
 
3.3.6 Yeast-2-Hybrid Screen 
We chose to use the Matchmaker Two-Hybrid System 3 from BD Biosciences Clontech 
(Heidelberg), a GAL4-based two hybrid screening technology, for identification of stonin 1 
and 2 interaction partners. The pretransformed Human Fetal Brain MATCHMAKER cDNA 
Library was also obtained from BD Biosciences. cDNAs obtained from normal, whole brains 
of 9 spontaneously aborted male/female Caucasian fetuses (age 20 to 25 weeks) were cloned 
into the pACT2 vector via XhoI and EcoRI restriction sites. The product analysis states that 
85% of the colonies contain inserts, there are 3.5 x 106 independent clones, the average 
cDNA size is 2.0 kb and the cDNA size ranges from 0.5 to 4.0 kb.  
We performed the yeast-2-hybrid screens essentially as suggested by the manufacturer (BD 
MatchmakerTM Pretransformed Libraries User Manual PT3183-1, Matchmaker GAL4 Two-
Hybrid System 3 & Libraries User Manual PT3247-1). In brief, library cDNAs are cloned into 
a vector containing a yeast GAL4 activation domain (the prey construct) and transformed into 
the Saccharomyces cerevisiae host strain Y187, a mating factor α strain. The bait construct is 
generated by cloning the target gene into pGBKT7, which allows for GAL4 DNA binding 
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domain fusion. The pGBKT7 constructs are transformed into the mating factor a reporter 
strain AH109. Library and target gene constructs are brought together by mating the mating 
factor a and α strains. Plating on selective medium selects for diploid clones expressing 


























Figure 3-6: Schematic overview: Yeast-2-Hybrid Screening 
(A) Schematic representation of the two-hybrid principle. The GAL4 protein binds to an upstream activating 
sequence (UAS) of a target gene activating transcription from a down-stream promoter. In the yeast-2-hybrid 
screen reporter genes will be switched on (here: HIS3, ADE2, MEL1) by binding of the completed GAL4 to very 
heterologous UAS sequences. This is supposed to decrease the occurrence of false positives in the screen. (B) 
Schematic representation of the yeast-2-hybrid procedure using the BD MatchmakerTM Two-Hybrid System with 
a pretransformed cDNA library. Taken from BD Biosciences Clontech Instruction Manual PT3183-1 
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Yeast-2-Hybrid constructs were generated as described in chapter 3.1.9.2 and transformed 
into the Saccharomyces cerevisiae reporter strain AH109 by the lithium acetate yeast 
transformation procedure (see 3.3.5.3). We verified transformation by yeast plasmid 
preparation (see 3.2.5) and subsequent PCR. In addition, we verified recombinant protein 
expression by protein extract preparation and subsequent Western blot analyses by decorating 
with anti-c-myc-tag antibodies. Verified clones were subjected to a control mating, testing for 
auto-activation by the generated construct. Constructs that did not exhibit auto-activation 
function were then applied for the yeast-2-hybrid screen using the pretransformed human fetal 
brain cDNA library. 
For the screen one large, fresh colony of AH109 transformed with the bait construct was 
inoculated in 50 ml SC/-Trp medium (see chapter 3.3.4.2) and cultured at 30°C and 250 rpm 
overnight. Cells were harvested by centrifugation at 1000 x g for 5 min after the OD600 has 
reached > 0.8. When discarding the supernatant we kept a remainder of around 5 ml in which 
we resuspended the pellet. One ml of the pretransformed cDNA library was thawed in a room 
temperature water bath. The entire pellet of the 50 ml overnight culture and the library were 
combined in a 2 L flask, 45 ml of YPDA medium supplemented with 50 µg/ml kanamycin 
were added, and the culture was incubated for 20 to 24 hours at 30°C with gentle swirling   
(30 to 50 rpm) with the purpose of mating. The mating mixture was transferred to a sterile 
centrifuge tube and harvested by centrifugation at 1000 x g for 10 minutes. The pellet was 
resuspended in 0.5 x YPDA/Kan and plated on 50 15 cm dishes either triple (TDO) or 
quadruple drop out (QDO) medium (TDO: SC/-Trp/-Leu/-His; QDO: SC/-Trp/-Leu/-His/-
Ade). Plates were incubated up side down for 8 to 21 days at 30°C until colonies appeared. 
Growing colonies were re-streaked on to QDO medium containing X-α-Gal. Ade+, His+, 
Mel1+ colonies were chosen for further analysis. Master plates were prepared for short term 
storage and glycerol stocks for long term storage. Plasmids were prepared from the putative 
‘interacting’ colonies and electro-transformed into Top10® E.coli (see 3.3.5.2) for 
amplification. Plasmids were purified from E.coli using the Wizard Plus SV miniprep Kit 
from Promega and subjected to PCR screening. We wanted to verify that picked clones 
contain inserts of appropriate length. The PCR screen was performed at 55°C annealing 
temperature and 4 minutes elongation time with primers AD-Seq-F 
(5’TTAATACCACTACAATGGATGATGTA3’) and pACT2-3’ (5’GAGATGGTGCACGATGCACA3’). 
Plasmids that contained inserts were subjected to sequencing (see 3.2.12) using the primer 
AD-Seq-F. Sequences were identified using the Blast tool on the NCBI homepage 
(www.ncbi.nlm.nih.gov/BLAST/). Plasmids containing coding sequence in frame with the 
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GAL4 activating domain sequence were re-transformed into AH109 and were checked for 
auto-activation by mating with Y187 carrying a negative control construct. Proteins that did 
not exhibit auto-activation were further tested for true interaction by biochemical methods 
such as GST pull down experiments (see 3.4.13) and co-immunoprecipitation (see 3.4.16).  
SV40 large T antigen (aa 87-708) in pGADT7 (pGADT7-T) and murine p53 (aa 72-320) in 
pGBKT7 (pGBKT7-53) were provided with the pretransformed human fetal brain library and 
were used as positive controls for interacting proteins throughout the experiment.  
 
3.4 Biochemical Methods 
3.4.4 Heterologous Gene Expression 
We used bacterial hosts for the purification of soluble proteins as a standard method. 
However, for proteins, i.e., stonin 2, that are not readily expressed and soluble in E.coli, we 
either tried to purify inclusion bodies with subsequent refolding or changed to other hosts, 
such as yeast, insect, or mammalian cells.  
 
3.4.4.1 Escherichia coli 
Expression of heterologous genes in E.coli was always the first choice, because it is the 
fastest, easiest, and cheapest method to produce significant amounts of recombinant protein. 
A variety of different systems are commercially available. We generally used the pGEX 
vectors (GE Healthcare, Munich) allowing for expression of GST-fusion proteins in 
combination with the GST•bindTM resin (Novagen, Darmstadt) or the pET vectors from 
Novagen allowing for production of His6-fusion proteins in combination with the Ni-NTA 
Agarose from Qiagen (Hilden). Our expression hosts were BL21(DE3)pLysS and ER2566. 
Expression conditions regarding expression temperature and time were optimized for each 
protein. As a starting point we used 0.5 mM Isopropyl-β,D-thiogalactopyranoside (IPTG) for 
induction and allowed expression for 3 hours at 30°C. If the results were not satisfactory 
regarding yield of full-length, soluble protein, we dropped the expression temperature to 25°C 
and shortened expression time to 2.5 hours, or allowed for expression at 15°C overnight. 
Bacteria were harvested after expression by centrifugation at 4000 x g and 4°C for 10 min. 
Pellets of 1 liter culture were resuspended in 70 to 135 ml binding buffer depending on the 
expected yield of fusion protein. Resuspended pellets were stored at -80°C until purification. 
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Expression of synaptotagmin 1 constructs was induced with 0.5 mM IPTG and performed at 
25°C for 2.5 hours.  
Stonin 2 was not successfully expressed as GST- or His6-fusion proteins. Therefore we chose 
to test for different fusion constructs. We used the thioredoxin-tag, the NusA-tag, and a 
maltose binding protein (MBP) fusion construct. 
 
3.4.4.2 Hansenula polymorpha 
Hansenula polymorpha has been used for successful high-level heterologous gene expression 
by various research groups and also for industrial protein production. Some examples are the 
expression of phytase at more than 13 g per liter of culture (Mayer et al., 1999), the 
expression of a range of cytokines (Degelmann et al., 2002) and of the anti-coagulant saratin 
(Barnes et al., 2001). By the addition of heterologous signal sequences such as the mating 
factor α prepro-sequence it is possible to secrete the recombinant protein into the medium. 
This was first explored by the recombinant expression of hirudin (Weydemann et al., 1995; 
Avgerinos et al., 2001). 
The facultative methylotrophic yeast Hansenula polymorpha has become attractive for high 
yield heterologous gene expression when it became clear that certain gene products were 
generated in massive amounts when methanol was provided as exclusive carbon source. 
These gene products were identified as methanol oxidase (MOX; Ledeboer et al., 1985), 
formate dehydrogenase (FMD; Hollenberg and Janowicz, 1988), and dihyrdoxyacetone 
synthase (DAS; Janowicz et al., 1985). MOX and FMD promoters appeared to be particularly 
strong after induction (Roggenkamp et al., 1984; Hollenberg and Janowicz, 1988, Gellissen et 
al., 1994). Therefore, plasmid constructs were generated that enable the expression of 
heterologous genes under the control of these promoters. The expression plasmids contain 
autonomously replicating sequence (HARS1; Roggenkamp et al., 1984) and the S. cerevisiae-
derived URA3 gene for selection (Roggenkamp et al., 1986) in combination with the uracil-
auxotrophic mutant strain RB11. Plasmid constructs are integrated as high-copy tandem 
repeats into the genome of Hansenula polymorpha upon transformation (see chapter 3.3.5.4) 
(Gellisen et al., 1992; Gatzke et al. 1995). We have used a modified pFPMT121 vector 
(Figure 3-7) (Gellissen and Hollenberg, 1997), comprising an FMD promoter, a multiple 
cloning site, and MOX terminator for controlling the ORF expression, an ampicillin resistance 
and origin of replication from pBR322 for selection and propagation in E.coli, HARS1 and 
URA3 for selection and propagation in RB11.  






Figure 3-7: pFPMT121 vector 
Typical integration/expression plasmid for 
heterologous gene expression in the uracil-auxotrophic 
Hansenula polymorpha strain RB11. Formate 
dehydrogenase promoter (FMD-P.) and methanol 
oxidase terminator (MOS-T.) drive ORF expression, 
the ampicillin resistance (ampR) and the origin of 
replication derived from pBR322 (ori) enable selection 
and propagation in E.coli, an autonomously replicating 
sequence (HARS) and the selection marker URA3 
from Saccharomyces cerevisiae allow for replication 
and selection in RB11.  
 
 
We chose to generate an expression construct that enables the secretion of a His6-tagged 
recombinant protein. Therefore we modified the pFPMT121 vector by adding the 
Saccharomyces cerevisiae mating factor α (Mfα) prepro-sequence and a His6-tag sequence 
(ATG CAC CAT CAC CAT CAC). By introducing a thrombin cleavage site (CTG GTT CCG 
CGT GGA TCC  L V P R G S) downstream of the His6-tag, the tag can be removed by 
thrombin cleavage after purification of the recombinant protein (Figure 3-8). We generated 
three expression constructs according to the scheme shown in Figure 3-8, introducing human 
stonin 2 full-length (aa 1-898), amino-terminus (aa 1-555), or carboxy-terminus (aa 556-898) 
in the position of the heterologous cDNA. For the purpose of protein production                     
H. polymorpha transformant strains were grown in a liter flask in 100 ml YNB medium 
(0.15% yeast nitrogen base, 0.5% ammonium sulfate, 0.2 mM myo-inositol) supplemented 
with 3% glycerol as sole carbon source for de-repression of the FMD promoter. Cells were 
incubated at 37°C in a shaking incubator at 250 rpm for 72 hours. After centrifugation of the 
culture at 1000 x g the supernatant was incubated with Ni-NTA Agarose beads (Qiagen, 
Hilden) for 2 hours at 4°C on a rotating wheel. Purified protein was analyzed by SDS PAGE 
and Western blotting.  
 
 




3.4.4.3 Baculovirus System 
As we have not established the Baculovirus expression system in our lab we are grateful to 
Stephan Hinderlich, Institute for Biochemistry and Molecular Biology, Charité, Berlin, for 
allowing us to use his facilities to test this method for protein expression and purification.  
We used the Bac-to-Bac® Baculovirus Expression system from Invitrogen (Instruction manual 
10359, version D) and chose the pFastBacTM-HT vector (Figure 3-9) allowing for expression 





We generated 2 constructs, human stonin 2 full-length (aa 1-898) and stonin 2 µ-homology 
domain (aa 563-874). For the purpose of recombinant bacmid generation we transformed 
DH10BacTM E.coli with the prepared pFastBacTM-HT stonin 2 constructs. The DH10BacTM 
E.coli strain contains a baculovirus shuttle vector (bacmid: bMON14272, 136 kb) with a 
 
Figure 3-8: Hansenula polymorpha expression 
construct 
(A) S. cerevisiae mating factor α prepro-sequence. 
(B) Expression construct for heterologous gene 
expression in Hansenula polymorpha with the aim 
to secrete His6-tagged recombinant protein into the 
medium. FMD P.: formate dehydrogenase 
promoter; Mfα: mating factor α prepro-sequence; 
TCS: thrombin cleavage site; MOX T.: methanol 
oxidase terminator; numbers indicate nucleotide 
length of the individual components. 
 




This vector was used to generate stonin 2 
constructs that for expression and 
purification from insect cells using the Bac-
to-Bac® Baculovirus expression system 
from Invitrogen. PPH: polyhedrin promoter, 
allows for efficient expression of 
recombinant protein in insect cells 
(O’Reilly et al., 1992); Tn7L and Tn7R: 
Mini Tn7 elements that permit site-specific 
transposition of the gene of interest into the 
baculovirus genome; Gentamicin resistance 
gene allows for selection of the 
recombinant bacmid in DH10BacTM E.coli. 
72  Materials and Methods 
 
mini-attTn7 target site and a helper plasmid. Once the pFastBacTM-HT construct is 
transformed, transposition occurs between the mini-Tn7 element on the pFastBacTM 
expression plasmid and the mini-attTn7 target site on the bacmid. The transposition reaction 
occurs in the presence of the transposition proteins supplied by the helper plasmid. The 
insertion of the gene of interest into the bacmid disrupts a LacZα gene causing cells 
containing recombined bacmid to exhibit white color instead of blue on plates containing a 
chromogenic substrate such as Bluo-gal and the inducer IPTG. 
DH10BacTM E.coli were transformed using chemically competent cells and heat shock (see 
3.3.5.1 Chemically competent Escherichia coli). Transformed cells were plated on selective 
LB agar plates containing 50 µg/ml kanamycin, 7 µg/ml gentamicin, 10 µg/ml tetracycline, 
100 µg/ml Bluo-gal, and 40 µg/ml IPTG. White colonies were re-streaked on selective agar 
plates to confirm the phenotype and bacmid recombination was verified by PCR. Stonin 2 
bacmids were purified from DH10BacTM E.coli. 2 ml LB medium containing 50 µg/ml 
kanamycin, 7 µg/ml gentamicin, and 10 µg/ml tetracycline were inoculated with a single 
colony and incubated overnight in a shaking incubator. Cells were harvested by centrifugation 
(20,000 x g, 1 minute) and resuspended in 300 µl Qiagen Plasmid Midi Prep buffer P1. 300 µl 
buffer P2 were added and incubated for 5 minutes at room temperature before 300 µl buffer 
P3 were added. Samples were incubated on ice for 10 minutes before they were centrifuged 
for 10 minutes at 20,000 x g. The supernatant was gently mixed with 800 µl isopropanol and 
placed on ice for 10 minutes. The samples were centrifuged for 15 minutes at 20,000 x g at 
room temperature. The pellet was washed with 500 µl 70% ethanol and centrifuged again for 
5 minutes at 20,000 x g before the pellet was air-dried for 5 minutes and gently resuspended 
in 40 µl TE buffer pH 8.0.  Dissolved DNA was stored at 4°C.  
 
Subsequent procedures have been performed in the facilities of the Biochemistry and 
Molecular Biology Institute of the Charité. All equipment, cells, media and transfection 
reagents have been supplied by Stephan Hinderlich. Purified bacmid was transfected into Sf9 
insect cells (derived from pupal ovarian tissue of the armyworm Spodoptera frugiperda) in a 6 
well plate using the Cellfectin® transfection reagent from Invitrogen, optimized for high 
efficiency insect cell transfection, according to manufacturer’s instructions. Transfected cells 
were grown in Sf-900 medium (available from Invitrogen) for 3 days at 27°C before the 
supernatant containing the recombinant baculovirus particles was harvested. To amplify the 
virus titer fresh Sf9 cells in a 6 well plate have been infected with virus containing 
supernatant. For further virus particle amplification 100 ml of Sf9 culture was infected with 
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virus and grown for another 3 days in a shaking incubator at 27°C. Cells as well as 
supernatant have been harvested. Supernatant was stored at 4°C for later infection of different 
expression strains. Cells were analyzed for expression of stonin 2 constructs. Protein extracts 
were essentially prepared as described in 3.4.9 Preparation of Protein Extracts from 
Fibroblasts and subjected to affinity purification using Ni-NTA Agarose from Qiagen. 
Purified protein was analyzed by SDS PAGE and immunoblotting.  
 







Proteins were purified from E.coli with the help of tags and fusion proteins. GST-fusion 
proteins were purified on GST•bindTM resin (Novagen, Darmstadt), His6-tagged proteins on 
Ni-NTA Agarose (Qiagen, Hilden), MBP-fusion proteins on Amylose Resin (NEB, 
Schwalbach).  
For preparation of bacterial protein extracts, resuspended and frozen cell pellets (volume       
35 ml) were thawed at 37°C and immediately put on ice. We added 1 mM Phenylmethyl-
sulphonylfluoride (PMSF: irreversibly inhibits serine proteases by sulfonylation of the serine 
residue in the active site of the protease, Prouty and Goldberg, 1972), 2 mM MgCl2, 100 units 
of Benzonase® endonuclease (SIGMA, Deisenhofen), and a tip of a spatula lysozyme. After 
incubation for 10 min on ice, we generally added 1% Triton. For some exceptions 1% 
CHAPS was added. Cells were further treated with sonification for membrane disruption after 
another 10 min of incubation on ice. Sonification was performed using a micro-tip system for 
1 minute at an energy level of 70% and sonification cycle frequency of 50%. After cell 
disruption the suspension was centrifuged at 39,000 x g and 4°C for 15 min. The supernatant 
was applied to the appropriate binding resin and incubated on a rotating wheel for 1 to 2 hours 
at 4°C. We generally used 1 ml of binding resin slurry for a cell pellet of 1 L culture. Proteins 
bound to beads were washed in 40 ml binding buffer 3 times for 5 min on the rotating wheel 
at 4°C. Fusion protein that was supposed to be used in GST- or His6-tag pull down assays 
were resuspended in 1 ml binding buffer and stored at 4°C until the pull down experiment was 
GST-elution buffer 
20 mM Tris-HCl pH 8.0 
500 mM NaCl 
20 mM reduced glutathione 
(optional: 10% glycerol) 
 
His6-elution buffer 
20 mM Tris-HCl pH 7.4 
500 mM NaCl 
400 mM imidazole 





20 mM Tris-HCl pH 7.4 
200 mM NaCl 
10 mM Maltose 
1 mM DTT 
0.1% CHAPS 
 
74  Materials and Methods 
 
performed (maximum time period between purification and pull down experiment: 20 hours). 
For elution beads were incubated in 1 ml elution buffer for 1 hour at 4°C on a rotating wheel 
(exception: GST-fusion proteins were eluted for 1 hour at room temperature). Eluted protein 
was generally dialyzed to remove imidazole, change the buffer, or lower salt conditions. 
Synaptotagmin 1 protein fragments were usually dialyzed against 20 mM Tris-HCl pH 7.4, 
100 mM NaCl, 1 mM DTT, aliquots were shock frozen in liquid nitrogen after the addition of 
10% glycerol and stored at -80°C.  
 






Stonin 2 µHD (563-874) and CT (557-898) were purified as inclusion bodies. ER2566 were 
transformed with His6-tagged expression constructs and 1 liter of 2xYT medium was 
inoculated with 50 ml overnight culture. Cells were grown at 30°C and 250 rpm until OD600 
reached 0.8. Expression was induced by the addition of 0.5 mM IPTG for 3 hours at 30°C. 
Cells were harvested by centrifugation at 4000 x g and 4°C for 10 minutes. Cell pellet was 
resuspended in 25 ml resuspension buffer, 500 units Benzonase nuclease and 1 mM PMSF 
were added. Cells were lysed by French Press and the cell lysate was centrifuged at 4°C,   
9000 x g for 15 minutes. The pellet was washed 3 times in 20 ml washing buffer and 
resuspended in 30 ml solubilization buffer. Protein concentration was determined by 
absorption at 280 nm (theoretical extinction coefficient: 1.03, calculated by the ProtParam 
tool on www.expasy.org). Ultra-centrifuged (125,000 x g, 4°C, 30 minutes), solubilized 
inclusion bodies were either bound to a 1 ml HisTrap FF column (GE Healthcare) or 
immediately subjected to refolding by dialysis or rapid dilution. For refolding on the column 
we reduced the urea concentration from 8 M to 0 M urea gradually over the period of 16 
hours and eluted potentially refolded protein in 20 mM Tris pH 9.0, 300 mM imidazole, 500 
mM NaCl, 10% glycerol, and 75 µM n-Dodecylmaltosid. For refolding in the dialysis tubing 
we exchanged the dialysis buffer from 20 mM Tris pH 9.0, 500 mM NaCl, 4 M urea to 3, 2, 1, 
0 M urea every hour. Refolding by rapid dilution was performed as suggested by Hampton 
Research (FoldIt screen, Hampton Research, CA, USA). Inclusion bodies were concentrated 
Resuspension solution 
20 mM Tris pH 8.0 
500 mM NaCl 
Washing solution 
20 mM Tris pH 8.0 
500 mM NaCl 
0.05% Triton X-100 
0.05% Chaps 
Solubilization solution 
8 M urea 
20 mM Tris pH 8.0 
500 mM NaCl 
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Washing buffer 1 
1 x homogenization buffer w/o 
protease inhibitor  
+ 500 mM NaCl 
+ 320 mM sucrose (stock 2M) 
+ 1% CHAPS (stock 20%) 
+ 1 mM DTT (stock 1M) 
+ 10 mM Imidazole (stock 1M) 
 
in solubilization buffer to 20 mg/ml using a Vivaspin20 VS2011 5000PES centrifugation 
column (Sartorius, Göttingen) and rapidly diluted 1:50 into agitated refolding buffers.  
 













In addition to Triton X-100 protein extracts of fibroblasts (see chapter 3.4.9) we also 
performed protein extraction of fibroblasts without detergents for the purpose of stonin 2-His6 
purification. We generated several stonin 2-His6 doxycycline inducible stable HEK293 cell 
lines (see chapter 3.5.10). Cells were grown on 15 cm diameter tissue culture dishes to about 
95% confluency before induction with 1 µg/ml doxycycline for at least 16 hours. Cells were 
washed once with PBS on the plate and harvested in 5 ml PBS by forceful pipetting. Cells 
were harvested by centrifugation at 200 x g and 4°C for 3 minutes, and resuspended in 4 ml 
homogenization buffer per cell pellet from one 15 cm dish. We decided to use a ball-bearing 
cell cracker for cell homogenization as this seemed the most reproducible and gentle method 
to produce cytosolic extract (Balch and Rothman, 1985). Using two syringes the cell 
suspension was repeatedly passed (6 to 8 times) through the ball-bearing cell cracker with a 
clearance of 12 µm. Cracked cells were centrifuged at 20,000 x g for 5 min before the 
supernatant was ultra-centrifuged at 180,000 x g and 4°C for 15 min. Ultra-centrifuged 
supernatant was supplemented with 320 mM sucrose, 500 mM NaCl, 1% CHAPS, 1 mM 
DTT, 10 mM imidazole, and 1 mM PMSF (see Ni-beads binding buffer) before application to 
100 µl washed Ni-NTA Agarose (Qiagen, Hilden). After incubation for 2 hours at 4°C on a 
rotating wheel (end-over-end rotation) beads were washed twice with 8 ml washing buffer 1 
Elution buffer  
20 mM HEPES pH 7.4 
150 mM NaCl 
320 mM sucrose 
2 mM MgCl2 
1% CHAPS 
1 mM DTT 
120 mM imidazole 
Washing buffer 2 
20 mM HEPES pH 7.4 
150 mM NaCl 
2 mM MgCl2 
320 mM sucrose (stock 2M) 
1% CHAPS (stock 20%) 
1 mM DTT (stock 1M) 
10 mM Imidazole (stock 1M) 
 
Homogenization buffer 
20 mM HEPES pH 7.4 
150 mM NaCl 
2 mM MgCl2 
+ 10 µl/ml protease 
 inhibitor cocktail 
+ 1 mM PMSF 
Ni-beads binding buffer  
1 x homogenization buffer 
+ 320 mM sucrose (2M stock) 
+ 500 mM NaCl (5M stock) 
+ 1% CHAPS (stock 20%) 
+ 1 mM DTT (stock 1M) 
+ 10 mM imidazole (stock 1M) 
+ 1 mM PMSF 
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for 5 min at 4°C under end-over-end rotation and once with washing buffer 2. Washing 
solution was removed completely before 300 µl elution buffer were added and incubated on a 
rotating wheel for 20 min at 4°C. Eluted proteins were harvested by centrifugation at     
20,000 rpm and 4°C for 1 minute. Protein quality and quantity was estimated by SDS PAGE, 
Coomassie staining, and Western blotting. In addition, we identified contaminating proteins 
by mass spectrometry (see 3.4.19) performed by Dr. Christoph Weise, Institute for Chemistry 
and Biochemistry, FU Berlin.  
 






Protein extracts from yeast were prepared to verify recombinant protein expression in the 
yeast-2-hybrid experiments. We used the urea/SDS method described by Printen and Sprague 
(1994). 50 ml appropriate SC drop out medium was inoculated with 5 ml overnight culture 
and incubated at 30°C and 230 rpm until OD600 reached 0.4 to 0.6. The OD600 units were 
calculated by multiplying the OD600 value by the culture volume (55 ml). The culture was 
quickly chilled by pouring it into a 250 ml centrifugation tube containing around 50 ml of ice. 
Cells were harvested by centrifugation in a pre-chilled rotor at 1000 x g and 4°C for 5 min. 
The cell pellet was once washed in 50 ml ice-cold water, immediately frozen in liquid 
nitrogen, and stored at -80°C. For protein extraction complete cracking buffer was prepared 
just prior to use by adding 1% (v/v) β-mercaptoethanol, 7% (v/v) µl protease inhibitor stock 
solution, and 5 mM PMSF. 100 µl of pre-heated (60°C), complete cracking buffer per         
7.5 OD600 units were added to frozen cell pellets. To hasten melting samples were put to 60°C 
for 2 minutes and put immediately on ice thereafter. We transferred the cell suspension to 1.5 
ml reaction tube containing approximately 80 µl of glass beads (425-600 µm diameter) per 
7.5 OD600 units. The samples were heated to 70°C for 10 min before vigorous vortexing for   
1 minute. Debris and unbroken cells were removed by centrifugation at 20,000 x g (14,000 
rpm in Eppendorf centrifuge 5417R) at 4°C for 5 minutes. Supernatants were transferred to 
new 1.5 ml reaction tubes and 50 to 100 µl fresh cracking buffer was added to the pellets, 
which were boiled 3 to 5 minutes at 100°C and centrifuged as described above. Supernatant 
Protease inhibitor solution 
0.1 mg/ml  pepstatin A 
0.03 mM   leupeptin 
145 mM  benzamidine 
0.37 mg/ml aprotinin 
  
Cracking buffer stock solution 
8 M   urea 
5% (w/v)   SDS 
40 mM   Tris-HCl pH 6.8 
0.1 mM   EDTA 
0.4 mg/ml  bromphenol blue 
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was pooled with the supernatant obtained from the first centrifugation. Pooled supernatants 
were boiled again and immediately analyzed on SDS PAGE or stored at -20°C.  
 







We prepared Triton X-100 protein extracts of transfected fibroblasts for the purpose of co-
immunoprecipitation or GST pull down experiments. Generally fibroblasts plated on 6 or     
10 cm diameter tissue culture dishes were transfected with desired plasmid constructs (see 
chapter 3.5.8) and incubated for 24 to 48 hours. Cells were washed twice with PBS on the 
plate and removed in 1 ml PBS with the help of a cell scraper. Cells were harvested by 
centrifugation at 4°C and 400 x g (2000 rpm in Eppendorf 5417R) for 2 minutes, resuspended 
in lysis buffer (1 ml for 6 cm dishes, 3 ml for 10 cm dishes) and incubated for 10 minutes on 
ice. Lysed cells were centrifuged at 20,000 x g and 4°C for 5 min. Supernatants were ultra-
centrifuged at 180,000 x g for 15 min before the protein concentration was determined by 
Bradford assay (see chapter 3.4.12). 
 





Rats have been anesthetized by carbon dioxide and euthanized by cervical dislocation. 
Decapitation was performed by the use of a guillotine. Brains were removed, washed in 
homogenization buffer, and frozen at -80°C. We used a douncer (12 strokes at 900 rpm) to 
homogenize ½ rat brain in 7.5 ml homogenization buffer supplemented with 1 mM PMSF and 
mammalian protease inhibitor cocktail (Sigma, Deisenhofen). To sediment nuclei the 
homogenate was centrifuged at 1,000 x g for 10 min. Supernatant was supplemented with 2 
5 x pull down buffer 
100 mM HEPES pH 7.4 
500 mM KCl 
10 mM MgCl2 
Lysis buffer 
20 mM HEPES pH 7.4 
100 mM KCl 
2 mM MgCl2 
1% Triton X-100 
1 mM PMSF 
3% (v/v) protease inhibitor cocktail 
for mammalian cells (Sigma, Deisenhofen) 
Homogenization buffer 
4 mM HEPES pH 7.4 
320 mM sucrose 
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ml 5 x pull down buffer, 1% Triton X-100 (500 µl of 20% stock), and incubated for 10 min on 
ice. The Triton X-100 extract was centrifuged at 40,000 x g and 4°C for 15 minutes before the 
supernatant was ultra-centrifuged at 180,000 x g for 15 minutes. Protein content was 
quantified by Bradford assay (see 3.4.12 Protein Quantification).  
 
3.4.11 Protein Precipitation with Trichloroacetic Acid (TCA) 
We used TCA precipitation to concentrate proteins prior to SDS PAGE. 1 volume -20°C 
20%TCA/80% acetone was added to the protein solution and incubated for 10 minutes on ice 
or overnight at -20°C. The samples were heated to 60°C for 10 minutes before centrifugation 
at 20,000 x g and 4°C for 30 minutes. The supernatant was removed with a pipette and the 
pellet was washed with 100% acetone. We removed the supernatant and air-dried the pellet. 
For neutralization we added 2 M Tris base (1/10 of the final volume) and 1 volume hot 1 x 
SDS PAGE sample buffer. The samples were heated to 95°C for 5 minutes before they were 
subjected to SDS PAGE or stored at -20°C.  
 
3.4.12 Protein Quantification 
We used the Bradford assay (Bradford, 1976) as standard method for protein quantification 
based on an absorbance shift in Coomassie brilliant blue G250 when bound to arginine or to 
aromatic residues. The anionic, bound form has an absorbance maximum at 595 nm, whereas 
the unbound (cationic) form exhibits its absorbance maximum at 470 nm. 2 x Bradford 
reagent was prepared and a standard curve using BSA was generated. The protein of unknown 
concentration was diluted in a total volume of 500 µl water and 500 µl 2 x Bradford reagent 
was added. After 10 minutes of incubation at room temperature we measured the OD595 and 
calculated the actual protein concentration by means of the BSA standard curve. All samples 
were determined in duplicates or triplicates. 
The Bradford assay is not compatible with higher concentrations of detergents, chaotropic 
reagents or organic solvents. For samples including these substances in considerable amounts 
we used the BCATM Protein Assay Kit from Pierce (Perbio Science, Bonn) according to 
manufacturer’s instructions (Instruction Manual 23225, 23227, 1296.3). This assay is a 
detergent-compatible formulation based on bicinchoninic acid (BCA) for the colorimetric 
detection and quantitation of total protein. Cu2+ is reduced to Cu1+ by protein in an alkaline 
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medium (biuret reaction). The BCA reagent chelates Cu1+ ions forming purple-colored 
complexes with an absorbance maximum at 562 nm (Smith et al., 1985).  
 





3.4.13.1 Small-Scale GST- and His6-Pull Down Experiments 
As a method to analyze protein-protein interactions we used GST- and His6 pull down assays. 
These experiments were either performed from rat brain extract (see chapter 3.4.10) or protein 
extracts prepared from transiently or stably transfected fibroblasts (see chapter 3.4.9). GST- or 
His6-tagged proteins, respectively, were purified as described (see chapter 3.4.5) and used 
immobilized on beads either immediately but not later than 20 hours after purification for the 
pull down experiment. Generally, 50 µg of immobilized fusion protein and 2 mg rat brain 
extract at 2 mg/ml, or 1 mg fibroblast protein extract at 1 mg/ml were used for one pull down 
experiment. Any discrepancies in bead volume of recombinant proteins were compensated for 
with empty beads. The pull down reaction was incubated for 1.5 to 2 hours on a rotating 
wheel at 4°C before 3 times 5 minutes washes with washing buffer containing 1% Triton X-
100 and one quick wash with washing buffer lacking Triton X-100 followed. Beads were 
pelleted at 1,300 x g and 4°C for 1 minute. The last washing supernatant was removed as 
completely as possible and 30 µl hot 2 x sample buffer were added. Beads were boiled for       
5 minutes at 95°C and pelleted at 20,000 x g. The volume of the supernatant was measured 
with a Hamilton pipette and transferred to a new tube. The volume was adjusted to 80 µl. 
Generally, 25 µl were loaded on SDS PAGE and 10 µl of each sample for Coomassie staining 
as loading control.   
 
3.4.13.2 Large-Scale GST-Pull Down Experiments 
We aimed at discovering novel stonin 2 interacting proteins by large scale GST-pull down 
experiments from rat brain using stonin 2 amino-terminal fragments fused to GST. We 
generated 4 amino-terminal stonin 2 fragments harboring proline rich domains (PRD) or NPF 
Washing buffer 
20 mM HEPES pH 7.4 
100 mM KCl 
2 mM MgCl2 
+/- 1% Triton X-100 
80  Materials and Methods 
 
motifs (1-414(PRD+NPF), 1-307(PRD), 308-351(NPF), 308-414(NPF)) as GST fusion 
proteins and eliminated the WVxF motifs by mutating the tryptophans to alanines in order to 
avoid AP-2 binding. Since AP-2 is a very strong binding partner of stonin 2 and interacts 
itself with a variety of proteins we wanted to prevent fishing for AP-2 interactors instead of 
stonin 2 binding proteins. GST fusion proteins were expressed and purified from E.coli on 
GST•bindTM resin (Novagen, Darmstadt) (see chapters 3.4.4.1 and 3.4.5). To avoid 
dominating fusion protein bands among the eluted proteins we cross-linked the GST fusion 
proteins to the beads before incubation with rat brain extract. For cross-linking we used the 
GST Orientation Kit from Pierce (Perbio Science, Bonn) essentially as suggested by the 
manufacturer (Pierce Instruction Manual 78201: GST Orientation Kit on 
www.piercenet.com). The applied cross-linker Disuccinimidyl Suberate (DSS) is depicted in 











DSS is a water-insoluble, non-cleavable, homobifunctional N-hydroxysuccinimide ester 
(NHS-ester). The principle targets are primary amines. Accessible α-amine groups present on 
amino-termini of proteins and peptides react with NHS-esters. In addition, the ε-amine of 
lysine reacts significantly with DSS. The reaction between primary amines and NHS-esters 
produces a covalent amide bond and releases N-hydroxysuccinimide.  
20 to 25 mg GST fusion proteins cross-linked to GST•bindTM resin were incubated with rat 
brain extract prepared from one rat brain (45 mg rat brain extract protein per pull down 
reaction) for 2 hours at 4°C on a rotating wheel. We packed a column with the beads using 
PIERCE disposable 5 ml polyethylene column and washed the column with 50 ml washing 
buffer without Triton X-100. We eluted bound protein with high salt solution (20 mM HEPES 
pH 7.4, 1 M NaCl, 2 mM MgCl2) and collected four 750 µl fractions. We pooled the fractions 
and precipitated eluted protein with trichloroacetic acid.  
 
Figure 3-10: Structure of the cross-linker 
Disuccinimidyl Suberate (DSS) 
Materials and Methods  81 
 







To test for direct interaction of proteins we performed in vitro binding experiments essentially 
like GST pull down experiments, however, employing purified or in vitro 
transcribed/translated proteins (see 3.4.15 In Vitro Transcription / Translation). GST fusion 
proteins were purified as described (see 3.4.5 Purification  of Soluble Protein from 
Escherichia coli) and kept immobilized on beads. His6-tagged proteins were purified either 
from E.coli (i.e. for His6-tagged synaptotagmin C2AB) or from stable HEK293 cells 
expressing stonin 2-His6 in a doxycycline-inducible manner (see 3.4.7 Stonin 2-His6 
Purification from Fibroblasts). Generally, 2 µg GST-fusion proteins were incubated with 1 µg 
His6-tagged protein in 100 µl binding buffer in 200 µl reaction cups for 1.5 hours at 4°C on a 
rotating wheel. We added 10 µl empty GST•bindTM slurry to the binding reaction to increase 
the bead volume. After incubation beads were transferred to 1.5 ml reaction tubes and washed 
4 times 5 minutes with binding buffer at 4°C on a rotating wheel. Beads were pelleted at 
1,300 x g and 4°C for 1 minute. The last washing supernatant was removed as completely as 
possible, and 30 µl hot 2 x sample buffer were added. Beads were boiled for 5 min at 95°C 
and pelleted at 20,000 x g for 1 minute. Supernatant was transferred to a new reaction tube, 
the volume was measured with a Hamilton pipette and adjusted to 50 µl. Either 45 µl or the 
entire sample was applied to SDS PAGE  and analyzed by Western blotting for the His6-tag.  
For in vitro binding assays using GST-stonin 2 µHD (aa 563-874) 30 µg GST fusion protein 
and 15 µg His6-tagged synaptotagmin 1 C2AB (aa 97-421) were used in 1 ml 1 x pull down 
buffer with 1% Triton X-100 (see 3.4.13 GST- and His6-Pull Down Assays). 
 
3.4.15 In Vitro Transcription / Translation 
We have used the TNT® T7 Coupled Reticulocyte Lysate System from Promega (Mannheim) 
for the combined in vitro transcription / translation reaction and radioactive labeling of T7 
promoter driven cDNAs essentially according to manufacturer’s instructions (Technical 
Bulletin # TB126 available on www.promega.com). We purchased the [35S]-labeled 
Binding buffer 
20 mM HEPES pH 7.4 
150 mM NaCl 
2 mM MgCl2 
320 mM sucrose 
1% CHAPS 
1 mM DTT 
10 mM imidazole 
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methionine from GE Healthcare (Munich). A typical in vitro transcription / translation 
reaction: 
 
  TNT® Rabbit Reticulocyte Lysate    12.5 µl 
  TNT® Reaction Buffer     1 µl 
  TNT® T7 RNA polymerase     0.5 µl 
  Amino acid mixture, minus methionine, 1mM   0.5 µl 
  [35S]methionine (>1000Ci/mmol at 10mCi/ml)  1 µl 
  RNasin® Ribonuclease Inhibitor (40 U/µl)   0.5 µl 
  DNA template (0.5 µg/µl)     1 µl 
  Nuclease-free water to a final volume of   25 µl 
 
The reaction was incubated for 90 minutes at 30°C in a thermocycler before it was ultra-
centrifuged at 180,000 x g for 15 minutes at 4°C.  
Radio-labeled, in vitro translated proteins were used for in vitro binding experiments (see 
3.4.14) and for limited proteolytic digest of stonin 2-His6 wild-type and mutants (see 3.4.20). 
 
3.4.16 Immunoprecipitation 





Co-immunoprecipitation experiments have been performed from rat brain extract (see 3.4.10) 
and protein extract from co-transfected fibroblasts (see 3.4.9). 40 µl pre-blocked protein A/G 
PLUS Agarose beads (Santa Cruz Biotechnology, Heidelberg) were washed with 1 ml 
washing buffer + Triton X-100. Beads were sedimented by centrifugation at 1,300 x g, 4°C 
for 1 minute. The pellet was resuspended in 1 ml washing buffer + Triton X-100 and the 
antibody to be conjugated was added. Generally we used 1 µl of anti-HA monoclonal 
antibody (HA11, BAbCo), 1 µl anti-FLAG monoclonal antibody (M2, Sigma), or 8 µl anti-
stonin 2 polyclonal antiserum per immunoprecipitation reaction. Antibodies were coupled to 
the beads for 1 hour at room temperature and washed twice with 1 ml washing buffer 
containing Triton X-100 before protein extract was added. Commonly, we used 1 ml of 2 
mg/ml rat brain extract or 500 µg/ml to 1 mg/ml fibroblast cell extract. The co-immuno-
precipitation reaction was performed at 4°C on a rotating wheel for 4 hours before the beads 
Washing buffer 
20 mM HEPES pH 7.4 
100 mM KCl 
2 mM MgCl2 
+/- 1% Triton X-100 
Materials and Methods  83 
 
were washed 3 times for 5 min at 4°C on a rotating wheel and once quick without Triton X-
100. The last washing supernatant was removed as completely as possible and 30 µl hot 2 x 
sample buffer supplemented with 1/10 vol fresh β-mercaptoethanol (to ensure complete 
reduction of the antibody heavy and light chains) were added. Samples were boiled at 95°C 
for 5 min before centrifugation at 20,000 x g. Supernatant was transferred to a fresh tube, the 
volume was determined with the help of a Hamilton pipette and adjusted to 50 µl. In general, 
45 µl were applied to SDS PAGE  and analyzed by Western blotting.  
 
3.4.16.2 Anti-Stonin 2 Polyclonal Antibody Purification and Large-










We aimed at identifying novel stonin 2 interaction partners by immunoprecipitating 
endogenous stonin 2 from rat brain and identification of co-precipitated proteins by mass 
spectrometry. To be able to visualize co-precipitated proteins on Coomassie stained SDS 
PAGE gels we set out to perform larger scale immunoprecipitations using purified anti-stonin 
2 IgGs immobilized on CNBr-activated SepharoseTM 4B (GE Healthcare, Munich). CNBr 
electrophilically reacts with hydroxyl groups of the polysaccharides forming imidocarbonate 
and carbamate groups. Imidocarbonate groups in turn react with amino groups of proteins 
with the formation of stable covalent linkages.  
We used 1 ml HiTrapTM protein G columns (GE Healthcare) to purify rabbit IgGs from anti-
stonin 2 polyclonal antiserum, and pre-immune serum as control. 9 ml filtered (0.22 µm) 
rabbit serum were applied on the column in 1 x binding buffer (9 ml serum were 
supplemented with 1 ml 10 x binding buffer). The column was washed with 30 x column 
volume column wash buffer at a flow rate of 1 ml/min and eluted using the elution buffer. We 
collected 500 µl fractions during the elution into 1.5 ml cups containing 50 µl neutralization 
Neutralization buffer 
1 M Tris pH 9.0 
Column wash buffer 
20 mM sodium phosphate 
buffer pH 7.0 
CNBr-coupling buffer 
100 mM NaHCO3 pH 8.3 
500 mM NaCl 
CNBr-swelling solution 
1 mM HCl 
Blocking buffer 
100 mM Tris pH 8.0 
Washing solution (acidic) 
100 mM sodium acetate pH 4.0 
500 mM NaCl 
Pull down buffer 
20 mM HEPES pH 7.4 
100 mM KCl 
2 mM MgCl2 
1% Triton X-100 
Elution buffer 
0.1 M glycine pH 2.7 
10 x binding buffer 
200 mM sodium phosphate 
buffer pH 7.0 
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buffer. OD280 was measured of each fraction and we calculated the protein concentrations 
assuming a specific extinction coefficient of 1.4 (ml•cm-1•mg-1) for IgGs. Fractions exhibiting 
concentrations higher than 0.7 mg/ml were pooled. We purified 28 mg of negative control 
IgGs (pre-immune) and 50 mg of anti-stonin 2 IgGs from 9 ml serum. Purified IgGs were 
dialyzed against CNBr-coupling buffer overnight.  
For coupling IgGs to Sepharose beads we incubated 700 mg of lyophilized CNBr-activated 
SepharoseTM beads in 10 ml CNBr-swelling buffer for 10 minutes at room temperature on a 
rotating wheel. To harvest the beads we centrifuged at 1000 x g for 5 minutes. We washed the 
beads 4 x in 10 ml CNBr-swelling buffer and 1 x in CNBr-coupling buffer. We loaded 28 mg 
of purified IgGs dialyzed against CNBr-coupling buffer at a concentration of 4.5 mg/ml on to 
the welled and washed activated Sepharose beads and incubated for 1 hour at room 
temperature on a rotating wheel. We verified successful binding by quantifying the protein 
concentration in the supernatant which was nearly zero. The beads were washed once with   
10 ml coupling buffer and incubated overnight at 4°C with blocking buffer to block free 
activated imidocarbonate groups on the Sepharose surface. We washed the beads 6 times 
alternating in washing buffer acidic and coupling buffer and twice with PBS thereafter. IgG 
beads were stored in 3 ml 80% PBS, 20% ethanol, 1 mM MgCl2.  
For the large-scale immunoprecipitation we used 200 µl of the anti-stonin 2 and pre-immune 
bead slurry and washed with pull down buffer containing 1 % Triton X-100. Rat brain extract 
of 1 rat brain was prepared as described in chapter 3.4.10. The brain extract was distributed 
equally on to anti-stonin 2 and control IgG beads and incubated at 4°C for 3 hours. Beads 
were washed 3 times in 1 ml pull down buffer and twice in 1 ml pull down buffer lacking 
Triton X-100. Supernatant was removed completely and bound proteins were eluted with   
100 µl 1 x SDS PAGE sample buffer. Samples were loaded on 8 and 10% SDS PAGE gels 
and stained with colloidal Coomassie. Precipitated protein bands were excised from the gel 
and subjected to mass spectrometry for identification (see 3.4.19). 
 
3.4.17 SDS PAGE 
Denaturing sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS PAGE) is a 
commonly used method to separate proteins on polyacrylamide gels according to their size 
(Laemmli, 1970). The anionic detergent sodium dodecyl sulfate (SDS) denatures the 
secondary and non-covalently linked tertiary structures of proteins. In addition, it provides the 
protein with a negative charge. SDS binds to the protein in a ratio of approximately 1.4 : 1 
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(SDS : protein), resulting in a relatively uniform mass : charge ratio for most proteins. In 
order to completely denature secondary, and also disulfide-bridged tertiary and quaternary 
structures the sample buffer is supplemented with reducing reagents, such as dithiothreitol 
(DTT) or β-mercaptoethanol (2-ME), and the samples are further denatured by boiling. The 
uniform mass to charge ratio and the complete elimination of secondary and tertiary structures 




















We used denaturing SDS PAGE for protein separation either in combination with Coomassie 
staining or for subsequent immunoblotting. We used the Rotiphorese® Gel 30 (30% 
Acrylamide / 0.8% bis-Acrylamide) stock solution from Roth (Karlsruhe) for separating and 
stacking gels, which were prepared and poured as described above. Protein samples were 
supplemented to a final sample buffer concentration of 1 x and heated to 95°C for 5 minutes 
before loading on to the gels using a Hamilton pipette. As molecular weight standards we 
either used self-made markers (low and high molecular weight marker) or commercially 
available protein ladders (Protein Marker Broad Range 2-212 kDa, Prestained Protein Marker 
4 x Stacking gel buffer 
0.5 M Tris pH 6.8 
0.4% (w/v) SDS 
4 x Separating gel buffer 
1.5 M Tris pH 8.8 
0.4% (w/v) SDS 
6 x Sample buffer 
375 mM Tris pH 6.8 
60% (v/v) glycerol 
30% (v/v) 2-mercaptoethanol 
18% (w/v) SDS 
0.3% (w/v) bromphenol blue 
3.8% Stacking gel (5 ml) 
ddH2O       3.25 ml 
4 x stacking gel buffer    1.25 ml 
30% acrylamide/0.8% bis-acrylamide  0.625 ml 
10% ammonium persulfate (APS)  75 µl 
TEMED       7.5 µl 
Separating gels (15 ml)     8%    10%     12%     14% 
ddH2O        7 ml   6 ml      5 ml   4 ml 
4 x separating gel buffer   3.75 ml  3.75 ml  3.75 ml  3.75 ml 
30% acrylamide/0.8% bis-acrylamide  4 ml   5 ml   6 ml   7 ml 
10% ammonium persulfate (APS)  75 µl   75 µl   75 µl    75 µl 
TEMED       7.5 µl   7.5 µl   7.5 µl   7.5 µl 
Low molecular weight marker  (LMW)  High molecular weight marker (HMW) 
1 µg lysozyme (14 kDa)    0.1 µg glutamic dehydrogenase (55 kDa) 
4 µg trypsin inhibitor (21 kDa)   1 µg transferrin (76 kDa) 
2 µg GST (27 kDa)    2 µg phosphorylase B (97 kDa) 
5 µg GST-Arf6 (45 kDa)    2 µg β-galactosidase (116 kDa) 
2 µg BSA (66 kDa)    10 µg myosin (220 kDa) 
2 µg phosphorylase B (97 kDa)   per 1 ml 1 x sample buffer 
5 µg myosin (220 kDa)     
per 1 ml 1 x sample buffer    
       
SDS PAGE Running buffer 
25 mM Tris pH 8.8 
192 mM glycine 
0.1% (w/v) SDS 
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Broad Range 6-175 kDa, NEB, Schwalbach). We used self-made vertical slab gel units for the 
actual electrophoresis in SDS PAGE running buffer at 20 mA. The electrophoresis was 
completed when the bromphenol blue band exited the gel (after approximately 90 minutes). 
Gels were then either stained in Coomassie staining solution for about 10 minutes or applied 
to Western blotting. Coomassie stained gels were destained 2 or 3 times in Destaining 
solution before they were incubated in water for a couple of hours. For storage gels were dried 








For Western blotting proteins were separated by SDS PAGE and subsequently transferred on 
to a nitrocellulose membrane (Whatman Biometra, Göttingen) using the semi-dry Biometra 
blotting system FastBlot B44. The size of the gel was measured and 6 3MM filter paper 
rectangles and one nitrocellulose piece in the same dimensions as the gel were prepared. 3 
filter papers were soaked in blotting buffer and subsequently placed on the anode of the 
blotting apparatus. Then the soaked nitrocellulose and the polyacrylamide gel were placed on 
the stack. Three soaked filter papers were put on top of the assembly. We transferred the 
proteins at 1 mA/cm² for 2 hours before the nitrocellulose membrane was stained with 
Ponceau S staining solution for 5 minutes on a shaker and destained in 1% acetic acid. The 
stained membrane was scanned and protein molecular weight marker bands were labeled 
before the membrane was blocked in blotto for 1 hour at room temperature. The membrane 
was shortly washed with TBS and primary antibodies were applied in TBS, 2% BSA, 0.02% 
sodium azide for 2 hours at room temperature on a shaker. The blots were washed 3 times for 
10 minutes in blotto before the secondary horseradish peroxidase labeled goat-anti-mouse or 
goat-anti-rabbit antibodies were applied in blotto at a dilution of 1:5000 for 1 hour at room 
temperature. The membranes were again washed 3 times 10 minutes in blotto and once in 
TBS before the blots were developed using the ECL Western Blotting Detection Reagents 
from GE Healthcare (Munich). ECL stands for enhanced chemiluminescence, a system taking 
advantage of the phenomenon of chemiluminescence, which is produced during the 
Blotto 
4% (w/v) non-fat dry milk 
in TBS 
Ponceau S staining solution 
0.2% (w/v) Ponceau S 
1% (v/v) acetic acid 
Blotting buffer 
20 mM Tris-HCl pH 8.8 
154 mM glycine 
0.08% (w/v) SDS 
20% methanol 
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horseradish peroxidase / hydrogen peroxide catalyzed oxidation of luminol, a cyclic 
diacylhydrazide, in alkaline conditions. Immediately following oxidation, the luminol is in an 
excited state, which then decays to ground state via a light emitting pathway. Using the ECL 
detection kit from GE Healthcare the light emitted peaks at around 5 to 20 minutes and decays 
with a half-life of 60 minutes. We used the Hyperfilm ECL (GE Healthcare) for detection of 
the emitted light with an emission maximum at a wavelength of 428 nm.  
As ECL detection does not offer a reliable means for quantification we used [125I]-Protein A 
decoration for quantitative analyses of Western blots. Protein A binds efficiently well to 
rabbit IgG, however, mouse IgGs are not recognized significantly. Therefore, we amplified 
the signal using unlabeled rabbit-anti-mouse (1:2000 in TBS, 2% BSA, 0.2% sodium azide 
for 1 hour at room temperature) antibodies for protein detection with mouse monoclonal 
antibodies. [125I]-Protein A was diluted 1:1000 in blotto and incubated for 1 hour at room 
temperature on a shaker. Membranes were washed 3 times 15 minutes in blotto and once in 
TBS before exposure to a phosphoimager screen for at least 1 hour or overnight. We used the 
Cyclone Autoradiography System (Packard Biosciences) for the read out.  
 
3.4.19 Tryptic ‘In Gel Digest’ for Mass Spectrometry  
For the identification of unknown protein bands on Coomassie stained SDS PAGE gels we 
excised the relevant bands and subjected them to in gel digest with trypsin. The actual mass 
spectrometric analysis was either performed by Dr. Peter Franke or Dr. Christoph Weise, 
Institute for Chemistry and Biochemistry, FU Berlin. For the Coomassie staining of the gels 
we used freshly prepared colloidal Coomassie and destaining according to manufacturer’s 
instructions (Roth, Karlsruhe). Gel bands were excised under very clean conditions with new 
razor blades and cut into 1 mm3 big pieces. Gel fragments were transferred to a 500 µl 
reaction tube and incubated in a shaker in 20 µl of a 1:1 solution of acetonitrile : 100 mM 
NH4HCO3 for 15 minutes. Samples were shortly centrifuged, supernatant was exchanged for 
100% acetonitrile, and incubated for 5 minutes or until the gel pieces turn white. Acetonitrile 
was removed and gel pieces lyophilized for 10 minutes. For reduction of disulfide bridges the 
lyophilized gel pieces were incubated in 20 µl 100 mM DTT in 100 mM NH4HCO3 for        
30 minutes at 56°C. After incubation samples were shortly centrifuged, supernatant was 
removed and volume was measured. Gel pieces were again dehydrated twice by the addition 
of 20 µl 100% acetonitrile. Cysteine residues were covalently modified by 
carbamidomethylation by addition of 20 µl of 55 mM iodacetamide in 100 mM NH4HCO3 
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and incubation for 20 minutes at room temperature in the dark. Supernatant was removed and 
exchanged for 100 mM NH4HCO3 and incubated for 15 minutes at room temperature. Gel 
pieces were incubated in 20 µl 100% acetonitrile until they turn white and lyophilized for     
10 minutes. 12.5 µg/ml trypsin in 25 mM NH4HCO3 were prepared and added to the 
lyophilized gel pieces (volume: 20 µl minus volume of supernatant measured after reduction 
in DTT + 3 µl). Samples were placed for 30 minutes on ice before incubation at 37°C 
overnight. Samples were centrifuged and again incubated at 37°C for 30 minutes before the 
supernatant was removed (around 3 µl) and subjected to mass spectrometric analyses.  
 
3.4.20 Limited Proteolysis 
Limited proteolysis has been successfully used to probe for conformational features in 
proteins (Milhalyi, 1978; Neurath, 1980; reviewed in Fontana 2004), based on the restricted 
accessibility of folded protein domains to proteolytic attack (Fontana et al., 1986). We used 
limited proteolysis to gain insight into the folding properties of stonin 2. First, we wished to 
identify putative folded and therefore possibly soluble protein domains in stonin 2, and 
second, we compared structural features between stonin 2 wild-type and mutant proteins.   
 
For the identification of stably folded domains we purified HA-stonin 2 from stably 
transfected HEK293 cells by immunoprecipitation using an anti-HA specific antibody. 
Purified HA-stonin 2 was digested in presence of antibodies with trypsin (0 µg/ml, 1 µg/ml,   
5 µg/ml, 20 µg/ml) in pull down buffer (20 mM HEPES pH 7.4, 100 mM KCl, 2 mM MgCl2, 
1% Triton X-100) for 10 minutes at 37°C before the reaction was stopped by addition of hot  
6 x sample buffer. The samples were heated for 5 minutes to 95°C and subjected to SDS 
PAGE and Coomassie staining. Apparently stable protein fragments were excised from the 
gel and subjected to mass spectrometry (see 3.4.19) for identification of cleavage positions.  
 
We performed limited proteolysis to assess the folding properties of stonin 2 mutants by 
digestion of stonin 2-His6 purified from stable HEK cells (see 3.4.7) or in vitro transcribed / 
translated stonin 2 (see 3.4.15). Trypsin (0 µg/ml to 20 µg/ml) and Proteinase K (0 ng/ml to 
80 ng/ml) were chosen for this purpose. Proteolysis reactions were performed in 20 mM 
HEPES pH 7.4, 100 mM KCl, 2 mM MgCl2 for in vitro translated stonin 2 and in 20 mM 
HEPES pH 7.4, 150 mM NaCl, 2 mM MgCl2, 320 mM sucrose, 1% CHAPS, 1 mM DTT,    
10 mM imidazole for purified stonin 2-His6 for 10 minutes at 37°C or 30°C. In vitro 
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translated digested protein was analyzed by SDS PAGE and autoradiography, stonin 2-His6 
by immunoblotting for the His6-tag.  
 
3.5 Cell Biological Methods 
3.5.4 Tissue Culture Cell Lines 
For immunostaining, immunoprecipitation, and endocytosis experiments we used the 
following mammalian cell lines: African Green Monkey Kidney fibroblasts (Cos7), Human 
Embryonic Kidney fibroblasts (HEK293), Mouse Neuroblastoma cells (N1E-155), Normal 
Rat Kidney fibroblasts (NRK), and HEK293 cells carrying an integrated FRT site allowing 
for Flp recombinase-dependent integration of a target gene into the host genome (Flp-InTM-
293). Cos7 and HEK293 cells were purchased from the German Resource Center for 
Biological Material (DSMZ, Braunschweig), NIE-115 were a gift from the lab of H. 
Neumann at the European Neuroscience Institute, Göttingen, and the NRK cells were kindly 
provided by S. Höning, Institute for Biochemistry, University Göttingen. Flp-InTM-293 cells 
were a generous gift from M. Missler, Institute for Physiology, University Göttingen, and are 
commercially available from Invitrogen (Karlsruhe). In addition to these commercially 
available cell lines we generated stable cell lines. HEK293 cells carrying a lumenally FLAG-
tagged rat synaptotagmin 1 construct were generated by M. Kasim Diril. Michael Krauß 
established a cell line allowing for inducible expression of a stably integrated target gene by 
introducing the pcDNA6/TR plasmid into the Flp-InTM-293 cells (Flp-InTM T-RExTM-293 
cells). These cells were used to generate HEK293 cell lines allowing for doxycycline 
inducible expression of amino-terminally HA-tagged stonin 2 constructs (wild-type; 
δWFδNPF mutant: all WVxF motifs are mutated to AVxA, and NPF moifs to NAV; δKYE 
mutant: KYE783.785AAA; δWFδNPFδKYE: δWFδNPF and δKYE mutations combined). 
For more information on stably transfected cell lines see chapter 3.5.10. 
 
3.5.5 Cultivation of Cell Lines 
Mammalian cell lines were cultured in carbon dioxide incubators from Thermo Electron 
(Langenselbold), at 37°C, 5% carbon dioxide, and 95% humidity. Media were purchased from 
GibcoBRL (Eggenstein). In general, we used Dulbecco’s modified Eagle’s medium (DMEM) 
containing glutamax, sodium pyruvate, pyridoxine, and glucose, supplemented with 10% heat 
inactivated (30 min at 56°C) fetal calf serum, and antibiotics (50 units/ml Penicillin, 50 µg/ml 
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Streptomycin). Cos7 and NRK cells were cultured in 1000 mg/ml glucose, HEK293 and NIE-
115 cells in 4500 mg/ml glucose medium. Stably transfected cells were supplemented with 
appropriate antibiotics (HEK293 FLAG-syt1: 250 µg/ml Geneticin, Flp-InTM-293: 100 µg/ml 
Zeocin, Flp-InTM T-RExTM-293: 10 µg/ml Blasticidin + 100 µg/ml Zeocin, Flp-InTM T-
RExTM-293 HA-stonin 2: 10 µg/ml Blasticidin + 100 µg/ml Hygromycin). For starvation 
conditions or transfection we used Opti-MEM® I reduced serum medium, a modification of 
Eagle’s Minimal Essential Medium, buffered with HEPES and sodium bicarbonate (2.4 g/L) 
and supplemented with hypoxanthine, thymidine, sodium pyruvate, L-glutamine, trace 
elements, and growth factors. We used exclusively adherent cell lines which were generally 
passaged twice a week using the trypsin/EDTA solution from GibcoBRL for detachment.  
 




We stored cell lines in freezing medium in liquid nitrogen. For freezing the cells we 
disattached the cells from a 10 cm tissue culture dish by treatment with 2 ml trypsin/EDTA 
(GibcoBRL, Eggenstein). Trypsin/EDTA was inactivated by the addition of 8 ml serum-
containing medium. Cells were pelleted at 200 x g for 3 minutes and resuspended in 3 ml 
freezing medium. 1 ml aliquots were frozen at -80°C and transferred to liquid nitrogen 1 day 
to half a year after freezing.  
 














2 mM L-glutamine 




0.5 mM L-glutamine 
2% B27-supplement (GibcoBRL) 
2 to 4 µM cytosine arabinoside 
Hank’s solution 
Hank’s balanced salt solution w/o calcium or magnesium 
1 mM HEPES pH 7.4 
50 mg/L NaHCO3 
 
 Basic medium 
 Minimal Essential Medium 
 1.25 g/L glucose 
 50 mg/L NaHCO3 
 25 mg/L transferrin 
Freezing medium 
10% DMSO 
90% fetal calf serum (FCS) 





Primary cortical and CA1 / CA3 hippocampal neurons of 1 to 3 day old Wistar rats were 
prepared in sparse culture according to previously described protocols with minor variations 
(Malgaroli and Tsien, 1992; Liu and Tsien, 1995). Reagents and media were purchased from 
GibcoBRL (Eggenstein), unless stated differently. The basic medium was Minimal Essential 
Medium without phenol red. The cortex of a Wistar rat (postnatal day P0 to P2) was prepared 
under sterile conditions by removing stem and hind brain as well as meninges. The two 
hemispheres were put separately into ice-cooled Hank’s containing 20% fetal bovine serum 
(FBS). When needed hippocampi were dissected under sterile conditions for the preparation 
of CA1 and CA3 hippocampal neurons. Hippocampi or cortices were sliced into small 
fragments (1 to 2 mm) and transferred to a 15 ml centrifuge tube. The supernatant was 
aspirated off and tissue slices were rinsed 2 times with Hank's solution + 20% FBS, and 2 to 3 
times with Hank's solution alone. Tissue pieces were then digested with 12 mg trypsin 
(Sigma) and 1mg DNase (Sigma) in 2 ml digestion for 10 min at 37 °C. After that, tissue 
pieces were rinsed 2 times with Hank's solution + 20% FBS to block tryptic activity and then 
3 times with plain Hank's solution. Cells were dissociated mechanically in the presence of      
1 mg DNase in 2 ml dissociation solution by gentle trituration using two siliconized pasteur 
pipettes, the second one fire-polished to nearly half the normal diameter (a little less than       
1 mm). Pipetting was continued until no chunks of tissue remained (usually about 15 times). 
Three ml of Hank's solution + 20% FBS were added, and cells were centrifuged for               
10 minutes at 200 x g at 4 °C. Pelleted cells were resuspended in 1 ml of Plating medium and 
cell density was determined by counting using a hemacytometer. 50,000 – 100,000 cells were 
plated per 18 mm diameter Matrigel-coated (Beckton-Dickinson) cover slips. Matrigel coating 
was performed by covering the cover slips with Matrigel (1:50 in basic medium) and 
incubation at 37°C for at least 1 hour. Matrigel was aspirated off shortly before plating. Cells 
were incubated for 60 to 120 minutes at 37 °C to allow cells to settle and attach. Finally, the 
wells were flooded with 1 ml Plating Medium containing 2 mM L-glutamine to promote 
proliferation of glial cells and antibiotics (50 units/ml Penicillin, 50 µg/ml Streptomycin). 
After two days cells were fed by removing 500 µl of the Plating Medium and addition of 1 ml 
growth medium. Cultures were maintained at 37 °C in a 95 % air/ 5 % CO2 humidified 
incubator and were fed 3 days after plating by removing about half of the medium and 
Dissociation solution 
Hank’s solution 
12 mM MgSO4 
Digestion solution 
25 mM HEPES pH 7.4 
137 mM NaCl 
5 mM KCl 
7 mM Na2HPO4 
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addition of the same volume fresh growth medium. Cells were maintained in culture for up to 
4 weeks.  
 
3.5.8 Transfection of Cell Lines  
For transfection of cell lines with plasmid constructs we used the liposome based transfection 
reagent LipofectamineTM 2000 from Invitrogen (Karlsruhe) essentially according to 
manufacturer’s instructions with minor variations (Table 3-4). DNA and LipofectamineTM 
2000 were separately diluted in Opti-MEM® in poly-styrol reaction tubes and incubated for   
5 minutes at room temperature before the solutions were mixed. After incubation of              
25 minutes at room temperature the DNA / LipofectamineTM 2000 mixture was added to the 
cells to be transfected, which were incubated at 37°C for 4 hours before the medium was 
changed. Cells were analyzed 24 to 48 hours after transfection 
 
Table 3-4: Commonly used reagent volumes for LipofectamineTM 2000 transfection 










12-well plate 0.75 50 1 2 
6-well plate 1.5 100 2 4 
6 cm dish 3.0 200 5 10 
10 cm dish 7.5 500 10 20 
*    volume for separate dilution of DNA and Lipofectamine
TM
 2000  final volume to be added to the 
cells double this amount 
 
3.5.9 Transfection of Primary Neurons and Astrocytes 
Primary hippocampal and cortical neurons as well as astrocytes were transfected using the 
Effectene transfection reagent from Qiagen (Hilden) according to manufacturer’s instructions. 
Effectene is a non-liposomal lipid formulation exhibiting minimal cytotoxicity by transfecting 
in the presence of serum and is therefore suitable for transfection of sensitive primary cells. 
The Effectene transfection kit provided EC buffer, enhancer, and Effectene reagent. We 
achieved the best transfection efficiencies when neurons were transfected at DIV9. For the 
transfection of cells in a 12 well plate well we diluted 0.3 µg DNA in EC buffer (final volume 
75 µl with DNA and enhancer) and added 2.4 µl enhancer. The solution was mixed by 
vortexing for 1 second and incubated at room temperature for 2 to 5 minutes before 6 µl 
Effectene were added. Again we mixed by vortexing for 10 seconds and incubated at room 
temperature for 5 to 10 minutes. We removed the medium of the neurons with a remainder of 
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800 µl and used 400 µl of the removed, conditioned medium to add to the Effectene / DNA 
mixture, which was added to the cells after short mixing. Medium was changed to conditioned 
medium 24 hours after transfection if cells were not analyzed by immunofluorescence by that 
time.  
For co-immunoprecipitation experiments performed from neuronal protein extracts, we used 
Semliki Forest Virus for transfection of neurons. The Semliki Forest Virus particles were 
generated and kindly provided by Ralf Nehring and Dirk Reuter, Department for membrane 
biophysics, Max-Planck-Institute for Biophysical Chemistry, Göttingen. We generally used 
400 µl of activated virus particle preparation for infection of a neuronal preparation at DIV5 
on a MatrigelTM coated 10 cm tissue culture dish.  
 
3.5.10 Generation of Stably Transfected Cell Lines 
For the generation of stably transfected cell lines we used the Flp-InTM T-RExTM-293 cell line 
generated by Michael Krauß. This cell line consists of a HEK293 strain that contains the FLP 
Recombination Target (FRT) site for Flp recombinase-mediated integration of a target gene 
into the host genome. In addition, this cell line was stably transfected with the pcDNA6/TR 
vector expressing high levels of the tetracycline (Tet) repressor under the control of the 
human cytomegalovirus immediate-early (CMV) promoter allowing for Tet-inducible 
(doxycycline-inducible) expression of a target gene. The cDNA of interest was cloned into the 
inducible expression vector pcDNA5/FRT/TO© (Figure 3-11) and co-transfected into Flp-
InTM T-RExTM-293 cells with a vector encoding for the Flp recombinase (pOG44). The Flp-
InTM T-RExTM system was developed and is available from Invitrogen (Karlsruhe) and 
detailed information can be obtained from their World Wide Web site www.invitrogen.com. 
Especially useful is the Flp-InTM T-RExTM Core Kit manual. In brief, pcDNA5/FRT/TO© 
carries the target cDNA under the control of a hybrid CMV/TetO2 promoter for high-level, 
Tet-regulated expression. A single FRT site is located immediately upstream of the 
hygromycin resistance gene that lacks a promoter and an ATG initiation codon. Upon co-
transfection of the pcDNA5/FRT/TO© construct with pOG44 (encoding for the Flp 
recombinase) into Flp-InTM T-RExTM cells the Flp recombinase catalyzes the integration of 
the entire pcDNA5/FRT/TO© construct into the genome of the host cells at precisely the FRT 
site. This reconstitutes the hygromycin resistance with a promoter and a start codon and 
disrupts the zeocin resistance gene of the host. In theory, by application of hygromycin, only 
clones with integrated target construct should be selected. By the addition of 1 µg/ml 
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doxycycline the Tet-repressor will be removed from the Tet-inducible promoter and the target 








For generating these stable cell lines we co-transfected the pcDNA5/FRT/TO© constructs 
(Figure 3-12) into Flp-InTM T-RExTM cells (cultured in medium containing blasticidin and 
zeocin) with LipofectamineTM 2000 (see 3.5.8) in a 6 well plate and transferred the cells to 
three 10 cm dishes 20 hours after transfection. The medium was supplemented with 
blasticidin and hygromycin for selection. Cells were incubated for up to 3 weeks before 
clones were picked into 96 or 24 well plates depending on the size of the colonies. 
Doxycycline-inducible expression of the target gene was confirmed by immunofluorescence 









This vector was used to generate cell lines 
allowing for stable, Flp recombinase-
mediated integration of a tetracycline-
inducible target construct. PCMV/2xTetO2: 
hybrid CMV promoter carrying Tet repressor 
responsive tetracycline operator; FRT: Flp 
recombination target site. Taken from 
Invitrogen instruction manual 110201, 25-
0368, version D 
Figure 3-12: Stonin 2 constructs 






Human stonin 2 constructs (aa 1-898) 
were cloned into pcDNA5/FRT/TO©. 
δWFδNPF: all WVxF motifs were 
mutated to AVxA, all NPF motifs were 
mutated to NAV; δKYE: KYE783-
785AAA; HA: hemagglutinin tag. 
Materials and Methods  95 
 
3.5.11 Transferrin and Epidermal Growth Factor Endocytosis in 
Fibroblasts 
We used fluorescence-labeled transferrin (Tf) and epidermal growth factor (EGF) 
internalization as a read out for endocytosis. Human Tf-Alexa488, -Alexa594, and EGF-
Texas Red (EGF-TxR) were purchased from Molecular Probes (MoBiTec, Göttingen). 18 mm 
diameter sterile glass cover slips were coated with MatrigelTM (1:50 in Opti-MEM®) for         
1 hour at 37°C, cells were plated and incubated overnight at 37°C. Medium was changed to 
Opti-MEM® 2 hours before Tf or EGF uptake for the purpose of starvation. Tf was diluted in 
Opti-MEM® to a concentration of 20 µg/ml, EGF to a concentration of 0.2 µg/ml. In general, 
cells were allowed to internalize labeled ligands for 15 to 20 minutes at 37°C. Cells were 
transferred on ice immediately after incubation time was completed and washed three times 
with ice-cold PBS containing 10 mM MgCl2. Cells were fixed with 4% paraformaldehyde, 
4% sucrose in 120 mM sodium phosphate buffer (pH 7.4) for 20 minutes at room 
temperature. Depending on the experiment, cells were either mounted immediately or further 
immunofluorescence staining was carried out. Cells were mounted using Immumount 
(Thermo Electron, Langenselbold) mounting reagent supplemented with x 4',6-Diamidino-2-
phenylindole (DAPI) to stain the nuclei.  
 
3.5.12 Inhibition of Endocytosis 
We used overexpression of dominant-negative constructs (see chapter 3.1.9.1) to inhibit 
endocytosis in fibroblasts and primary hippocampal neurons (Figure 3-13). Fibroblasts were 
transfected with LipofectamineTM 2000, neurons were transduced by application of Semliki 
Forest Virus particles (see chapter 3.5.8). The effect of endocytosis inhibition was studied by 
assaying internalization of fluorescence-labeled transferrin (see chapter 3.5.11). 
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Our second approach to inhibit endocytosis was the application of Dynasore (Figure 3-14), a 
small molecule, cell-permeable inhibitor of dynamin (Macia et al., 2006). Serum-containing 
medium was removed, cells were washed with PBS, and cultured in Opti-MEM® for 1 hour. 
Dynasore was applied at 80 µM from a 40 mM stock in DMSO for at least 5 minutes before 
endocytosis assays were carried out. We performed transferrin, EGF, or antibody uptake 











Figure 3-13: Schematic representation of the effect of dominant-negative 
amphiphysin constructs on clathrin-mediated endocytosis. 
By overexpression of the clathrin an AP-2 binding (CLAP) B/C domain of 
amphiphysin we aimed at disrupting AP-2 and clathrin function in clathrin-mediated 
endocytosis. Overexpression of the SH3 domain is supposed to inhibit endocytosis 
by mis-targeting dynamin.  
 
Figure 3-14: Chemical structure of Dynasore 
Dynasore is a small molecule, cell-permeable inhibitor of dynamin and 
can be applied for inhibition of dynamin-dependent endocytic pathways 
by inhibiting the GTPase activity of dynamin. Taken from Macia et al., 
2006. 
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3.5.13 Antibody Internalization in Fibroblasts 
To follow synaptotagmin endocytosis in fibroblasts we performed antibody internalization 
experiments. Cells were transfected with lumenally FLAG-tagged synaptotagmin 1 constructs 
either in presence or absence of HA-tagged stonin 2. Alternatively, stable HEK293 FLAG-
syt1 cells were transfected with HA-tagged stonin 2 constructs. Transfected cells were plated 
on MatrigelTM coated cover slips and allowed to spread for 15 to 24 hours. Anti-FLAG 
monoclonal (M2, 1:1000) or polyclonal (1:100) antibodies were diluted in Opti-MEM® and 
70 µl of the antibody solution was applied per cover slip on Parafilm® M plastic film. 
Internalization was generally allowed for 20 minutes at 37°C before samples were placed on 
ice, washed 2 x 2 minutes in ice cold PBS, fixed in 4% paraformaldehyde, 4% sucrose in    
120 mM sodium phosphate buffer. In some exceptions methanol fixation for 7 minutes at       
-20°C was performed. Generally, we stained for surface bound antibody under non-
permeabilizing conditions by application of Alexa594-labeled goat-anti-mouse (-rabbit) 
antibodies at a dilution of 1:200. Then cells were permeabilized and internalized antibodies 
were stained in green (Alexa488-labeled goat-anti-mouse or -rabbit antibodies 1:200). For a 
more detailed staining protocol see chapter 3.5.15Indirect Immunofluorescence .  
 
3.5.14 Membrane Recruitment Assay 
Membrane recruitment assays were performed in N1E-115 cells, which were co-transfected 
with lumenally FLAG-tagged synaptotagmin 1 and amino-terminally HA-tagged stonin 2 
constructs. We wanted to assess the ability of different synaptotagmin 1 mutants to recruit 
stonin 2 (δWFδNPF) to the plasma membrane, or of different stonin 2 mutants to be recruited 
by synaptotagmin 1 wild-type. After transfection cells were plated on Matrigel® coated cover 
slips and incubated for 15 hours at 37°C before fixation in 4% paraformaldehyde, 4% sucrose 
in 120 mM sodium phosphate buffer. Cells were stained for surface synaptotagmin 1 under 
non-permeabilizing conditions using the monoclonal anti-FLAG antibody (M2) and the goat-
anti-mouse Alexa594-labeled (red) secondary antibody. After permeabilization we used the 
polyclonal anti-stonin 2 antiserum and the Alexa488-labeled goat-anti-rabbit secondary 
antibody to decorate for internal stonin 2. Cells were mounted using the DAPI supplemented 
Immumount (Thermo Electron) mounting reagent.  
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18 mm diameter glass cover slips were coated with MatrigelTM (1:50 in Opti-MEM) for at 
least 1 hour at 37°C. Excess MatrigelTM was aspirated off the cover slips, cells were plated 
and cultured in a carbon dioxide, humidified incubator at 37°C. For immunofluorescence 
staining cells were washed twice with PBS before fixation. Cells were fixed either with 4% 
paraformaldehyde, 4% sucrose in 120 mM sodium phosphate buffer pH 7.4 for 1 hour at 
room temperature or with 100% ice cold methanol for 7 min at -20°C. After removing the 
fixative and washing with PBS, cells were blocked either under non-permeabilizing 
conditions with non-permeabilizing blocking solution or permeabilized in GSDB for 15 min 
at room temperature. Primary antibodies were diluted in the respective blocking solution and 
applied to the cover slips in a humidity chamber. Cover slips were placed upside down onto 
antibody solution drops of 30 – 50 µl. Incubation was performed at room temperature for 1 
hour before cells were washed three times for 10 min each (for non-permeabilizing conditions 
in HSPBS lacking Triton X-100, for permeabilizing conditions in HSPBS containing Triton 
X-100). Alexa-labeled secondary antibodies were also diluted in the appropriate blocking 
solution and applied in a humidity chamber for 1 hour at room temperature. Secondary 
antibodies were generally used at 1:200 dilutions (exception: GαR-Cy5 1:50). Cells were 
washed once for 5 minutes with HSPBS, and twice for 5 minutes each with 120 mM sodium 
phosphate buffer pH 7.4 and subjected to microscopic analyses (see 3.5.16 Microscopical 
Analyses and Fluorescence Quantification) after mounting with Immumount mounting 
reagent from Thermo Electron supplemented with x 4',6-Diamidino-2-phenylindole (DAPI).  
 
3.5.16 Microscopical Analyses and Fluorescence Quantification 
We used the Zeiss Axiovert 200M Digital Research Microscopy System (see 3.1.12 Devices 
and Equipment) under the control of the Slidebook 4.0.8 Digital Microscopy Software from 
Intelligent Imaging Innovations (Göttingen) for analyzing immunofluorescence experiments. 
Goat serum dilution buffer (GSDB) 
15 mM sodium phosphate buffer pH 7.4 
385 mM NaCl 
0.23% (w/v) Triton X-100 
30% (v/v) goat serum 
Non-permeabilizing blocking solution 
15 mM sodium phosphate buffer pH 7.4 
385 mM NaCl 
30% (v/v) goat serum 
High salt PBS (HSPBS) 
20 mM sodium phosphate buffer pH 7.4 
500 mM NaCl 
+/- 0.3% (w/v) Triton X-100 
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This microscope image processing setup allows for quasi-confocal imaging by the 
deconvolution technology, using three possible software algorithms, ‘no neighbor 
deconvolution’, ‘nearest neighbor deconvolution’, and ‘constrained iterative deconvolution’ 
employing the point spread function (PSF) of the objective used as basis for the algorithm. 
The term ‘deconvolution’ is specifically used to refer to the process of reversing the optical 
distortion that takes place in a microscope or other optical instruments, thus greatly improving 
z-resolution. The PSF, a mathematical function that describes the distortion in terms of the 
pathway a theoretical point source of light takes through the instrument, for our setup was 
determined using samples provided by Intelligent Imaging Innovations for this purpose.  
For quantification of antibody or transferrin internalization assays we used the Mask function 
of the Slidebook software. To quantify internalization of synaptotagmin 1 by different stonin 
2 wild-type and mutant constructs, a mask was generated representing all stonin 2 transfected 
cells (EGFP channel). Red fluorescence units lying within the green mask were quantified and 
related to the number of transfected cells. In doing so we determined a mean red fluorescence 
level per transfected cell. Generally, we used the 40 x objective and averaged over at least 10 
frames. To avoid problems caused by differences in syt1 expression levels between individual 
cells, we performed the experiment using the stable HEK293 FLAG-syt1 cell line.  
 
In order to quantify the inhibiting effect of dominant-negative constructs on transferrin 
endocytosis we used a similar setup as described above. Cos7 cells were transfected with HA-
tagged dominant-negative constructs and mutants thereof. Transferrin uptake was performed 
as described in chapter 3.5.11 and immunostaining for the HA-tag was performed. For the 
quantitative analysis we generated three masks, one for green fluorescence (transfected cells), 
one for red fluorescence (internalized transferrin), and one for DAPI (representing the total 
number of cells in this particular frame). We made use of following functions: number of 
green objects containing red fluorescence objects (number of transfected cells taking up 
transferrin), number of blue objects within green mask ( number of transfected cells), and 
number of blue objects outside the green mask ( number of untransfected cells). In addition 
we counted the number of untransfected cells that have internalized transferrin according to 
the parameters we set for the red mask. Using this information we calculated the percentage 
of transfected cells taking up transferrin normalized to the percentage of untransfected cells 
taking up transferrin per frame. In doing so we eliminated fluorescence intensity variations 
between frames and cover slips. This procedure was applied to at least 10 frames taken from 
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at least three different cover slips per sample. Quantitative data were displayed using the 
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4 Results 
The major aims of this work were (1) to study the role of clathrin/AP-2- and dynamin-
mediated endocytosis in hippocampal neurons in vivo, (2) to molecularly dissect the 
interaction of the AP-2 binding sorting adaptor stonin 2 with the synaptic vesicle membrane 
protein synaptotagmin 1, and (3) to identify novel stonin 2 interaction partners. In 
collaboration with the group of Dr. Jürgen Klingauf (Max-Planck-Institute for Biophysical 
Chemistry, Göttingen) we discovered that under intense stimulation the majority of synaptic 
vesicles is recycled via a clathrin/AP-2- and dynamin-dependent endocytic pathway in 
primary hippocampal neurons (chapter 4.1). Several studies have indicated an important role 
for the synaptic vesicle protein synaptotagmin 1 in clathrin-mediated synaptic vesicle 
recycling (Poskanzer et al., 2003; Llinas et al., 2004; Nicholson-Toshima et al., 2004). We 
found that stonin 2 mediated the AP-2/clathrin-dependent endocytosis of synaptotagmin 1. 
We will deal with the characterization of the stonin 2 – synaptotagmin 1 interaction in detail 
in chapter 4.2. 
In addition, we set out to learn more about stonin 2 functions by identifying additional 
interaction partners. We were able to identify a putative novel stonin 2 interacting protein, the 
G protein-coupled receptor kinase interacting protein 1 (GIT1), by large scale co-
immunoprecipitation from rat brain. The stonin 2 – GIT1 interaction is discussed in chapter 
4.3. 
 
4.1 Synaptic Vesicles in Primary Hippocampal Neurons Appear to 
be Mainly Recycled by Clathrin-Mediated Endocytosis 
Already thirty years ago Heuser & Reese (1973) found evidence for close coupling of 
exocytosis with appearance of clathrin-coated pits and vesicles in neurons. While it is 
indisputable that synaptic vesicle membrane has to be recycled, the mode of retrieval is 
controversially discussed. Depending on the type of synapse and the protocol of stimulation at 
least two modes of endocytosis were observed, a fast mode and a slow mode. While the slow 
mode is generally considered to be clathrin-dependent, there are different opinions regarding 
the fast mode of synaptic vesicle recycling. While some groups seem to have evidence that 
this fast form is also a clathrin-dependent mechanism, others show indications for a clathrin-
independent pathway, frequently referred to as kiss-and-run mechanism of synaptic vesicle 
recycling.  
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In this work, we wanted to contribute to the clarification of this controversial, highly complex 
topic. Our goal was to combine molecular tools allowing for elimination of clathrin-mediated 
endocytosis in primary hippocampal synapses with live cell imaging analyses of synaptic 
vesicle recycling. We reasoned that inhibiting essential molecular components of the 
clathrin/AP-2- and dynamin-dependent endocytosis should profoundly affect the extent and 
rate of SV retrieval while leaving putative kiss and run type exo/endocytic events 
unperturbed. To this aim we made use of a dominant-negative approach based on the 
sequestration of clathrin/AP-2 or dynamin following overexpression of amphiphysin 
inhibitory domains as detailed below (chapter 4.1.1). Blocking clathrin-mediated endocytosis 
by applying this method showed that a major fraction of synaptic vesicles is recycled via a 
clathrin-mediated pathway.  
 
4.1.1 Biochemical Characterization of Dominant-Negative Amphiphysin 
Constructs 
We decided to benefit from the detailed knowledge regarding amphiphysin-derived protein-
protein interaction domains and their effects on clathrin-mediated endocytosis. We chose the 
SH3 domain of amphiphysin, which interacts with the proline-rich region (PRD) of dynamin, 
recruiting dynamin to the neck of emerging clathrin coated pits. Dynamin in turn possesses 
the ability to pinch off free coated vesicles via a GTP hydrolysis-induced conformational 
change. Overexpression of the amphiphysin SH3 domain has been shown to inhibit vesicle 
fission essential for dynamin-dependent endocytic processes. Although dynamin is required 
for several forms of endocytosis, the dynamin PRD – amphiphysin SH3 domain interaction 
appears to be specific for clathrin-mediated endocytosis. The second dominant-negative 
domain we selected was the B/C domain of amphiphysin, harboring AP-2 and clathrin 
binding sites. Overexpression of the B/C domain has been shown to sequester clathrin and 
AP-2 and thereby inhibit their function. A schematic representation of the chosen domains 
and their mode of action are shown in Figure 4-1. As negative controls we generated mutated 
constructs deficient in binding their respective target proteins. In the SH3 domain G684 was 
mutated to arginine and P687 to leucine, which abolishes dynamin binding. The B/C domain 
was mutated within the AP-2 [FFD323-325SSR] and the clathrin binding sites [DLD355-
357HSR; WD382,382SR; compare Slepnev et al., 2000].  
In order to achieve rapid transfection and high protein expression we used the Semliki Forest 
Virus (SFV) system that allows for massive heterologous gene expression already 8 to          
Results  103 
 
16 hours post infection. To visualize infected neurons we co-expressed the cyan fluorescence 
protein (CFP) down-stream of an internal ribosomal entry site (IRES). The generated 




To biochemically characterize the developed tools we investigated whether the chosen 
domains were able to interact with their target proteins in living primary neurons. Rat 
embryonic (E18) cortical neurons were plated on 10 cm tissue culture dishes and infected 
with dominant-interfering Semliki Forest Virus (SFV) constructs at DIV5. 16 hours after 
infection Triton X-100 extracts were prepared from the infected neurons. Since the dominant-
negative domains contained an HA-tag, we performed anti-HA immunoprecipitation and 
analyzed for co-precipitated proteins by immunoblotting. We found that the SH3 domain was 
 
Figure 4-1:  Schematic representation of amphiphysin dominant-negative 
domains 
(A) We generated two dominant-negative constructs, the SH3 domain (545-695) 
and the B/C domain (250-578) of amphiphysin. The SH3 domain interacts with 
dynamin. Overexpression of this domain should mis-localize/sequester dynamin 
and thereby inhibit its function in vesicle fission. The B/C domain of amphiphysin 
harbors clathrin and AP-2 binding sites (CLAP). Following overexpression this 
domain sequesters clathrin and AP-2. (B) Schematic representation of the Semliki 
Forest Virus constructs generated to inhibit clathrin-mediated endocytosis in 
primary hippocampal neurons. An HA-tagged dominant-negative domain is 
followed by an IRES and the cDNA for CFP. IRES: internal ribosomal entry site; 
CFP: cyan fluorescence protein. 
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indeed able to interact with dynamin, while the SH3 GPRL mutant did not (Figure 4-2, panel 
A lane 4). AP-2 co-precipitated with the B/C domain of amphiphysin. Surprisingly, clathrin 
was not detected amongst the interacting proteins in this experiment (Figure 4-2, panel B), 
presumably due to its comparably low affinity binding site (Kd(CHC) ~ 20 - 30 µM; Kd(AP-2) 
~ 50 nM; Miele et al., 2004). Both clathrin and AP-2 were detected in affinity 
chromatography experiments using GST-fused amphiphysin B/C wild-type, but not its mutant 




Figure 4-2:  Co-immunoprecipitations of dominant-interfering amphiphysin domains with their 
target proteins from primary cortical neurons 
Rat embryonic (E18) cortical neurons were prepared and plated on 10 cm tissue culture dishes. Neurons 
were infected with the dominant-interfering Semliki Forest Virus constructs at DIV5. (A) We used the SH3 
domain of amphiphysin to target dynamin and as negative control a dynamin binding-deficient mutant 
thereof (GPRL: G684R, P687L, David et al., 1994). (B) To target clathrin and AP-2 we chose the B/C 
domain of amphiphysin harboring clathrin and AP-2 binding sites and as control a clathrin and AP-2 
binding-deficient B/C domain mutant (Slepnev et al., 2000). We prepared Triton X-100 extracts of the 
infected neurons 16 hours after infection and performed anti-HA immunoprecipitations, since the 
dominant-interfering domains harbor an HA-tag. Mock immunoprecipitation was performed using  
monoclonal anti-c-myc antibodies. Co-precipitated proteins were identified by immunoblotting for clathrin 
heavy chain (CHC), AP-2, and dynamin. Arrows mark co-precipitated target proteins, the asterix marks a 
ghost band recognized by the polyclonal anti-dynamin antibody. Standards correspond to 4% of the input.  
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4.1.2 Dominant-Negative Constructs Inhibit Transferrin Internalization in 
Fibroblasts 
We could show that both dominant-interfering domains were able to bind to their target 
proteins in neurons by co-immunoprecipitation or affinity chromatography. Next, we 
investigated whether these domains inhibit clathrin-mediated endocytosis in living cells. We 
chose transferrin uptake in fibroblasts as a model system for clathrin-dependent endocytosis. 
We transfected Cos7 cells with dominant-interfering constructs and examined their ability to 
internalize fluorescently labeled transferrin (Figure 4-3). Overexpression of both domains 
significantly reduced the ability of the transfected cells to take up transferrin. Around 70% of 
the transfected cells did not take up transferrin. A slight inhibition was also seen upon 
expression of mutant domains when compared to untransfected cells, presumably owed to 
non-specific effects caused by massive protein overexpression.  
 
 
In summary, we successfully generated molecular tools to inhibit clathrin-mediated 
endocytosis in neurons.  
 
Figure 4-3: Dominant-negative amphiphysin domains reduce transferrin internalization in fibroblasts 
(A) Cos7 fibroblasts were transfected with dominant-interfering amphiphysin domains. Transfected cells were 
visualized by co-expressed EGFP. After starving the cells in serum-free medium for 3 hours we applied 20 
µg/ml Alexa594-labeled transferrin and allowed for internalization for 20 minutes at 37°C. Cells were fixed in 
paraformaldehyde (4%) and mounted in presence of DAPI. The scale bar is 20 µm. (B) Quantification of the 
transferrin internalization depicted in (A). Two masks were generated using the Slidebook 4.0.8 Digital 
Microscopy Software (Intelligent Imaging Innovations). One mask included all transfected cells, the other 
mask all cells that had internalized transferrin. The fraction of cells internalizing transferrin was determined by 
applying a function calculating the number of objects in one mask that are contained in the second mask. The 
percentage of cells taking up transferrin was normalized to the fraction of untransfected cells with internalized 
transferrin. Error bars correspond to the standard error of the mean. n represents the number of cells used for 
the statistical analysis.  
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4.1.3 Hippocampal Synapses Perturbed in CME Contain Less Vesicles 
but Perform Exocytosis at Unaltered Release Probability 
This part of my work was performed in close collaboration with the group of Dr. Jürgen 
Klingauf. To assess the role of clathrin-mediated endocytosis in synaptic vesicle recycling in 
primary hippocampal neurons we overexpressed dominant-negative protein domains derived 
from the clathrin accessory protein amphiphysin and performed synaptic vesicle recycling 
analysis using the optical tracers FM1-43 and synaptopHluorin. In order to be able to interpret 
effects on endocytosis of synaptic vesicles (SVs) it is essential to determine the exocytosis 
competent SV pool size in the first place. Ultra-structural studies by electron microscopy 
(EM) (Figure 4-4, panel A) indicated a minor reduction in the vesicle number per bouton area 
at SH3 or B/C domain expressing boutons (Figure 4-4, panel B). However, the number of 
docked vesicles at the active zone was not significantly altered (Figure 4-4, panel C).  
 
Figure 4-4: Hippocampal synapses perturbed in CME contain fewer vesicles but undergo exocytosis at 
normal release probability  
(A) Electron micrographs of wild-type and synapses overexpressing SH3 and B/C domains of amphiphysin 
under resting conditions. (B) Ultrastructural analysis reveals a significant decrease of total vesicle number per 1 
µm of synapse area in synaptic boutons overexpressing B/C or SH3 domains. Morphological analysis was 
performed with Metamorph software. (C) The number of vesicles per active zone length appears to be unaltered 
between control and SH3 / B/C domain overexpressing neurons. (D) Average FM1-43 release kinetics are 
similar for neurons overexpressing control peptides (open circles), SH3 (closed circles), and B/C domains 
(closed triangles). The data are normalized to fluorescence signals before unloading after subtraction of non-
releasable background. Each data set represents the average of n(3)=142 (SH3 mutant) and n(4)=225 (B/C 
mutant) single boutons (within N measurements). Error bars are confidence intervals of the mean on 95% level. 
Experiments were carried out by Nataliya Glyvuk, Yaroslav Tsytsyura, and Maria Krikunova. 
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In order to assess the effect of overexpressing these inhibitory domains on SV cycling at 
hippocampal synapses FM1-43 dye release experiments were performed. Hippocampal 
neurons were transfected with control (open circles), SH3 (closed circles), or B/C (closed 
triangles) domain containing SFV constructs. Neurons were stimulated in presence of FM1-43 
with 750 action potentials (APs) at 10 Hz to guarantee loading saturation. The dye was kept 
on the cells for 1 minute after stimulation to ensure labeling of most endocytosed vesicles. 
After extensive washing for 10 minutes neurons were stimulated with 900 APs at 10 Hz for 
maximal destaining, and destaining kinetics were recorded. ∆F values between fluorescence 
(F) units before and after destaining were calculated and normalized to F before destaining. 
No significant differences were observed for synapses expressing control peptides or 
amphiphysin SH3 or B/C domains regarding destaining kinetics (Figure 4-4, panel D), 
indicating normal release probability for CME perturbed neurons. In summary, together with 
our co-workers we found that the number of vesicles at the active zones was not significantly 
different between control synapses and boutons expressing SH3 or B/C domains, even though 
the total number of vesicles per bouton was slightly decreased in CME perturbed neurons. 
Docked vesicles in CME-impaired boutons were released with unaltered release probability 
compared to control synapses.  
 
4.1.4 The Total Recycling Vesicle Pool is Decreased and Endocytosis is 
Slowed in CME Perturbed Synapses 
Since release probability and exocytosis were comparable between control synapses and 
boutons expressing dominant-interfering domains, endocytosis in CME perturbed neurons 
was analyzed. First, the recycling vesicle pool size was evaluated. Control, SH3, and B/C 
domain transfected neurons were stimulated in presence of FM1-43 dye with varying AP 
numbers (40 to 750 APs at 10 Hz). After extensive washing, boutons were maximally 
destained by application of 900 APs at 10 Hz. ∆F, the difference between total fluorescence 
after staining and fluorescence post destaining, was calculated and plotted versus AP number 
(Figure 4-5, panel A). The total recycling vesicle pool size can be calculated from the 
maximal ∆F. Taking the recycling vesicle pool size of control synapses (open circles) as 
100%, the recycling pool size in SH3 domain (closed circles) overexpressing boutons was 
reduced to 44%, in B/C domain (closed triangles) transfected synapses to 20% for strong  
stimulation conditions. Since there were no obvious defects in release probability and 
exocytosis-competent vesicle number we concluded that this drastic difference in total 
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recycling vesicle pool size must have resulted from endocytic defects. Inhibition of CME did 
not lead to significant differences regarding recycling vesicle pool size under mild stimulation 
of 40 APs at 10 Hz (only readily releasable pool affected; Stevens and Williams, 2000). 
Maximum ∆F values reached a plateau at around 600 APs, indicating that endocytosis can 
compensate for exocytic events up to an action potential number of 600. SH3 domain 
expressing boutons were working at full capacity already when 200 APs were applied, and 
B/C domain transfected synapses at 40 APs (Figure 4-5, panel A).  
 
SynaptopHluorin, a synaptobrevin lumenally tagged with a pH-sensitive GFP, was used to 
directly measure endocytosis kinetics at boutons expressing SH3 and B/C domains. 
Hippocampal neurons were transfected with dominant-interfering domains and 
synaptopHluorin constructs. Exocytosis (increase in fluorescence) and endocytosis (decrease 
of synaptopHluorin fluorescence) were recorded during stimulation with 300 APs. 
Fluorescence values were normalized to Fmax. Endocytosis was drastically slowed down at 
synapses transfected with dominant-interfering domains compared to control synapses (Figure 
 
Figure 4-5: Analysis of synaptic vesicle recycling in CME perturbed hippocampal neurons using the 
optical tracers FM1-43 and synaptopHluorin 
(A) Size of the functional synaptic vesicle pool in dependence on stimulus length measured on synapses 
overexpressing control (open circles), SH3 (closed circles) and B/C (closed triangles) peptides. Boutons were 
loaded with different numbers of APs and fully destained with 900 APs at 10 Hz. Number of individual 
boutons (n) and of experiments (N) for a given number of APs are as follows. Control (open circles): 40AP 
n(2)=31, 100AP n(1)=52, 200AP n(4)=196, 300AP n(3)=217, 500AP n(2)=131, 750AP n(2)=128. SH3 
(closed circles): 40AP n(2)=49, 100AP n(2)=24, 200AP n(4)=157, 300AP n(3)=94, 500AP n(2)=139, 750AP 
n(3)=116. B/C (closed triangles): 40AP n(1)=70, 100AP n(1)=67, 200AP n(6)=137, 300AP n(5)=112, 500AP 
n(2)=119, 750AP n(7)=183. The total recycling pool size for control and SH3 domain overexpressing 
synapses estimated from a single exponential fit is 1±0.02 (S.D.) and 0.44±0.02 (S.D.). The total recycling 
pool size for B/C domain over-expressing synapses does not show any dependence on stimulus length and 
was estimated as averaged value from all measurements taken for all stimulation conditions 20±0.02 (S.D.) 
Error bars are confidence intervals of the mean on 95% level. (B) Time course of AP train-evoked (300 APs) 
synaptopHluorin signals measured at 0.5 Hz from hippocampal synaptic boutons overexpressing SH3 (filled 
circles; n(6)=294 and B/C domains (closed triangles; n(6)=389) are significantly slowed down compared to 
control synapses (open circles; n(10)=745.The experiments were performed by Maria Krikunova and 
Yaroslav Tsytsyura.  
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4-5, panel B). In summary, synapses transfected with amphiphysin SH3 and B/C domains are 
reduced in total recycling vesicle pool size as a direct consequence of an endocytic defect. 
Endocytosis capacity is saturated at milder stimuli when compared to control synapses and 
slowed down.  
 
4.1.5 Dominant-Interfering Amphiphysin Domains Affect Synaptic 
Vesicle Size 
In order to understand the mechanistic reason for the endocytic defect caused by 
overexpression of SH3 and B/C domains at the ultra-structural level, EM analysis on 
stimulated boutons (750 APs at 10 Hz) was carried out. A significant increase in vesicle size 
and accumulation of endosome-like structures was observed for CME perturbed boutons 
compared to control synapses (Figure 4-6). Overexpression of the SH3 domain resulted in 
accumulation of endocytic intermediates resembling endocytic structures coated with clathrin. 
















Figure 4-6: Inhibition of CME results in increased synaptic vesicle size  
(A) Histogram of vesicle diameter for wild-type (gray, n=3729 vesicles, 34 synapses) and synapses 
overexpressing SH3 (black, n=2796 vesicles, 36 synapses) and B/C (red, n=2467 vesicles, 20 synapses) 
domains. (B) EM micrographs of wild-type and synapses overexpressing SH3 and B/C domains of amphiphysin 
1, after stimulation 750 APs at 10 Hz. The black scale bar is 0.5 µm, the white scale bar 0.07 µm. The 
experiment was performed by Nataliya Glyvuk and Yaroslav Tsytsyura. 
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In summary, we found that overexpression of dominant-negative SH3 and B/C domains 
inhibited clathrin-mediated endocytosis in fibroblasts. Application of these domains in 
neurons resulted in a slight decrease of total vesicle number, however, the number of docked 
vesicles and the release probability were unaltered. Inhibition of CME drastically reduced the 
total recycling vesicle pool size under prolonged stimulation as direct consequence of an 
endocytic defect. In addition, endocytosis was slowed down in SH3 and B/C domain treated 
neurons. On the ultra-structural level CME inhibition led to an increase in vesicle size and 
accumulation of endosomal or vacuolar structures, some of which corresponding to clathrin-
coated vesicle intermediates.    
These data indicate that at prolonged stimulation synaptic vesicle endocytosis is mediated via 
a clathrin-dependent endocytic pathway. Inhibition of this pathway by dominant-negative 
amphiphysin protein domains is probably compensated for by bulk endocytosis. Our data are 
in conflict with a kiss-and-run mechanism as major synaptic vesicle recycling route, however, 
we cannot exclude kiss-and-run exo/endocytosis for a minor fraction of vesicles under mild 
stimulation conditions.  
 
4.2 Investigation of the Stonin 2 – Synaptotagmin 1 Interaction 
Investigation of Drosophila stoned mutants yielded the first indications for a stoned/stonin – 
synaptotagmin 1 interaction. Synaptotagmin 1 is mis-localized and degraded in these mutants. 
In addition, in vitro interaction assays using Drosophila brain extracts provided evidence for a 
physical interaction between the µ-homology domain of Drosophila stoned B and the 
synaptotagmin 1 C2B domain (Fergestad et al., 1999 and 2001; Stimson et al., 2001; Phillips 
et al., 2000). Synaptotagmin 1 is supposed to play a crucial role in the essential process of 
synaptic vesicle cycling.  
 
4.2.1 Stonin 2: a Synaptotagmin-Specific Endocytic Adaptor 
Although synaptotagmin 1 is able to interact with AP-2 in vitro (Zhang et al., 1994), 
exogenously expressed synaptotagmin 1 in fibroblasts is localized to the plasma membrane, 
while other synaptic vesicle proteins such as synaptophysin or SV2 localize to distinct 
vesicular compartments (Feany et al., 1993). This suggests that synaptotagmin 1 endocytosis 
requires components not present in fibroblasts. First indications for stonin 2 as a 
synaptotagmin 1 specific endocytic adaptor were obtained by M. Kasim Diril when he 
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observed that transfected synaptotagmin 1 was readily endocytosed in fibroblasts if stonin 2 
was co-transfected (Diril et al., 2006). When lumenally FLAG-tagged synaptotagmin 1 was 
expressed in Cos7 fibroblasts, it localized to the plasma membrane. Upon co-expression of 
stonin 2 synaptotagmin 1 was internalized and re-distributed to a peri-nuclear compartment 
(Figure 4-7). Stonin 2 co-localized with synaptotagmin 1 in this endocytic compartment 
(Figure 4-7, right panel). We could also show by siRNA experiments that synaptotagmin 1 
endocytosis in fibroblast was AP-2-dependent (Diril et al., 2006) and that AP-2 partially co-
localized with synaptotagmin 1 in endocytic organelles (Diril, 2005). 
 
To further explore the endocytic adaptor function of stonin 2 we analyzed its effect on other 
cargo proteins. Transferrin-uptake was unaffected by stonin 2 expression (Figure 4-8, panel C 
and D). Internalization of chimeric constructs harboring tyrosine (YxxΦ)- and dileucine 
(D/ExxxLL)-based internalization signals (Letourneur and Klausner, 1992) was not affected 
by doxycycline-induced stonin 2 expression (Figure 4-8, panel A) either. These data indicate 
that stonin 2 indeed represents the first endocytic adaptor known to date that is dedicated to 
the internalization and recycling of a synaptic vesicle membrane protein, i.e., synaptotagmin 1 
(Diril et al., 2006).  
 
    
 
 
Figure 4-7: Stonin 2 mediates synaptotagmin 1 internalization in fibroblasts 
Cos7 fibroblasts were transfected with lumenally FLAG-tagged synaptotagmin 1 either with or without HA-
tagged stonin 2. 24 hours after transfection monoclonal anti-FLAG antibody (1:1000) in Opti-MEM was 
allowed to be internalized for 20 minutes. We stained for surface bound antibody with Alexa594-labeled goat-
anti-mouse antibodies under non-permeabilizing conditions. After permeabilization we decorated for stonin 2 
with polyclonal anti-stonin 2 antiserum and detected stonin 2 with goat-anti-rabbit-Cy5 and internalized 
synaptotagmin 1 with goat-anti-mouse-Alexa488. Cells were mounted in ImmuMount containing DAPI. Equal 
exposure times and identical intensity normalization were used during the acquisition of the images. The scale 
bar is 20 µm. 
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4.2.2 Synaptotagmin 1 Lacking the C2B Domain is Stonin 2-Dependently 
Endocytosed and Recruits Stonin 2 to the Plasma Membrane  
In order to identify the domains of synaptotagmin 1 interacting with stonin 2 we generated C2 
domain deletion constructs and expressed them in HEK293 fibroblasts. We observed that 
upon co-transfection with stonin 2 full-length synaptotagmin 1 or a C2B domain deletion 
 
Figure 4-8: Stonin 2 specifically stimulates endocytosis of synaptotagmin 1 and not other endocytic cargo 
(A) HEK293 cells were transfected with chimeras composed of the extracellular and transmembrane domains 
of the human T lymphocyte antigen CD25 (Tac) fused to cytosolic tails bearing either dileucine (t3-t2)- or 
tyrosine (t1-t0)-based endocytosis motifs. We performed antibody uptake experiments using an anti-Tac 
monoclonal antibody for 15 minutes at 37°C. Equal exposure times and identical intensity normalization were 
used during the acquisition of the images. The scale bar is 20 µm. (B) Internalization of FLAG-synaptotagmin 
1 transiently transfected into a HEK293 cell line stably expressing stonin 2 under the control of an inducible 
promoter. Where indicated, cells were induced by treatment with 1 µg/ml doxycycline overnight. Uptake 
experiments (1 hr at 37°C) were essentially performed as described in Figure 4-7. The scale bar is 20 µm. (C) 
Transferrin internalization assays were performed by using a HEK293 cell line stably expressing stonin 2 under 
the control of an inducible promoter. Prior to a transferrin uptake assay, both induced (1 µg/ml doxycycline 
overnight) and uninduced cells were starved for 4 hr in serum-free medium. After incubation with 20 µg/ml 
Alexa594-labeled transferrin for 15 min at 37°C, surface bound ligand was removed with 0.1 M Na-Acetate, 
0.5 M NaCl (pH 5.2). Cells were fixed, stained, and analyzed. The scale bar is 20 µm. (D) Internalized 
transferrin was quantified by using the Mask function of the Slidebook 4.0.10 software (Intelligent Imaging 
Innovations) applied on the Texas red channel. Nine data sets were acquired from 2 independent experiments 
(277 uninduced and 241 induced cells). The bars represent the mean fluorescence value from nine data sets in 
arbitrary units (±SD). 
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protein (syt1∆C2B) were efficiently endocytosed, whereas a C2A deletion protein 
(syt1∆C2A) was not (Figure 4-9).  
 
Consistent with this we also found that syt1∆C2B was capable of re-localizing stonin 2 from 
the cytosol to the plasma membrane (Figure 4-10, row 3) while syt1∆C2A was not (Figure 
4-10, row 4). We took advantage of the AP-2 binding-deficient stonin 2 (δWFδNPF) in this 
experiment to increase plasma membrane staining. Stonin 2 expressed alone exhibited 
cytosolic distribution (Figure 4-10, row 1), while it was recruited to the plasma membrane by 
synaptotagmin 1 full-length and ∆C2B (Figure 4-10, rows 2 and 3).  
 
Figure 4-9: Synaptotagmin 1 lacking the C2B domain is readily internalized 
FLAG-synaptotagmin 1 constructs (∆C2B: 1-265; ∆C2A: ∆140-270; ∆C2AB: 1-139) were 
transiently transfected into a HEK293 cell line stably expressing stonin 2 under the control 
of a doxycycline inducible promoter. Stonin 2 expression was induced by treatment with     
1 µg/ml doxycycline overnight. The antibody internalization experiment was essentially 
performed as described in Figure 4-7 by allowing uptake of anti-FLAG antibodies for          
20 minutes at 37°C. Equal exposure times and identical intensity normalization were used 
during the acquisition of the images. The scale bar is 20 µm. 
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Based on these combined data we speculated that the C2A domain of synaptotagmin 1 
harbors the main stonin 2 interaction site.  
 
4.2.3 The C2A-Domain is the Primary Interaction Partner for Stonin 2  
The clathrin adaptor AP-2 has been shown to interact directly with synaptotagmin 1 (Zhang et 
al., 1994; Haucke and De Camilli 1999). The interaction seems to be primarily mediated by 
the µ2 subunit of AP-2 and a patch of basic residues in the C2B domain of synaptotagmin 
(Grass et al., 2004; Haucke et al., 2000). Considering the similarity between the stonin 2 µHD 
 
Figure 4-10: Syt1∆C2B recruits stonin 2 to the plasma membrane 
NIE-115 cells were transfected with stonin 2 and lumenally FLAG-tagged synaptotagmin 1 constructs 
(∆C2A: ∆140-270; ∆C2B: 1-265). We stained for surface synaptotagmin 1 under non-permeabilizing 
conditions using the monoclonal anti-FLAG antibody M2 and decorated with Alexa594-labeled goat-
anti-mouse antibodies. After permeabilization we used the anti-stonin 2 polyclonal antiserum in 
combination with goat-anti-rabbit-Alexa488 to stain for stonin 2. Cells were mounted in ImmuMount 
containing DAPI. We acquired images using the Z-stack function of the microscope (0.5 µm sections) 
and analyzed the data applying constrained iterative deconvolution (Slidebook 4.0.10 Software, 
Intelligent Imaging Innovations). Scale bars = 20 µm. 
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and AP-2µ and based on previous results we initially suspected that the C2B domain of 
synaptotagmin 1 may harbor the main binding site for stonin 2. We were surprised to see that 
the major binding site lies within C2A as shown by GST pull down experiments from 
transfected fibroblasts (Figure 4-11 right panel). Since AP-2, stonin 2, and synaptotagmin 1 
interact with each other, any interpretation of binding contributions of stonin 2 and AP-2 in 
affinity chromatography experiments using GST-synaptotagmin 1 constructs is impossible. 
Therefore, we transfected HEK293 cells with stonin 2 wild-type or an AP-2 binding-deficient 
mutant (δWFδNPF). GST-fused C2A, C2B, and C2AB constructs were incubated with 
protein extracts from stonin 2 transfected HEK293 cells and binding of stonin 2 and AP-2 was 
analyzed by immunoblotting. GST-C2A was only able to efficiently affinity purify AP-2 in 
presence of wild-type stonin 2, but not with stonin 2 δWFδNPF (compare lane 3 left panel 
and lane 4 right panel Figure 4-11). This indicates that the C2A – AP-2 interaction is mainly 
bridged by stonin 2. Vice versa the same holds true for the interaction with stonin 2 and the 
C2B domain. This coupling effect needs to be considered for the interpretation of experiments 
carried out in a wild-type setting, i.e., in GST pull down experiments from rat brain extracts. 
In order to uncouple the stonin 2 – AP-2 interaction and therefore detect the true binding 
capacity of stonin 2 for the C2 domains, we used the AP-2 binding-deficient stonin 2 mutant. 
This clearly showed that stonin 2 exhibits substantially greater binding affinity for the C2A 






Figure 4-11: C2A is the major 
interaction partner for stonin 2  
HEK293 cells were transfected 
with either HA-stonin 2 (WT) or 
HA-stonin 2 (δWFδNPF). GST-
C2A (140-265), GST-C2B (271-
421), and GST-C2AB (140-421) 
were purified from E.coli and a 
GST pull down experiment from 
HEK cell extract was performed. 
GST alone was used as a control. 
We blotted for AP-2µ, stonin 2 
using the polyclonal HA antibody 
Y11, and for clathrin heavy chain 
(CHC). The Coomassie stained 
gel is shown as loading control.  
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Membrane recruitment and synaptotagmin 1 internalization experiments suggested that stonin 
2 interacts with syt1∆C2B in vivo. To further substantiate this indication we performed co-
immunoprecipitation experiments from co-transfected HEK293 cells expressing either full-
length synaptotagmin 1 or synaptotagmin 1 lacking either its C2A or C2B domains, 














Co-immunoprecipitation of stonin 2 with synaptotagmin 1 lacking the C2B domain showed 
that syt1∆C2B interacts with stonin 2 in vivo in transfected fibroblasts (Figure 4-12, lane 7). 
Synaptotagmin 1 lacking the C2A domain did not interact with stonin 2 (Figure 4-12, lane 8). 
We conclude that the C2A domain of synaptotagmin 1 is both required and sufficient for 
binding to stonin 2.  
 
 
Figure 4-12: Synaptotagmin 1 lacking the 
C2B domain interacts with stonin 2 in 
vivo 
Cos7 fibroblasts were co-transfected with 
lumenally FLAG-tagged synaptotagmin 1 
full-length, synaptotagmin 1 lacking the 
C2A (∆C2A) or the C2B domain (∆C2B), 
respectively. We performed an anti-FLAG 
co-immunoprecipitation from the Cos7 cell 
extract and stained for clathrin heavy chain 
(CHC), stonin 2 using the anti-HA antibody 
Y11, AP-2α, and synaptotagmin 1 using the 
anti FLAG antibody, in a Western blot. 
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4.2.4 Stonin 2 Purified from Stable HEK293 Cells  
Given that stonin 2 effectively interacts with synaptotagmin 1 in pull down and 
immunoprecipitation experiments we wanted to know whether this reflected a direct physical 
interaction. We therefore set out to purify both proteins recombinantly. While synaptotagmin 
1 can readily be expressed and purified from E.coli, stonin 2 proved to be a challenge in this 
regard. We were not able to purify stonin 2 from E.coli, yeast (Hansenula polymorpha), or 
insect cells (Baculovirus system). Therefore we decided to purify soluble stonin 2 from 
doxycycline-inducible, stable HEK293 cells expressing carboxy-terminally His6-tagged full-
length stonin 2. We generated the following cell lines: wild-type, δKYE (KYE783-785AAA), 
δWFδNPF (AP-2 binding-deficient), δWFδNPFδKYE. Cells were grown on 15 cm tissue 
culture dishes and stonin 2 expression was induced overnight with doxycycline when cells 
reached 90% to 100% confluency. Cytosolic extracts were prepared and subjected to Ni-NTA 
agarose. Bound protein was eluted and analyzed by SDS PAGE in combination with 
Coomassie staining and immunoblotting using antibodies directed against the carboxy-
terminal His6-tag. We found the method applied for cell lysis suitable to extract most soluble 
stonin 2 into the supernatant (compare lanes ‘pellet’ and ‘extract’ in Figure 4-13). The 
majority of the recombinant protein was bound to the beads (lane ‘flow through’ Figure 4-13) 
and eluted with 120 mM imidazole (lane ‘elution 2’ Figure 4-13) with three major carboxy-







Figure 4-13: Stonin 2-His6 purification from 
stable HEK293 cells 
HEK293 cells stably expressing stonin 2-His6 under 
the control of an inducible promoter were grown on 
three 15 cm tissue culture dish. Stonin 2 expression 
was induced by addition of 1 µg/ml doxycycline 
when cells had reached 95% confluency. Cells were 
harvested 18 hours after induction and lysed using a 
ball-bearing cell cracker. The ultra-centrifuged 
cytosolic extract was subjected to Ni-NTA Agarose 
for 1 hour. Bound protein was eluted first with 30 
mM imidazole and second with 120 mM imidazole. 
5% of the eluted protein were subjected to SDS 
PAGE and analysis by immunoblotting for the 
carboxy-terminal His6-tag or by Coomassie staining. 
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We found that the purified protein was contaminated with 4 prominent protein bands that co-
purified with stonin 2 and did not correspond to degradation bands as shown by 
immunoblotting. Since proteins bound to Ni-beads were washed under stringent conditions 
using 500 mM sodium chloride, we assumed that the low molecular weight bands might 
correspond to contaminants exhibiting intrinsic nickel binding ability. Hence, we identified 
the contaminating proteins by mass spectrometry and found exclusively proteins interacting 














Protein yields were estimated to be around 1 to 2 µg of stonin 2 per 15 cm tissue culture dish, 
by SDS PAGE and Coomassie staining. Stonin 2 from this highly enriched fraction was also 
able to bind to synaptotagmin 1 in vitro indicating functionality of the recombinant protein 
(see below).  
 
 
Figure 4-14: Identification of contaminating bands by mass spectrometry 
Indicated bands were excised from the Coomassie stained SDS PAGE gel and we performed an in gel tryptic 
digest. Mass spectrometric analysis was performed by Dr. Chris Weise, Institute for Chemistry and 
Biochemistry, FU Berlin. The following proteins were identified:              
DEAD box polypeptide 42 protein [Homo sapiens] / 103 kDa, Entry  Q86XP3_HUMAN Score 209, E-value 
4,8e-15, 26/45 matches; Splicing factor prolin/glutamin-rich (SFPQ protein)/76 kDa, Synonym:  DNA-
binding p52/p100 complex, 100 kDa subunit, Swiss-Prot entry SFPQ_HUMAN Score 86, E-value 0.00057, 
10/15 matches; DEAH-box polypeptide 15/ 92 kDa, Synonym: Putative pre-mRNA-splicing factor ATP-
dependent RNA helicase DHX15, Swiss-Prot entry DHX15_HUMAN, Score 88, E-value 0.00024, 14/33 
matches; Similar to non-POU domain containing octamer-binding protein / 54 kDa, Synonyms:  NonO 
protein 54 kDa nuclear RNA- and DNA-binding protein Swiss-Prot entry NONO_HUMAN Score 181, E-value 
1.8e-13, 31/56 matches. 
Results  119 
 
4.2.5 Stonin 2 and Synaptotagmin 1 Interact Directly  
GST pull down and co-immunoprecipitation experiments indicated an interaction between 
stonin 2 and the C2A domain of synaptotagmin 1. So far we excluded that the interaction 
between stonin 2 and synaptotagmin 1 was linked by AP-2, however, there was still the 
possibility that other proteins contained within the cell extracts might bridge this interaction. 
To exclude this possibility we carried out in vitro binding experiments using either in vitro 
translated stonin 2 or stonin 2-His6 purified from HEK293 cells in GST pull down 
experiments. GST-fused synaptotagmin 1 C2A (140-265), C2B (271-421), or C2AB (140-
421) were purified from E.coli. GST-fusion proteins immobilized on beads were incubated 
either with in vitro translated or purified stonin 2 and binding was detected by 
autoradiography or immunoblotting for the His6-tag. We observed direct and specific binding 
of stonin 2 to GST-fused C2A or C2AB domains (Figure 4-15). Weak binding could be 
observed for the C2B domain.  
 
Figure 4-15: Stonin 2 binds directly to synaptotagmin 1 
(A) in vitro translated, [35S]-labeled stonin 2 was incubated with GST-syt1 C2A (140-265), C2B (271-421), and 
C2AB (140-421) immobilized on beads. Stonin 2 that bound to synaptotagmin 1-beads was run on SDS PAGE 
and detected by autoradiography on the dried gel. GST was used as a control. As a second control we incubated 
the GST-fusion protein with in vitro translated luciferase, which did not bind to any of the proteins (data not 
shown). (B) Stonin 2-His6 was purified from HEK293 cells and incubated with GST-syt1 fusion proteins as 
indicated in (A). Bound stonin 2-His6 was detected by immunoblotting for the His6-tag. The arrow marks full-
length stonin 2-His6 on the Ponceau stained nitrocellulose membrane.  
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We conclude that stonin 2 directly interacts with synaptotagmin 1 and that the C2A domain 
represents the major binding partner. Next we set out to identify individual residues necessary 
for this interaction.  
 
4.2.6 Basic Residues in the C2 Domains are Essential for Interaction 
To analyze the contribution of individual residues to the stonin 2 – synaptotagmin 1 
interaction we looked at the AP-2µ – synaptotagmin 1 interaction. It was shown that AP-2µ 
binds to a cluster of basic residues in the synaptotagmin 1 C2B domain (Haucke et al., 2000). 
Considering the homology between µ2 and the µHD, we hypothesized that homologous 
residues might be involved in the stonin 2 – synaptotagmin 1 interaction. First, we performed 
a competition experiment by incubating rat brain extract with immobilized His6-C2AB and 
added increasing amounts of a basic peptide derived from the C2B domain 
(320GKRLKKKKTTIKK332). As shown in Figure 4-16 we observed a dose-dependent 







To further verify the indication that basic residues play a crucial role in interaction we 
performed site-directed mutagenesis. The C2A and C2B domains of synaptotagmin 1 each 
contain a cluster of basic residues lining one side of the respective C2 domain. These basic 
residues were mutated in combination as depicted in Figure 4-17, panel A. First we incubated 
 
 
Figure 4-16: Basic peptides partially 
inhibit the stn2 – synaptotagmin 1 
interaction in a dose-dependent manner 
His6-C2AB (97-421) and His-EGFP as 
control were purified from E.coli. 
Immobilized fusion proteins were incubated 
with rat brain extract (RBE) and either 100 
µM synaptophysin control protein or 
increasing amounts of the synaptotagmin 1 
C2B basic peptide 320GKRLKKKKTTIKK332. 
Bound stonin 2, AP-2, and clathrin heavy 
chain (CHC) were analyzed by 
immunoblotting.  
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immobilized GST-fused C2A and C2B wild-type and mutants with rat brain extract and 
analyzed for AP-2/stonin 2 binding by immunoblotting. We found that the AP-2/stonin 2 – 
synaptotagmin 1 interaction was indeed perturbed by mutation of basic residues within the 
respective C2 domains (Figure 4-17, panel B). While mutation of two basic residues in the 
C2A domain was sufficient to abolish AP-2/stonin 2 to synaptotagmin 1 binding (compare 
Figure 4-17, panel B, lanes 3 and 4), mutation of at least 6 basic residues within C2B was 
necessary to achieve the same effect (Figure 4-17, panel B, lanes 7 to 10). Since affinity 
chromatography experiments performed from rat brain extracts only deliver information 
regarding the binding ability of the AP-2/stonin 2 complex, we performed the GST pull down 
experiments from transfected HEK293 cells. In order to be able to distinguish between the 
different binding contributions of AP-2 and stonin 2 we made use of an AP-2 binding-
deficient stonin 2 mutant (δWFδNPF) (compare Figure 4-11). Incubating immobilized GST-
fused C2B wild-type and mutant proteins with HEK293 cell extracts from stonin 2 
(δWFδNPF) transfected cells showed that both interactions, synaptotagmin 1 – AP-2, and 
synaptotagmin 1 – stonin 2 are indeed dependent on basic residues (Figure 4-17, panel C) and 
that mutation of at least 6 basic residues abolishes these interactions (Figure 4-17, panel C, 
lane 6). As seen in Figure 4-11 stonin 2 interacts only weakly with the C2B domain (compare 
stonin 2 δWFδNPF standard lane 1 with affinity purified protein lanes 3 to 5 Figure 4-17, 
panel C). Application of HEK293 cell extract derived from stonin 2 (δWFδNPF) transfected 
cells on GST-fused C2A wild-type and mutants showed a substantial reduction of stonin 2 
binding upon mutation of 6 basic residues (Figure 4-17, panel D, compare lanes 3 and 8). 
However, we were not able to abolish the interaction completely (Figure 4-17, panel D, lane 
8). The AP-2 – C2A interaction was less efficient and mutation of two basic residues was 
sufficient to abolish the interaction completely (Figure 4-17, panel D, compare lane 3 with 
lanes 4 and 5).  
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Thus, mutation of basic residues in either C2 domain abolished AP-2 binding completely and 
substantially reduced binding of stonin 2 in affinity chromatography experiments. These data 
were confirmed by co-immunoprecipitation experiments from HEK293 cells. Syt1∆C2B 
carrying mutations in lysine residues 189 to 192 was not co-precipitated from stonin 2 
 
Figure 4-17:   Basic patches in both C2 domains of synaptotagmin 1 play a major 
role in stonin 2 binding  
(A) Synaptotagmin C2A and C2B mutants used for the GST pull down experiments. We 
mutated basic residues (red) that are potentially involved in stonin 2 binding. (B) GST-
C2A (140-265) and –C2B (271-421) fusion proteins were purified from E.coli. Protein 
extract was prepared from rat brain and incubated with GST fusion proteins. Bound 
protein was analyzed by immunoblotting for clathrin heavy chain (CHC), stonin 2, and 
AP-2µ. (C) and (D) HEK293 cells were transfected with AP-2 binding-deficient HA-
stonin 2 (δWFδNPF). GST-C2A and -C2B wild-type and mutant fusion proteins were 
incubated with transfected HEK293 cell extract and bound proteins were analyzed by 
immunoblotting using antibodies against CHC, HA-tag (stonin 2), and AP-2µ.  
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expressing HEK293 cell extracts (Figure 4-18, lane 8), whereas its wild-type counterpart or 



















4.2.7 The C2B Basic Peptide (13mer) is Sufficient for AP-2 and Stonin 2 
Binding 
To elucidate whether basic stretches are not only required but also sufficient for stonin 2 
binding we generated GST fusion constructs allowing for expression of C2A and C2B-
derived peptides (C2A: 186LPDKKKKFETKVHR199; C2B: 320GKRLKKKKTTIKK332). GST-
peptide fusions were purified and used for pull down experiments from cell extracts prepared 
from HEK293 cells transfected with AP-2 binding-deficient stonin 2 (δWFδNPF). The C2B 
peptide was sufficient for binding to stonin 2 and AP-2, however, the C2A-derived peptide 
 
Figure 4-18: Syt1∆C2B mutated in lysine residues 189-192 cannot interact with stonin 2 in vivo 
HEK293 cells were co-transfected with HA-tagged stonin 2 and either wild-type, FLAG-tagged syt1∆C2B 
(1-265) or syt1∆C2Bm3 (K189-192A). We performed immunoprecipitation using anti-stonin 2 antiserum on 
the cell extract and detected co-precipitated protein by immunoblotting for clathrin heavy chain (CHC) as 
control, stonin 2 using the polyclonal anti-HA antibody Y11, AP-2, and synaptotagmin 1 using the 
monoclonal FLAG antibody M2. The arrow indicates co-precipitated syt1∆C2B. 
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was not (Figure 4-19). It is noteworthy that the binding efficiency of AP-2 and stonin 2 to the 
C2B peptide was essentially the same as to the entire C2B domain (compare lanes 3 and 4 in 









4.2.8 C2 Domains of Synaptotagmin Exhibit Cooperativity with Respect 
to Stonin 2 Binding 
Since we had evidence that basic residues within the C2A and C2B domains play a crucial 
role in stonin 2 binding, we set out to analyze the mutations described above in the context of 
synaptotagmin 1 tandem C2 domain or full-length constructs. All experiments carried out so 
far indicated that the C2A domain harbors the major binding site for stonin 2. Therefore, we 
were very surprised to see that the C2A mutations in the context of a C2AB (aa 140-421) or a 
full-length construct had no apparent effect on stonin 2 binding (lane 5 in Figure 4-20 B and 
lane 8 in Figure 4-20 C), in GST pull down or co-immunoprecipitation experiments. If 
assayed by co-immunoprecipitation of the full-length synaptotagmin 1, mutations in C2B 
displayed a more severe effect on stonin 2 binding compared to C2A mutants (compare lanes 
8 and 9 in Figure 4-20 panel C). It was also unexpected to see that synaptotagmin 1 mutated 
in both domains was still able to interact with stonin 2 in GST pull down and co- 
 
 
Figure 4-19: The C2B basic peptide is 
sufficient for AP-2 and stonin 2 binding 
HEK293 cells were transfected with HA-tagged, 
AP-2 binding-deficient stonin 2 (δWFδNPF). 
GST fusion proteins were expressed and purified 
from E.coli. Immobilized GST fusion proteins 
were incubated with HEK293 cell extract and 
bound proteins were identified by immunoblotting 
for clathrin heavy chain (CHC) as control, for 
stonin 2 using the polyclonal anti-HA antibody 
Y11, and for AP-2. GST was used as a negative 
control. 
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immunoprecipitation experiments, albeit with somewhat reduced affinity in the latter (see 
lanes 6 in panel B and 10 in panel C of Figure 4-20).  
 
 
These results suggest that despite of the fact that the C2A domain is sufficient for a functional 
interaction with stonin 2 in vitro and in vivo both C2 domains cooperate in the context of the 
native, full-length synaptotagmin 1 protein in regard to stonin 2 binding. For the AP-2 – 
synaptotagmin 1 interaction, however, we did not observe any cooperativity between the C2 
domains. We found that AP-2 mainly interacts with the C2B domain when offered 
 
Figure 4-20:  Mutations in the C2A and C2B domains are not tight in the C2AB and full-length 
context 
(A) Sequences of wild-type and mutant basic clusters used in (B) and (C). (B) GST pull down experiment 
from HEK293 cells transfected with an HA-tagged, AP-2 binding-deficient stonin 2 (δWFδNPF). We 
purified GST-C2AB from E.coli and incubated the immobilized fusion proteins with cell extract. Bound 
proteins were analyzed by immunoblotting for clathrin heavy chain (CHC), stonin 2 using the polyclonal 
anti-HA antibody Y11, and AP-2. (C) Co-immunoprecipitation experiment applying the anti-stonin 2 
polyclonal antiserum immobilized on beads to cell extract derived form HEK293 fibroblasts co-transfected 
with HA-tagged stonin 2 and FLAG-tagged variants of synaptotagmin 1 (Am4E: K189-192E, K213E, 
K244E; Bm3E: KR321,322EE, K324-327E). Co-precipitated proteins were detected by immunoblotting 
essentially as described in (B). We used the monoclonal anti-FLAG antibody M2 to detect co-precipitated 
synaptotagmin 1. 
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individually and that mutating residues within C2B abolishes binding completely when 
assayed in the context of C2B, C2AB, or native full-length synaptotagmin 1.  
 
4.2.9 Mutations in the Basic Patches of Synaptotagmin 1 Cannot Abolish 
Internalization  
In order to assay the functional consequences of impaired association of syt1∆C2B with 
stonin 2 we made use of the previously described internalization in transfected fibroblasts (see 
chapter 4.2.1, Figure 4-7). We co-transfected fibroblasts with stonin 2 and FLAG-syt1∆C2B 
wild-type or mutant constructs (mutant: K189-192A, K213E, K244S) and performed antibody 
uptake experiments 8 hours post transfection. We were unable to detect any obvious 
differences in internalization efficiencies between wild-type and mutant syt1∆C2B (compare 
row 2 and 3 Figure 4-21).  
 
 
Full-length synaptotagmin 1 mutated in both domains was also readily endocytosed (data not 
shown), as expected from the cooperation between C2A and C2B domains. We conclude that 
the remaining affinity of synaptotagmin 1 mutants is sufficient for stonin 2-dependent 
 
Figure 4-21: Mutations of basic residues in C2A cannot abolish syt1∆C2B internalization 
Cos7 fibroblasts were co-transfected with HA-tagged stonin 2 and lumenally FLAG-tagged syt1∆C2B 
constructs (∆C2B: 1-265). ∆C2Bmut corresponds to the C2A mutant K189-192A, K213E, K244S. Antibody 
internalization assays were performed 8 hours post transfection (to reduce stonin 2 levels) essentially as 
described in Figure 4-7). Internalization in presence of anti-FLAG antibodies was allowed for 20 minutes at 
37°C. Equal exposure times and identical intensity normalization were used during the acquisition of the 
images. The scale bar is 20 µm. 
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internalization. All synaptotagmin 1 mutants that have been analyzed for stonin 2-mediated 
endocytosis are listed in Table 4-1. We were unable to identify a synaptotagmin 1 mutant that 





pcFLAG-∆C2Bm4 K191H, K213E, K244S 
pcFLAG-∆C2Bm5 K189-192A, K213E, K244S 
pcFLAG-∆C2Bm6 W259A (WRDL  ARDL) 
pcFLAG-∆C2Bm7 K189-192A, W259A (WRDL  ARDL) 
pcFLAG-∆C2Bm3E K189-192E 
pcFLAG-∆C2Bm5E K189-192E, K213E, K244E 
pcFLAG-FLm1 KR321,322AA; K324-327A 
pcFLAG-FLm2 K189-192A 
pcFLAG-FLm3 KK189,190AA; KR321,322AA; K324-327A 
pcFLAG-FLm4 K189-192A; KR321,322AA; K324-327A 
pcFLAG-FLm5 
 
K189-192A; KR321,322AA; K324-327A; 
K313A 
pcFLAG-FLm6 K191H, K213E, K244S 
pcFLAG-FLm7 
 
K191H, K213E, K244S; KR321,322AA; 
K324-327A; K313A 
pcFLAG-FLm8 K189-192A, K213E, K244S 
pcFLAG-FLm9 K189-192A, K213E, K244S; KR321,322AA; 
K324-327A; K313A 
pcFLAG-FLm1E KR321,322EE; K324-327E 
pcFLAG-FLm8E K189-192E, K213E, K244E 
pcFLAG-FLm9E K189-192E, K213E, K244E; KR321,322EE; 
K324-327E; K313E 
pcFLAG-FLm10 W404A (WHTLAHTL) 
 
It was astonishing to see that even abolishing the AP-2 – synaptotagmin 1 interaction 
completely (see Figure 4-20) did not result in block of stonin 2-dependent synaptotagmin 1 
internalization. This suggests, although AP-2 is required for stonin 2-dependent 
synaptotagmin 1 endocytosis in fibroblasts (Diril et al., 2006), the actual physical interaction 
between synaptotagmin 1 and AP-2 might be dispensable.   
 
In summary, we could show that stonin 2 and AP-2 used essentially different binding sites on 
synaptotagmin 1. AP-2 mainly bound to the C2B domain, while stonin 2 made use of the C2A 
Table 4-1: Synaptotagmin 1 mutants that were internalized in a stonin 2-dependent manner 
Mutations in the C2A domain are marked in red, those in the C2B in green. Mutations in the putative WxxL 
protein-protein interaction motifs are underlined. Charge reversal mutations are marked in blue 
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domain as major interaction partner if individual C2 domains were offered. Binding seemed 
to be mediated via stretches of basic amino acid residues of which the C2B basic peptide 
appeared to be sufficient for stonin 2 and AP-2 binding. Nonetheless, the identification of the 
interaction interface between stonin 2 and synaptotagmin 1 in the full-length context turned 
out to be more complex as the C2 domains seemed to exhibit cooperativity with respect to 
stonin 2 binding. Gaining insight into interaction interfaces composed of three dimensional 
binding pockets is rather impossible if X-ray crystallographic or nuclear magnetic resonance 
(NMR) studies are not applicable. This remains a challenge for future studies. We therefore 
turned our attention to the cognate synaptotagmin 1 recognition site within stonin 2. 
 
4.2.10 The Synaptotagmin – Stonin 2 Interaction is Mediated via the µ-
homology Domain and is AP-2-Independent  
Previous work by Martina et al. (2001) and our own group (Walther et al., 2001) indicated 
that the µ-homology domain (µHD) of stonin 2 mediates interaction with synaptotagmin 1 in 
GST pull down experiments from rat brain extracts or transfected fibroblasts. To confirm 
these data and to provide evidence that the µHD is required and sufficient for synaptotagmin 
1 interaction in vivo we performed co-immunoprecipitation experiments from transfected 
fibroblasts using several HA-tagged stonin 2 fragments. As seen in Figure 4-22 
synaptotagmin 1 was efficiently co-immunoprecipitated in cells expressing wild-type or AP-2 
binding-deficient mutants of stonin 2 (Figure 4-22, panel A, lanes 6 and 7). A carboxy-
terminal fragment comprising the µHD retained the ability to interact with synaptotagmin 1 
(Figure 4-22, panel A, lane 8) whereas a corresponding amino-terminal fragment lacking the 
µHD did not (Figure 4-22, panel A, lane 9). This indicates a major role for the µHD in 
synaptotagmin 1 binding and shows that the interaction is not bridged by AP-2.   
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We also analyzed whether expression of stonin 2 would affect the ability of synaptotagmin 1 
to interact with AP-2 in transfected fibroblasts. We transfected stonin 2 wild-type or a mutant 
lacking the AP-2 binding motifs (stonin 2δWWW) in HEK293-syt1 cells and performed 
immunoprecipitation experiments using anti-AP-2 antibodies immobilized on protein A/G 
sepharose. As shown in Figure 4-23 synaptotagmin 1 was only found in immunoprecipitates 
from cells expressing wild-type stonin 2 but not an AP-2 binding-deficient mutant (compare 
Figure 4-23, lanes 4 and 6). We conclude that the interaction between AP-2 and 
synaptotagmin 1 is bridged by stonin 2 in fibroblasts.  
 
Figure 4-22: The stonin 2 µHD is required and sufficient for synaptotagmin 1 binding in vivo 
(A) HEK-syt1 cells were transfected with various HA-tagged stonin 2 constructs: full-length (FL), 
stonin 2 mutated in the three AP-2 binding WVxF motifs (WVxF  AVxF), an amino-terminal 
fragment (1-555), and a carboxy-terminal fragment consisting of mainly the µHD. We performed an 
anti-HA immunoprecipitation and analyzed for synaptotagmin 1, AP-2, and clathrin heavy chain 
(CHC) binding by immunoblotting. (B) Schematic representation of the applied stonin 2 constructs.  
Figure 4-23: Stonin 2 functions as a 
linker between synaptotagmin 1 and 
AP-2 in vivo 
HEK-syt1 cells were mock transfected, 
with stonin 2 WT or AP-2 binding-
deficient stonin 2. Protein extracts were 
incubated with AP-2 antibodies coupled 
to beads. We analyzed for 
synaptotagmin 1 co-precipitation by 
immunoblotting. This experiment was 
performed by M. Kasim Diril (Diril et 
al., 2006) 
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4.2.11 Approaches to Confine the Synaptotagmin 1 Binding Site within 
Stonin 2 
We and others have demonstrated that the synaptotagmin 1 binding site in stonin 2 is located 
within the µ-homology domain (µHD). As a first approach to identify peptides that were able 
to interact with purified His6-C2AB we used peptide spot libraries (PepScan). In collaboration 
with the group of Rudolph Volkmer (Molecular Libraries, Charité, Berlin) we have tried to 
get at the binding site by PepScan screening. 15mer stonin 2-µHD peptides with a shift of 3 
residues between consecutive peptide spots were synthesized on a nitrocellulose membrane. 
The membrane was decorated with His6-C2AB and bound synaptotagmin 1 was detected by 
immunoblotting for the His6-tag. One putative binding peptide was identified which 
corresponded to a putative loop region that is unique to stonin 2, i.e., missing in AP-2µ 
(residues 736-765). We generated a stonin 2 construct lacking these residues (stonin 2 ∆loop), 
transfected HEK293 cells and performed a GST pull down experiment using GST 
synaptotagmin 1 C2A (140-265), C2B (271-421), and C2AB (140-421) fusion proteins. As 











Figure 4-24: The stonin 2 ∆loop mutation did 
not abolish synaptotagmin 1 binding 
HEK293 cells were transfected with HA-tagged, 
stonin 2 ∆loop (∆736-765) or AP-2 binding-
deficient stonin 2 (δWFδNPF). GST-
synaptotagmin fusion proteins were expressed and 
purified from E.coli. Immobilized GST fusion 
proteins were incubated with HEK293 cell extract 
and bound protein was identified by 
immunoblotting for clathrin heavy chain (CHC) as 
control, for stonin 2 using the polyclonal anti-HA 
antibody Y11, and for AP-2. GST was used as a 
negative control. 
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Next, we set out to gain information from homology considerations. It had been shown that 
the interaction between AP-2µ and the C2B domain is mediated by subdomain B of AP-2µ 
(residues 283-394) (Haucke et al., 2000). The data by Haucke et al. (2000) also indicated a 
participation of residues Y344 and K354 in this interaction. Independently of these findings a 
collaborative group (Prof. Wolfram Saenger, Institute for Chemistry – Crystallography, FU 
Berlin) succeeded in co-crystallizing AP-2µ with a basic peptide derived from the GABAA-
receptor β3-subunit (Figure 4-25), which uses an overlapping if not identical site within    
AP-2µ as synaptotagmin 1 (Kittler et al., 2005).  
 
The crystal structure indicated that residues K343, Y344, and E348 might be involved in 
interaction with basic endocytic motif peptides including GABAA receptor β3, GluR2 
 
Figure 4-25:  Co-crystal of AP-2µ with the GABAR peptide indicates 
participation of residues K343, Y344, and E348 in binding 
(A) Possible interaction interface between AP-2µ (blue) and the GABAA-receptor 
subunit β3 derived basic peptide (red). (B) Alignment of adaptor complex µ 
subunits and stonin. Residues in red are conserved and could play a putative role 
in interaction; blue are residues that are not conserved, but might be essential for 
binding, green boxes mark residues that are involved in binding to 
phosphatidylinositol(4,5)bis-phosphate (PIP2). 
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(Kastning et al., submitted), and synaptotagmin 1 C2B (Grass et al., 2004). Alignment of µ2 
with the stonin 2-µHD showed that these residues might correspond to K783, Y784, and E785 
within stonin 2 (Figure 4-25 B).  
 
4.2.12 Tyrosine Residue 784 in Stonin 2 Plays a Major Role in 
Synaptotagmin 1 Binding 
Bearing the information we obtained from our homology considerations in mind and 
assuming that the mode of interaction of AP-2 and stonin 2 with basic peptides is similar, we 
started out to generate stonin 2 mutants. We chose to modify several residues in the putative 
interaction interface resulting in the mutants described in Table 4-2. 
 
Table 4-2: Stonin 2 mutants generated based on homology studies  
construct mutations 
stonin 2 δKYE KYE783-785AAA 
stonin 2 YF Y784F 
stonin 2 YA Y784A 
stonin 2 YR Y784R 
stonin 2 F788E F788E 
stonin 2 DID RIN794-796DID 
 
Initially we screened stonin 2 mutants for functional relevance in the synaptotagmin 1 
endocytosis assay in fibroblasts. These experiments showed that the δKYE as well as the YR 
mutation were effective in inhibiting synaptotagmin 1 endocytosis. Using this information we 
started out to further analyze these mutants biochemically by GST pull down and 
immunoprecipitation experiments. Incubation of GST-synaptotagmin fusion proteins with 
protein extract derived from HEK293 cells transfected with stonin 2 δKYE or a corresponding 
AP-2 binding-deficient stonin 2 δWFδNPFδKYE mutant demonstrated that mutating residues 




















A minimal amount of stonin 2 δKYE was detected in material affinity-purified with GST-
C2B and GST-C2AB. This may reflect bridging by AP-2. Mutating the AP-2 binding sites in 
addition to the KYE site (stonin 2 δWFδNPFδKYE) resulted in complete loss of interaction.  
Similar results were seen if the experiment was repeated by using purified stonin 2-His6 or in 
vitro transcribed / translated [35S]-labeled stonin 2 instead of crude cell extracts (Figure 
4-27). Mutant stonin 2 δKYE was not able to bind to GST-C2AB when either synthesized by 
coupled transcription / translation (see lane 6 panel B in Figure 4-27) or if purified from 
HEK293 cells (see lane 4 panel A in Figure 4-27). Mutation of Y784 to arginine was 
sufficient for this effect (see lane 7 in panel B Figure 4-27). 
 
 
Figure 4-26: The stonin 2 δKYE mutation efficiently 
abolishes synaptotagmin 1 binding 
HEK293 cells were transfected with HA-tagged stonin 2 
(stonin 2 δWFδNPF: AP-2 binding-deficient; stonin 2 
δKYE; stonin 2 δWFδNPFδKYE). GST or GST-
synaptotagmin fusion proteins were expressed and purified 
from E.coli. Immobilized GST fusion proteins were 
incubated with HEK293 cell extracts and bound proteins 
were identified by immunoblotting for clathrin heavy chain 
(CHC), stonin 2 (using the polyclonal anti-HA antibody 
Y11), and AP-2. 
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We also characterized the δKYE and YR stonin 2 mutants by co-immunoprecipitation 
experiments. To this aim HEK293 cells co-transfected with stonin 2 wild-type, δWFδNPF, 
δKYE, or YR mutants and synaptotagmin 1 were subjected to immunoprecipitation using 
anti-stonin 2 antisera. Co-precipitated synaptotagmin 1 was detected by immunoblotting. We 
could confirm that mutating residues KYE783-785AAA and Y784R results in loss of the 
ability of stonin 2 to bind to synaptotagmin 1 (Figure 4-28). Both mutants were able to co-
immunoprecipitate AP-2 (lane 8 panel A and lane 6 panel B in Figure 4-28). This could be an 
indication for conformational integrity of the mutants. However, since the AP-2 binding sites 
and the KYE site locate to different domains in stonin 2 we set out to verify the 
conformational features of the respective mutants by independent means.  
 
 
Figure 4-27:  δKYE and YR mutations in stonin 2 result in inhibition of 
synaptotagmin 1 binding shown by in vitro binding 
experiments 
(A) Stonin 2-His6 wild-type and δKYE mutant were purified from stably 
transfected HEK293 cells. GST-syt1 C2AB (140-421) was purified from 
E.coli. Immobilized GST fusion protein was incubated with purified stonin 2 
proteins and bound stonin 2 was detected by blotting for the His6-tag. (B) 
Stonin 2 wild-type, δKYE, and YR were in vitro transcribed / translated and 
[35S]-labeled. GST-C2AB was purified from E.coli and incubated with [35S]-
labeled stonin 2 variants. Bound stonin 2 was detected by autoradiography. 
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4.2.13 Verification of Conformational Features of Stonin 2 Mutants by 
Limited Proteolysis 
Although we could show that δKYE and YR stonin 2 mutants were able to bind to AP-2 in 
vivo, we wanted to further confirm their structural integrity. One option to address this issue is 
limited proteolysis. However, for this approach it is essential that sufficient amounts of 
purified protein can be provided. We therefore decided to use stonin 2 synthesized by coupled 
in vitro transcription / translation in presence of [35S]-methionine as well as stonin 2-His6 
purified from HEK293 cells. These were subjected to limited proteolytic digestion using 
trypsin and proteinase K. [35S]- and His6-labeled stonin 2 fragments were detected by 
autoradiography, or immunoblotting for the His6-tag, respectively (Figure 4-29).  
 
 
Figure 4-28:  Stonin 2 δKYE and YR mutations abolish synaptotagmin 1 – stonin 2 
interaction in co-immunoprecipitation experiments 
HEK293 cells were co-transfected with FLAG-tagged synaptotagmin 1 and HA-tagged 
stonin 2 constructs (wild-type; δWFδNPF: AP-2 binding-deficient; δKYE; YR). Protein 
extract was prepared and incubated with anti-stonin 2 polyclonal antibodies coupled 
beads. Co-precipitated synaptotagmin 1 was identified by applying the monoclonal anti-
FLAG antibody M2 to immunoblotting. In addition, we decorated the Western blot for 
clathrin heavy chain (CHC) as negative control, for AP-2, and the immunoprecipitated 
stonin 2 constructs by the polyclonal anti-HA antibody Y11.  









Immunoblotting for the carboxy-terminal His6-tag of trypsin-digested stonin 2-His6 revealed 
the presence of a ~19 kDa stable fragment (panel A, marked with * Figure 4-29). Assuming 
an average molecular weight of 120 kDa per amino acid the cleavage site should be located 
around residue 750, which is positioned in a putative loop region (736-765; see 4.2.11). This 
fragment includes the introduced mutations (KYE783-785AAA, Y784R). A second carboxy-
terminal ~33 kDa fragment also seemed to be fairly resistant to proteolytic cleavage. Both 
fragments were generated using purified or in vitro transcribed / translated stonin 2 wild-type 
and mutant proteins, suggesting that they were properly folded.  
 
Figure 4-29: Limited 
proteolytic digest of stonin 2 
mutants confirms structural 
integrity 
(A) Stonin 2-His6 wild-type (left 
panel) and [35S]-labeled in vitro 
transcribed / translated stonin 2 
(right panel) were subjected to 
limited proteolytic digest using 
trypsin at indicated 
concentrations for 10 minutes at 
30°C. Stonin 2-His6 fragments 
were detected by 
immunoblotting for the His6-tag, 
[35S]-labeled stonin 2 fragments 
by autoradiography. It is 
noteworthy that in both cases a 
stable ~19 kDa fragment was 
generated (marked with an 
asterix). (B) and (C) [35S]-
labeled in vitro transcribed / 
translated stonin 2 was digested 
with indicated amounts of trypsin 
(B) or proteinase K (C) for       
10 minutes at 30°C and subjected 
to SDS PAGE and 
Autoradiography. Putative 
carboxy-terminal 19 kDa and   
33 kDa fragments including the 
introduced mutations (δKYE: 
KYE783-785AAA, YR: Y784R) 
are marked with an arrow. 
**
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4.2.14 Characterization of Stonin 2 Mutants In Vivo 
4.2.14.1 Localization of Stonin 2 Mutants in Primary Hippocampal 
Neurons and Astrocytes 
Stonin 2 mutants δKYE and YR did not bind to synaptotagmin 1 while retaining the ability to 
interact with AP-2. In addition, we had good evidence for the conformational integrity of the 
mutants by limited proteolysis studies. Here, we wanted to further characterize the mutants by 
analyzing their localization in neurons and glial cells. It has been shown that stonin 2 localizes 
to synapses in primary hippocampal neurons (Walther et al., 2004) and to AP-2 positive 
squiggle-like structures in glial cells (Diril, 2005). We transfected DIV9 primary hippocampal 
neurons or glial cells with stonin 2 wild-type and mutant constructs. We then analyzed the 
subcellular distribution of stonin 2 in both cell types by deconvolution fluorescence 
microscopy. In contrast to wild-type stonin 2 the mutants failed to accumulate at synapses 
(Figure 4-30) indicating that the synaptic localization might be a consequence of the 
interaction between stonin 2 and synaptotagmin 1.  
 
 
Figure 4-30: Stonin 2 δKYE and YR mutants loose synaptic localization 
DIV9 primary hippocampal neurons prepared from P0 new-born rats were transfected with HA-tagged stonin 2 
constructs (wild-type; δKYE: KYE783-785AAA; YR: Y784R) using Effectene. Neurons were incubated for 
two days after transfection and stained for stonin 2 (using anti-HA decoration) and synaptotagmin 1. Scale bar 
= 15 µm.  
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Some co-localization of synaptotagmin 1 and stonin 2 mutants was observed for very large 
spots that may represent growth cones. While the stonin 2 wild-type localization was axonal 
and spot like, mutants were more homogenously distributed and appeared to be mis-localized 
to dendrites. However, to prove dendritic localization counter-staining with a dendritic marker 
such as mictrotubule-associated protein 2 (MAP2) would be required.  
 
In astrocytes stonin 2 exhibits a characteristic squiggle-like distribution where it co-localizes 
with the endocytic proteins AP-2, intersectin, and eps15 (Diril, 2005). Stonin 2 mutants were 
targeted to spot-like structures where they partially co-localized with AP-2. The precise 
morphology of the AP-2-containing spots appeared to differ somewhat between wild-type and 




Figure 4-31: Stonin 2 δKYE and YR mutant co-localize with AP-2 in glial cells 
DIV9 glial cells were transfected with HA-tagged stonin 2 constructs (wild-type; (wild-type; δKYE: 
KYE783-785AAA; YR: Y784R) using Effectene. Glial cells were incubated for two days after transfection 
and stained for stonin 2 (using anti-HA decoration) and AP-2. Scale bar = 20 µm.  
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4.2.14.2 Stonin 2 Mutants are not Recruited to the Plasma Membrane in 
NIE-115 Cells 
In this set of experiments, we assessed the ability of synaptotagmin 1 to recruit different 
stonin 2 mutants to the plasma membrane in NIE-115 cells transfected with synaptotagmin 1 
and stonin 2 constructs (wild-type; δWFδNPF: AP-2 binding-deficient; δKYE: KYE783-
785AAA; YR: Y784A). We stained for surface synaptotagmin under non-permeabilizing 
conditions and for stonin 2 after permeabilization. Images were taken using the Z-stack 
acquisition function of the microscope applying Z-steps of 0.5 µm and analyzed with the help 
of the constrained iterative deconvolution function of the Slidebook 4.0.10 software 
(Intelligent Imaging Innovations) to obtain quasi-confocal images. Stonin 2 facilitated 
synaptotagmin 1 internalization in NIE-115 cells similar to the effects seen in HEK293 or 
Cos7 fibroblasts (data not shown). Stonin 2 localized mainly to a peri-nuclear compartment 
immuno-positive for endocytosed synaptotagmin 1. We also observed plasma membrane 
localization for wild-type stonin 2 (row 1 in Figure 4-32). Stonin 2 deficient in AP-2 binding 
did not mediate synaptotagmin 1 endocytosis and was clearly localized to the plasma 
membrane (row 2 in Figure 4-32). By contrast δKYE and YR stonin 2 mutants were entirely 
cytosolic and no membrane recruitment was observed (row 3 and 4 in Figure 4-32).  
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4.2.14.3 Characterization of Stonin 2 Mutants using the Synaptotagmin 1 
Internalization Assay in Fibroblasts 
We could show that stonin 2 facilitates specifically the AP-2-dependent endocytosis of 
synaptotagmin 1 in fibroblasts. We could also demonstrate that stonin 2 and synaptotagmin 1 
interact in vitro and in vivo. By mutation of residues KYE783-785 to alanines we abolished 
this interaction. In this section, we will describe the effect of stonin 2 mutations on 
synaptotagmin 1 endocytosis in fibroblasts. We found that mutants that were not able to 
physically attach to synaptotagmin 1 or AP-2 were not able to initiate synaptotagmin 1 




Figure 4-32: Stonin 2 δKYE and YR mutants are not recruited to the plasma membrane 
NIE-115 cells were transfected with lumenally FLAG-tagged synaptotagmin 1 and stonin 2 
constructs (wild-type; δWFδNPF: AP-2 binding-deficient; δKYE: KYE783-785AAA; YR: Y784R). 
Staining and analysis was performed as described in Figure 4-10. Scale bars = 20 µm. 
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Table 4-3: Stonin 2 mutants analyzed in the synaptotagmin 1 internalization assay 






stonin 2 WT  + + + 
stonin 2 δNPF all NPF motifs 
mutated to NAV 
+ + + 
stonin 2 
δWWW 
all WVxF motifs 
mutated to AVxA 
- + - 
stonin 2 NT aa 1-555 + - - 
stonin 2 
E702A 
E702A N.A. N.A. + 
stonin 2 
S695A 
S695A N.A. N.A. + 
stonin 2 DE DE820,822AA N.A. N.A. + 
stonin 2 EDE EDE702,820,822AAA N.A. N.A. + 
stonin 2 δKYE KYE783-785AAA + - - 
stonin 2 YF Y784F N.A. N.A. + 
stonin 2 YA Y784A N.A. N.A. + 
stonin 2 YR Y784R + - - 
stonin 2 
F788E 
F788E N.A. N.A. + 
stonin 2 DID RIN794-796DID N.A. N.A. + 
stonin 2 ∆loop ∆736-765 + + + 
 
 
We co-transfected Cos7 cells with FLAG-tagged synaptotagmin 1 and stonin 2 constructs. 
We performed antibody internalization experiments offering anti-FLAG antibodies 24 hours 
post transfection. In contrast to wild-type stonin 2 an AP-2 binding-deficient mutant was 
unable to mediate synaptotagmin 1 endocytosis (Figure 4-33, third row). The same was true 
for stonin 2 lacking its synaptotagmin 1 binding µHD (Figure 4-33, last row), which retains 
its ability to associate with AP-2. Mutation of the NPF motifs, which are essential for 
intersectin and eps15 binding, did not impair stonin 2 endocytic function (Figure 4-33, second 
row), indicating that an interaction with these proteins is not required for synaptotagmin 1 
internalization in fibroblasts. 
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Biochemical experiments have shown that stonin 2 interacts with the C2 domains of 
synaptotagmin 1 at least in part via basic residues (see 4.2.6). Therefore we considered the 
possibility that the cognate recognition site within stonin 2 might be lined with negatively 
charged amino acid residues. Since stonin 1 does not interact efficiently with synaptotagmin 
1, we identified acidic residues located within the µHD that are contained in stonin 2, but not 
in stonin 1. In addition, we identified a unique serine residue (S695) that could potentially be 
phosphorylated and thereby negatively charged. We generated stonin 2DE mutants by 
exchanging these residues for alanines (E702A, S695A, DE, EDE, see Table 4-3). The 
synaptotagmin 1 internalization assay revealed that none of these mutations affected the 
ability of stonin 2 to target synaptotagmin 1 for endocytosis (Figure 4-34).  
 
Figure 4-33:  AP-2 binding deficient stonin 2 or stonin 2 lacking the µHD cannot mediate 
synaptotagmin 1 internalization in fibroblasts 
Cos7 cells were co-transfected with lumenally FLAG-tagged synaptotagmin 1 and HA-tagged stonin 2 wild-
type and mutant constructs (δNPF: mutated in NPF motifs; δWWW: mutated in AP-2 binding motifs; NT: 
lacking µHD, aa 1-555). We performed an antibody internalization assay offering monoclonal anti-FLAG 
antibodies essentially as described in Figure 4-7. Equal exposure times and identical intensity normalization 
were used during the acquisition of the images. Scale bar = 20 µm. 
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Residues KYE783-785 in stonin 2 appeared to participate in synaptotagmin 1 binding as 
mutating these residues to alanines abolished the interaction (see chapter 4.2.12). Mutating 
Y784 to arginine resulted in loss of synaptotagmin 1 binding. Antibody uptake assays 
revealed that expression of stonin 2 δKYE and YR did not result in detectable synaptotagmin 
1 internalization (Figure 4-35). Mutating Y784 to phenylalanine or alanine did not cause loss 
of stonin 2 function. Since the δKYE and YR mutants were still able to interact with AP-2 
(Figure 4-28), we conclude that the observed impairment of synaptotagmin 1 uptake is a 
direct consequence of loss-of-binding.  
 
 
Figure 4-34: Stonin 2
DE
 mutants mediate synaptotagmin 1 internalization 
HEK293 cells stably transfected with lumenally FLAG-tagged synaptotagmin 1 were transiently transfected 
with HA-tagged stonin 2 constructs mutated in acidic residues potentially required for synaptotagmin 1 
interaction (S695A, E702A, DE820,822AA). 24 hours post transfection we performed anti-FLAG antibody 
internalization allowing uptake for 20 minutes before cells were fixed and stained essentially as described in 
Figure 4-7. Equal exposure times and identical intensity normalization were used during the acquisition of the 
images. The scale bar is 20 µm. 
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We confirmed by mutational analyses the potential synaptotagmin 1 – stonin 2 interaction 
interface suggested by X-ray crystallographic and homology studies (see chapter 4.2.11). 
Next, we asked the question if mutation of other residues in the vicinity of the KYE site 
would also be detrimental to stonin 2 function. Therefore, we generated mutants F788E and 
DID (RIN794-796DID), and tested their ability to facilitate synaptotagmin 1 endocytosis. We 
could not observe any obvious effects on stonin 2 endocytic function by any of these 
mutations (Figure 4-36, rows 3 and 4). In addition, we examined a stonin 2 mutant lacking a 
putative loop region (∆loop: ∆736-765) that had been suggested as potential binding partner 
for synaptotagmin 1 by PepScan analysis (see chapter 4.2.11). Since this construct was able to 
bind to both AP-2 and synaptotagmin 1 (Figure 4-24) it was not surprising to see that the 
∆loop mutation did not affect stonin 2-mediated synaptotagmin 1 endocytosis (Figure 4-36, 
row 2).   
 
 
Figure 4-35:  δKYE and YR mutations abolish the ability of stonin 2 to mediate synaptotagmin 1 
endocytosis 
HEK293 cells stably transfected with lumenally FLAG-tagged synaptotagmin 1 were transiently transfected 
with HA-tagged stonin 2 constructs mutated in the putative synaptotagmin 1 binding site (δKYE: KYE783-
785AAA; YA: Y784A; YR: Y784R). 24 hours post transfection we performed anti-FLAG antibody 
internalization allowing uptake for 20 minutes before cells were fixed and stained essentially as described in 
Figure 4-7. Equal exposure times and identical intensity normalization were used during the acquisition of 
the images. The scale bar is 20 µm. 
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To further substantiate our data we set out to quantify the effect of synaptotagmin 1 
endocytosis inhibition by the δKYE and δWFδNPF mutants of stonin 2. HEK293-syt1 cells 
were transfected with HA-tagged stonin 2 constructs. We performed antibody uptake assays 
24 hours post transfection and stained for internalized synaptotagmin 1 and stonin 2. For 
quantification we used the mask function of the Slidebook 4.0.10 software (Intelligent 
Imaging Innovations). We defined a mask for the stonin 2 channel (red) and quantified 
fluorescence intensity for the green channel (internalized synaptotagmin 1). For cells not 
transfected with stonin 2 we generated a mask in the Differential Interference Contrast (DIC) 
channel and quantified internalized synaptotagmin 1 inside this mask. Fluorescence units per 
cell were calculated and we defined fluorescence units per cell for untransfected cells as 0% 
and those for stonin 2 WT transfected cells as 100%. By this we estimated that mutating 
residues 783-785 KYE to alanines resulted in a reduction by about 85% with respect to the 
amount of internalized synaptotagmin 1 compared to cells expressing wild-type stonin 2. The 
 
Figure 4-36: Characterization of stonin 2 mutants by the synaptotagmin 1 internalization assay 
Cos7 fibroblasts were co-transfected with lumenally FLAG-tagged synaptotagmin 1 and either of the following 
HA-tagged stonin 2 constructs: wild-type; ∆loop: ∆736-765; F788E. HA-tagged stonin 2 DID (RIN794-
796DID) was transfected into HEK293-syt1 cells stably expressing lumenally FLAG-tagged synaptotagmin 1. 
Anti-FLAG monoclonal antibody was offered for internalization for 20 min at 37°C 24 hours post transfection. 
Cells were fixed and stained as described in Figure 4-7). Equal exposure times and identical intensity 
normalization were used during the acquisition of the images. The scale bar is 20 µm. 
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δWFδNPF mutation impaired stonin 2-driven synaptotagmin 1 internalization by about 75%. 
No inhibition was seen for stonin 2 F788E (Figure 4-37). 
 
 
In summary, we were able to show that stonin 2 and synaptotagmin 1 interact directly via the 
µ-homology domain of stonin 2 in vitro and in living cells. Binding is mainly mediated by 
basic residues within both C2 domains of synaptotagmin 1, with C2A representing the major 
binding partner. Deletion of the C2A domain resulted in loss of binding, block of stonin 2-
dependent synaptotagmin 1 endocytosis, and loss of stonin 2 membrane recruitment by 
syt1∆C2A. A construct lacking the C2B domain was essentially behaving as full-length 
synaptotagmin 1 in internalization and membrane recruitment assays. We were able to 
identify a putative synaptotagmin 1 interaction site in stonin 2. Mutation of residues KYE783-
785 to alanines or Y784R resulted in loss of binding and function regarding stonin 2-
dependent synaptotagmin 1 endocytosis and stonin 2 membrane recruitment by 
synaptotagmin 1. From these data and molecular modeling analysis performed together with 
Dr. Gerd Krause (Leibnitz Institut für Molekulare Pharmakologie, Berlin) we postulate the 
following structural model.  
 
 
Figure 4-37: Stonin 2 δKYE mutation reduces synaptotagmin 1 internalization by 85% 
Stable HEK293-FLAG-syt1 cells were transfected with HA-tagged stonin 2 constructs (wild-type; 
δKYE: KYE783-785AAA; δWFδNPF: AP-2 binding-deficient stonin 2; F788E). Anti-FLAG 
antibodies were offered for endocytosis for 20 minutes 24 hours post transfection. Cells were fixed 
and we stained for stonin 2 using the polyclonal anti-stonin 2 antiserum and goat-anti-rabbit-
Alexa594. We also stained for internalized synaptotagmin 1 using Alexa488-labeled goat-anti-
mouse antibodies. We acquired data with the microscope using the 40x objective. Images were 
taken from at least 3 different cover slips, 3 frames per cover slip (5 to 10 transfected cells per 
frame) and internalized fluorescence units were quantified using the mask function of the Slidebook 
4.0.10 software (Intelligent Imaging Innovations). We calculated the fluorescence units per cell per 
frame and averaged over all frames. Fluorescence counts per cell for untransfected cells were 
defined as 0% those for cells transfected with stonin 2 WT as 100%. Error bars represent the SEM.  
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4.2.15 Structural Model of the Stonin 2 – C2A Interaction 
Together with Dr. Gerd Krause we developed a molecular model for the µHD of stonin 2 
based on the known crystal structure of AP-2µ (Figure 4-38).  
 
 
The homology model of stonin 2 µHD and the known NMR structure of the synaptotagmin 1 
C2A domain were then used for molecular docking analysis in silico. Three alternative 
models were derived: (1) interaction via salt bridges, (2) interaction via aromatic residues, and 
(3) β-strand interactions. Site-directed mutagenesis indicated that binding via salt bridges is 
unlikely. Mutation of acidic residues within the stonin 2 µHD predicted to play a role in this 
type of interaction did not result in loss of stonin 2-driven synaptotagmin 1 internalization 
(compare Figure 4-34). Similarly, we were able to exclude the relevance of a predicted 
aromatic residue on the side of synaptotagmin 1 (F788). Mutation of F788 to glutamate did 
not affect stonin 2 endocytic function. We thus favor the third model of putative modes of 
interaction, i.e., binding via β-strands (Figure 4-39). According to this residues R776, E772, 
H786, E785, K783 form an elongated interaction surface with corresponding residues in the 









Figure 4-38: Structure prediction model of the stonin 2 µHD 
Based on the known structure of AP-2µ, a molecular model for the µHD of stonin 2 was developed. The regions 
where mutations were introduced are color-coded: KYE783-785 in green, RIN794-796 in blue, ∆loop (∆736-
765) in red. Changes between AP-2µ and stonin 2 µHD are also depicted: small loops in yellow, medium loops 
in orange, and large loops in red. µHD: µ homology domain; SA: subdomain A; SB: subdomain. Molecular 
modeling was performed by Dr. Gerd Krause. 
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4.3 Characterization of the Stonin 2 – GIT1 Interaction 
Since stonin 2 was not functionally disturbed for example by mutating the binding sites of 
intersectin and eps15, we hypothesized that stonin 2 might possess further unknown 
functions. We decided to search for novel stonin 2 interacting proteins to gain insight into 
pathways in which stonin 2 might play a role. Our first choice for identification of novel 
interaction partners was the yeast-2-hybrid screening technology. We were able to identify 
two putative stonin 2 interactors, KIBRA and orf32. However, during further biochemical 
analysis we were unable to confirm these interactions. Therefore we decided to perform large 
scale GST pull down and co-immunoprecipitation experiments from rat brain. We were able 
to identify all known stonin 2 interacting proteins by this approach. In addition, we identified 
the G protein-coupled receptor kinase interacting protein 1 (GIT1) as a putative stonin 2 
interaction partner in the course of these studies. In this section we will deal with the 
verification of this interaction and speculate about its functional relevance.  
 
 
Figure 4-39: Model of the stonin 2 – C2A interaction 
(A) Structural model of the stonin 2 – C2A interaction performed by Dr. Gerd Krause. (B) Potentially 
interacting residues in synaptotagmin 1 and stonin 2. 
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4.3.1 Large Scale Co-immunoprecipitation from Rat Brain Revealed GIT1 
as Stonin 2 Interacting Protein 
We purified anti-stonin 2 IgGs from anti-stonin 2 rabbit polyclonal antiserum for performing 
large scale immunoprecipitation from rat brain. Pre-immune IgGs were used as negative 
control. Purified IgGs were immobilized on CNBr-activated Sepharose and were subjected to 
immunoprecipitation from approximately 45 mg rat brain extract. Bound proteins were eluted 
with SDS PAGE sample buffer, separated by SDS PAGE, and analyzed by Coomassie blue 
staining. We excised potential stonin 2 interacting proteins and subjected them to mass 
spectrometry for identification (Figure 4-40). Elution with SDS PAGE sample buffer resulted 
also in co-elution of antibodies covering putative stonin 2 interacting proteins of low 
molecular weight. We were able to identify GIT1 as a novel putative stonin 2 binding partner 







GIT1 is a multi-domain protein (Figure 4-41) implicated in GPCR (G-protein coupled 
receptor) endocytosis. It acts as a GTPase activating protein (GAP) for the ADP-ribosylation 
factor (ARF) family of small GTP-binding proteins (Premont et al., 1998; Claing et al., 2000), 
interacts with liprin-α and has been implicated in AMPA receptor targeting (Ko et al., 2003a). 
GIT1 has been shown to associate with piccolo which is localized at presynaptic sites (Kim et 
al., 2003). GIT1 is also present at postsynaptic spines, where it may influence synapse 
 
Figure 4-40: Large scale co-immunoprecipitation  
Anti-stonin 2 IgGs were immobilized on CNBr-activated 
Sepharose and subjected to immunoprecipitation from        
45 mg rat brain extract prepared from ½ rat brain. We used 
pre-immune IgGs as control. Bound proteins were eluted 
using SDS PAGE sample buffer and subjected to SDS 
PAGE on 8% and 12% SDS PAGE gels (8% gel is shown 
here) and Coomassie staining. Putative interacting proteins 
were excised and identified by mass spectrometry. We were 
able to identify GIT1 as putative stonin 2 binding partner, 
however, other protein bands were not identified, probably 
due to the dominant antibody heavy chain band (marked 
with an asterix).   
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formation (Zhang et al., 2003). In addition, GIT1 functions in a multi-molecular signaling 




We could show that immunoprecipitation of endogenous stonin 2 from rat brain results in co-
precipitation of GIT1. Next, we wanted to confirm this interaction and exclude a possible 
cross-reactivity of the anti-stonin 2 polyclonal antibodies for GIT1. 
 
4.3.2 Stonin 2 Amino-Terminus Interacts with GIT1 
We thus performed co-immunoprecipitation experiments from co-transfected fibroblasts. 
FLAG-tagged GIT1 (1-694) and HA-stonin 2 (full-length: 1-898; NT: 1-555) constructs were 
transfected either alone or in combination into HEK293 cells. Upon immunoprecipitation 
using HA-, or FLAG-tag antibodies we found that stonin 2 and GIT1 co-precipitate in a sub-
stoichiometric complex (Figure 4-42, panel A lane 5, panel B lane 6). Since stonin 2 avidly 
binds to AP-2, one possibility is that the interaction between stonin 2 and GIT1 could be 
bridged by AP-2. To exclude this we mutated the AP-2 binding sites (WVxF motifs) within 
stonin 2 (see Figure 4-22, panel A lane 7). Stonin 2 δWWW retained its ability to interact 
 
Figure 4-41: Schematic representation of GIT1 and its binding partners 
G protein-coupled receptor kinase interacting protein 1 (GIT1) is a multi-domain protein 
interacting with a variety of proteins. It is known to mediate GAP function for the Arf-family of 
small GTPases, it is implicated in cytoskeletal rearrangements, and in synapse formation. Numbers 
correspond to amino acid residues. 
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with GIT1 in co-immunoprecipitation experiments (Figure 4-42, panel A lane 8, panel B lane 
7). We had the impression that the efficiency with which GIT1 co-immunoprecipitated with 
stonin 2 was increased upon mutation of the WVxF motifs (compare lanes 6 and 7 in panel B 
Figure 4-42), indicating a possible competition between AP-2 and GIT1 binding on stonin 2. 
A stonin 2 truncation mutant lacking its µ-homology domain (aa 1-555) retained the ability to 
associate with GIT1 (Figure 4-42, panel B, lane 8). 
 
 
4.3.3 Stonin 2 Interacts Directly with the Arf-GAP Domain of GIT1  
To analyze whether stonin 2 and GIT1 interact directly we performed in vitro binding 
experiments using in vitro translated [35S]-labeled stonin 2. We prepared the following GST-
GIT1 fusion proteins: GAP-Ankyrin repeats (GAP-A; 1-254), Spa2-homology domain (SHD; 
251-374), and G protein-coupled receptor kinase binding domain (GRKBD; 363-645) on 
 
Figure 4-42: Stonin 2 and GIT1 co-immunoprecipitate from transfected fibroblasts 
HEK293 cells were transfected with FLAG-tagged GIT1 (1-694), HA-tagged stonin 2 full-length (1-898) 
or amino-terminus (NT: 1-555) wild-type or δWWW mutant (AP-2 binding-deficient; WVxF  AVxA), 
alone or in combination. Cell extracts were prepared using Triton X-100 and immunoprecipitations for the 
FLAG-tag (A) or the HA-tag (B) were performed. Precipitated proteins were identified by immunoblotting 
for the tags. Detection of clathrin heavy chain (CHC) was used as control. The WVxF motifs were not 
necessary and the amino-terminus was sufficient for the stonin 2 – GIT1 interaction. Black arrows mark the 
antibody heavy chains, blue arrows the immunoprecipitated proteins. 
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GST•bindTM resin. GST-fusion protein beads were incubated with in vitro translated stonin 2. 







4.3.4 Stonin 2 and GIT1 Co-localize to Membrane Ruffles in Fibroblasts  
To gain further insight into the functional relevance of this interaction we checked the 
localization of both proteins in fibroblasts. We transfected HEK293 cells with HA-tagged 
stonin 2 and FLAG-tagged GIT1, either alone or in combination, and performed indirect 
immunofluorescence microscopy using anti-HA and anti-FLAG antibodies. Both proteins 
were mainly located to the cytosol. A fraction of stonin 2 and GIT1 co-localized in membrane 
ruffle-like structures at the cell periphery (Figure 4-44). Stonin 2 was absent from 
characteristic GIT1-induced cytoplasmic protein complexes (Manabe et al., 2002).  
 
 
Figure 4-43: Stonin 2 and GIT1 interact 
directly 
Stonin 2 was in vitro transcribed / translated in 
presence of [35S]-labeled methionine. 
Following GST-fused GIT1 constructs were 
expressed and purified from E.coli: GAP-
Ankyrin repeats (GAP-A: 1-254), Spa2-
homology domain (SHD; 251-374), and G 
protein-coupled receptor kinase binding 
domain (GRKBD; 363-645). 2 µg GST fusion 
proteins were incubated with [35S]-stonin 2. 
Bound stonin 2 was detected by 
Autoradiography. This experiment was 
performed by Jasmin Podufall.  




In summary, we found that stonin 2 and GIT1 interact in vivo shown by co-
immunoprecipitation experiments. We could show that the interaction is direct and not 
mediated via the AP-2 binding WVxF motifs or bridged by AP-2. The amino-terminus of 
stonin 2 (1-555) is sufficient for binding. GST pull down experiments performed with in vitro 
transcribed / translated stonin 2 have shown that stonin 2 associates with the amino-terminal 
Arf-GAP domain of GIT1. Both proteins co-localize in membrane ruffle-like structures in the 
cell periphery of fibroblasts. Since stonin 2 interacts with the Arf-GAP domain of GIT1 it will 
be very interesting to elucidate a potential regulatory function of stonin 2 on the enzymatic 
activity of GIT1 in future experiments. 
 
Figure 4-44: Stonin 2 and GIT1 co-localize in membrane ruffles 
HEK293 cells were co-transfected with FLAG-tagged GIT1 and HA-tagged stonin 2. We stained for the 
proteins using anti-FLAG and anti-HA-antibodies. The FLAG-tag was stained in red using the secondary 
Alexa594-labeled goat-anti-mouse antibody, the HA-tag with goat-anti-rabbit-Alexa488. We used mounting 
reagent containing DAPI for staining of the nuclei. The scale bar is 20 µm. 
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5 Discussion 
5.1 There is Not Much Room for Kiss-and-Run in Small Central 
Synapses 
Ever since it has been shown that synaptic vesicle (SV) recycling follows two different kinetic 
phases, a slow and a fast phase (von Gersdorff and Matthews, 1994; Neves and Lagnado 
1999), there has been a long lasting debate about the molecular mechanisms of these 
kinetically different endocytic pathways. Early studies by Heuser (1973) indicated that 
clathrin plays a role in synaptic vesicle cycling, an observation confirmed later by others. In 
addition, a clathrin-independent kiss-and-run mechanism of exo/endocytosis has been 
proposed by Ceccarelli and co-workers (1973). Here, we wanted to shed light on synaptic 
vesicle recycling pathways in small central synapses. Our strategy was to inhibit clathrin-
mediated endocytosis in primary hippocampal neurons and assess the ability of CME 
impaired synapses to recycle synaptic vesicles upon stimulation.  
 
5.1.1 The Tools for CME Disruption in Primary Hippocampal Neurons 
We achieved inhibition of CME by overexpression of dominant-interfering protein domains 
derived from the clathrin accessory protein amphiphysin 1 using the Semliki Forest Virus 
transfection system. Chosen domains were the SH3 domain that has been shown to interact 
with dynamin (David et al., 1994; Grabs et al., 1997; Owen et al., 1998) and the B/C domain 
harboring AP-2 and clathrin binding sites (Ramjaun and McPherson, 1998; Slepnev et al., 
2000; Miele et al., 2004). We characterized the generated tools biochemically and found that 
both domains were able to bind their target proteins and efficiently inhibited CME in 
fibroblasts analyzed on the basis of transferrin internalization.   
In primary hippocampal neurons our co-workers (group of Dr. Jürgen Klingauf, Max-Planck-
Institute for Biophysical Chemistry, Göttingen) found by electron microscopy (EM) a slight 
reduction of total vesicle number in resting synapses harboring dominant-negative domains. 
However, the number of docked and exocytosis-competent vesicles was unaltered between 
control synapses and boutons expressing SH3 or B/C domains. This indicated that 
overexpression of chosen dominant-interfering domains did not disturb exocytic events. This 
knowledge is essential for interpreting putative endocytic defects.  
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5.1.2 Blocking CME Causes Severe Defects in SV Recycling 
SV endocytosis was analyzed by fluorescence imaging using the optical tracer FM1-43 and 
the pH-sensitive exo/endocytosis marker synaptopHluorin. We found a drastic reduction of 
the total recycling vesicle pool size in synapses expressing dominant-interfering domains. 
Since exocytosis was normal in these boutons we concluded that the reduced recycling vesicle 
pool size was a direct effect of the endocytic defects caused by SH3 and B/C domain 
overexpression. Furthermore, the endocytic machinery appeared to be exhausted for milder 
stimulation conditions in the presence of dominant-interfering domains. While control 
synapses could compensate for exocytosis up to 600 action potentials (APs), CME perturbed 
synapses were working at the limit already when stimulated with 200 (SH3 domain) or 40 
APs (B/C domain), respectively, in agreement with a severe endocytic defect. It was 
noticeable that under mild stimulation conditions with 40 APs at 10 Hz, supposedly only 
affecting the readily releasable pool (Stevens and Williams, 2000), FM1-43 staining for 
control and CME perturbed synapses was indistinguishable. Thus, we cannot exclude an AP-
2/clathrin-independent SV recycling pathway operating at small central synapses for very 
mild stimulation conditions. However, the question arises regarding the significance of such a 
pathway. One characteristic feature of the kiss-and-run mechanism and advantage over CME 
is its speed. Therefore, the fast component of SV retrieval is frequently considered to be the 
most likely scenario for a kiss-and-run type mechanism. In small central synapses where SV 
number is limited and strong stimulation would lead to SV depletion, a fast vesicle recycling 
mode would appear to be convenient. However, our data clearly indicate that under strong 
stimulation the majority of synaptic vesicles are recycled via a clathrin-dependent pathway. 
We see only room for clathrin-independent SV retrieval under mild stimulation conditions, 
where rapid recycling would not be required as exocytosed vesicles can be replenished from 
the recycling or reserve pools. 
Defects in SV endocytosis are particularly pronounced in neurons expressing the B/C domain 
of amphiphysin, a well characterized AP-2 and clathrin binding domain (Slepnev et al., 2000; 
Miele et al., 2004). Application of the B/C domain resulted in severe SV recycling defects 
already under relatively mild stimulation conditions (> 40 AP, 10 Hz), indicating that only the 
readily releasable pool is functional under these conditions. While clathrin and AP-2 are 
specific for CME, dynamin has also been suggested to play a role in a kiss-and-run type 
recycling pathway. Three findings make the possibility for a dynamin-dependent kiss-and-run 
mechanism in small central synapses unlikely. First, in our experiments the clathrin and AP-2 
binding B/C domain had a more severe effect on SV recycling compared to the dynamin-
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targeting SH3 domain. Second, both domains did not affect recycling under very mild 
stimulation conditions. Third, all trapped vesicle intermediates in dynamin-targeted boutons 
were clathrin-coated. However, we cannot exclude a dynamin-independent kiss-and-run type 
SV recycling mechanism (Heidelberger, 2001; Zhang et al., 2004) for mild stimulation 
conditions. There are some considerations when interpreting our data. The different influence 
on SV recycling between the two domains could be due to varying efficiency regarding 
inhibition of targeted proteins. Meaning the different effects of the SH3 and B/C domains on 
SV recycling might not reflect the different contributions of the target proteins (dynamin 
versus AP-2/clathrin) to SV endocytosis, but could equally well result from different 
remaining functional pools of dynamin or AP-2/clathrin. However, inhibition of transferrin 
internalization in fibroblasts did not suggest different efficiencies of SH3 and B/C domains in 
blocking their target proteins. Furthermore, we used the SH3 domain of amphiphysin to block 
dynamin function. Since the dynamin – amphiphysin interaction is specific for CME, using 
the SH3 domain as dominant-negative construct might only affect CME-specific dynamin 
functions, and may leave other functions, i.e., in kiss-and-run exo/endocytosis, unperturbed.  
 
5.1.3 Blocking CME Significantly Slows Endocytic Events at Small 
Central Synapses 
Fluorescence imaging of exo/endocytic events using synaptopHluorin showed that 
interference with CME in primary hippocampal synapses equally affected all phases of 
synaptic vesicle retrieval, indicating that potentially different kinetic modes of endocytosis are 
AP-2/clathrin- and dynamin-dependent. This is in contrast to the data obtained by Jockusch et 
al. (2005) who have investigated the molecular nature of synaptic vesicle recycling in the 
large terminal of retinal bipolar cells. They also chose to disrupt the amphiphysin – dynamin 
and AP-2/clathrin interactions by injecting a peptide derived from the proline-rich region 
(PRD) of dynamin, the clathrin terminal domain, an amphiphysin-derived peptide containing 
the clathrin binding sites, or a peptide containing the DNF α-appendage binding motif into the 
goldfish retinal bipolar terminal using the patch pipette. Synaptic vesicle exo/endocytosis was 
analyzed by capacitance measurements, which showed that only the slow phase of 
endocytosis was affected by injection of the dominant-negative peptides and domains while 
the fast phase was unaltered. They found that injection of a non-hydrolyzable GTP analog, 
GTPγS, affected both kinetic endocytosis phases. They concluded that the slow phase of SV 
retrieval is indeed clathrin-dependent, however, that fast endocytic phase is not, and both 
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endocytic modes are dependent on dynamin. The discrepancy between our data obtained from 
small central synapses indicating an identical mechanism for all phases of SV retrieval and 
data obtained by Jockusch et al. (2005) showing two molecularly distinct endocytic modes for 
the kinetically different slow and fast components at the retinal bipolar terminal might be 
explained as follows. First, small central synapses and the retinal bipolar terminal of the 
goldfish are morphologically very different. While the bipolar terminal can draw from a 
massive amount of synaptic vesicles, central synapses need to sustain neurotransmitter release 
only with a few hundred vesicles. It may be that the requirements for SV recycling differ 
between these synapses, and that therefore the modes or the ratio of the modes of SV retrieval 
are different between the synapse types. Second, it is possible that the molecular players, e.g., 
clathrin, AP2, dynamin, involved in SV retrieval may be identical for fast and slow vesicle 
retrieval, but that their assembly mechanism differs. One could imagine, that pre-assembled 
clathrin lattices account for the fast phase of endocytosis, while the slow phase corresponds to 
recycling via de novo assembled clathrin cages. The putative pre-assembled pool of clathrin 
might not be accessible for dominant-interfering domains with the same efficiency as clathrin-
coated pits assembled de novo. In this case both kinetic components of endocytosis would 
underlie the same molecular machinery, however, the difference in inhibition efficiency of the 
CME dominant-interfering domains might reflect a difference in assembly mechanism.   
 
5.1.4 What is the Molecular Mechanism of Endocytosis at Small Central 
Synapses? 
Our data suggest that the majority of SVs are retrieved via a clathrin-dependent pathway in 
small central synapses. We cannot exclude the possibility for a clathrin-independent SV 
recycling mechanism under mild stimulation conditions. Although a variety of approaches 
have provided evidence for a kiss-and-run mode of exo/endocytosis, these data generally have 
indicated that this mode occurs relatively rarely (Klyachko and Jackson, 2002), under very 
low release probability conditions (Gandhi and Stevens, 2003), or only for a small fraction of 
the vesicle pool (Pyle et al., 2000). There is a number of studies suggesting a clathrin-
independent mode of SV recycling for the kinetically fast component of SV endocytosis 
(Jockusch et al., 2005), which might contradict our data indicating that both kinetic 
components are equally affected by perturbing CME. Nonetheless, we do not detect any 
effects of dominant-negative domains on the readily releasable pool. We can only speculate 
about the molecular nature of a putative clathrin-independent SV endocytosis pathway. One 
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possibility could be the kiss-and-run mode of exo/endocytosis, where synaptic vesicle shape 
is conserved during the SV cycle (Aravanis et al., 2003). However, for the retinal bipolar 
terminal of the goldfish the group of Lagnado showed by interference reflection microscopy 
allowing for direct monitoring of surface membrane expansion that all SVs undergoing 
exocytosis (Jockusch et al., 2005) fully collapse into the plasma membrane (Llobet et al., 
2003), arguing against a kiss-and-run type mode of exo/endocytosis. Other groups have 
indications for full collapse of SVs during exocytosis as well. Zenisek and colleagues showed 
that a membrane marker leaves SVs in milliseconds after exocytosis. This indicates free 
exchange of lipids between the vesicle and the plasma membrane arguing against a kiss-and-
run mechanism using a proteinaceaus pore to release neurotransmitter (Zenisek et al., 2002). 
Wienisch and Klingauf (2006) as well as the group of Ryan (Fernandez-Alfonso et al., 2006) 
found that vesicular proteins exocytosed and subsequently retrieved by compensatory 
endocytosis are not identical. This makes a kiss-and-run type mechanism rather unlikely. Our 
data suggest that SV retrieval is largely clathrin-dependent, at least under the stimulation 
conditions tested. On the one hand, B/C and SH3 domain overexpression might only partially 
block CME. The residual CME capacity might be enough to accomplish SV recycling under 
mild conditions when only few vesicles need to be retrieved. On the other hand this could 
argue for a clathrin-independent pathway, for instance kiss-and-run under mild stimulation 
conditions. However, it is clear that this potential alternative pathway is unable to compensate 
for the loss of CME under prolonged stimulation. Ultrastructural studies have shown that bulk 
membrane retrieval compensates for the endocytic defect under strong stimulation. Other 
groups have also reported evidence for bulk endocytosis at synapses (Lenzi et al., 2002; Holt 
et al., 2003; Paillart et al., 2003). Overexpression of the SH3 domain led to an accumulation 
of large endosome-like structures covered with clathrin. This was expected since the SH3 
domain blocks dynamin function thus vesicle fission and not AP-2/clathrin assembly. Similar 
clathrin-coated intermediates were also observed by Shupliakov et al. (1997) following 
disruption of the amphiphysin – dynamin interaction at the lamprey reticulospinal synapse. 
Injection of the amphiphysin SH3 domain resulted in depletion of synaptic vesicles from the 
synapse in these studies. In our experiments overexpression of the B/C domain resulted in 
increasing vesicle diameters and the accumulation of vacuolar structures. However, in most 
cases these structures were not clathrin-coated. This was somewhat expected, since the target 
of the B/C domain is AP-2/clathrin assembly.  
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5.1.5 Clathrin-Mediated Endocytosis: The Major Pathway of Synaptic 
Vesicle Recycling 
Altogether, we could show that AP-2/clathrin-dependent endocytosis is the major retrieval 
pathway for SV membranes at primary hippocampal synapses. Should kiss-and-run 
exo/endocytosis operate in this type of boutons it most likely occurs only during very mild 
stimuli affecting the readily releasable pool.  
Clathrin coated vesicle (CCV) formation is a ubiquitous process in distinct trafficking 
pathways. CCVs are generated at the late Golgi, on endosomal membranes, and on the plasma 
membrane, and transport a diverse set of cargo proteins. It has been shown that the process of 
CCV formation is very similar in neuronal and non-neuronal cells and the question arises how 
the clathrin machinery can be targeted for the specific process of recycling SV membrane 
proteins. Synaptic vesicles contain about 250 proteins belonging to at least 10 functionally 
different protein families implicated in different aspects of SV functionality. It has been 
shown that the molecular identity of SVs is not preserved during vesicle recycling 
(Fernandez-Alfonso et al., 2006; Wienisch and Klingauf, 2006). Strong genetic evidence 
indicates that the endocytic machinery is required to recognize and properly sort SV proteins 
in order to generate functional SVs (Koenig and Ikeda, 1989; Gonzales-Gaitan and Jäckle, 
1997; Zhang et al., 1998a; Cremona et al., 1999; Di Paolo et al., 2002; Kim et al., 2002). 
Generally, recognition and sorting of cargo proteins is achieved by specific endocytic 
adaptors and sorting signals. However, specific sorting signals are largely unknown for most 
SV proteins. Nonetheless, some SV proteins have been implicated in SV endocytosis. It has 
been suggested that the v-SNARE synaptobrevin contributes not only to vesicle fusion but 
also to SV recycling (Desnos et al., 1995; Grote et al., 1995; Deak et al., 2004). In addition, 
the vesicular monoamine and acetylcholine transporters carry dileucine-like motifs in their 
cytoplasmic domains, potentially recognized by the clathrin adaptor AP-2 (Tan et al., 1998; 
Krantz et al., 2000). The vesicular glutamate transporter V-GLUT1 has been shown to 
directly associate with the clathrin machinery via the accessory protein endophilin (Voglmaier 
et al., 2006). Furthermore synaptotagmin 1 has been implicated to play a crucial role in SV 
endocytosis. First, deletion of synaptotagmin 1 in mice (Geppert et al., 1994; Nicholson-
Tomishima and Ryan, 2004), worms (Jorgensen et al., 1995), and flies (DiAntonio et al., 
1993; Poskanzer et al., 2003) results in pleiotropic defects in neuroexocytosis and impaired 
retrieval of SV membranes. Second, interfering with synaptotagmin function by mutation 
(Littleton et al., 2001; Poskanzer et al., 2006), acute chemical inactivation (Poskanzer et al., 
2003), or injection of antibodies (Llinas et al., 2004) leads to a partial depletion of the SV 
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pool. Third, synaptotagmin 1 has been shown to interact with the µ2 subunit of the 
heterotetrameric clathrin adaptor complex AP-2 (Grass et al., 2004; Haucke et al., 2000). This 
interaction is mediated via a stretch of basic amino acid residues in the C2B domain of 
synaptotagmin (Chapman et al., 1998; Haucke et al., 2000). This basic patch may serve as 
endocytic signal. Synaptotagmin was also shown to influence endocytic efficiency of other 
SV proteins (Nicholson-Tomishima and Ryan, 2004; Poskanzer et al., 2003) through specific 
regions in its cytoplasmic tail (Poskanzer et al., 2006). Therefore it was hypothesized that the 
endocytic signal is provided by one specific SV protein, for instance synaptotagmin 1, which 
might trigger endocytosis and sorting of other SV proteins. Apart from sorting signals in 
cargo proteins, endocytic adaptors play a crucial role in specifying endocytic events. We were 
able to identify a synaptotagmin-specific endocytic sorting adaptor, stonin 2, the first 
endocytic protein shown to facilitate recycling of a SV protein. Therefore, we set out to 
functionally and molecularly dissect the protein – protein interaction between stonin 2 and 
synaptotagmin 1.      
 
5.2 The Stonin 2 – Synaptotagmin 1 Interaction 
Ectopically expressed synaptotagmin 1 in fibroblasts is localized to the plasma membrane 
(Feany et al., 1993). We could show that upon co-expression of stonin 2 synaptotagmin 1 was 
internalized in an AP-2-dependent manner and sorted to a peri-nuclear endocytic 
compartment in fibroblasts (Diril et al., 2006; see this thesis work). We therefore hypothesize 
that stonin 2 may function as synaptotagmin 1-specific endocytic sorting adaptor. We found 
that stonin 2 and synaptotagmin 1 interacted directly in vitro as well as in vivo, whereas AP-2 
appeared to be unable to associate with synaptotagmin 1 in fibroblasts in the absence of stonin 
2. The stonin 2 – synaptotagmin 1 interaction and the stonin 2 endocytic function were 
dependent on residues KYE (783-785) located within the µ-homology domain (µHD) of 
stonin 2. The synaptotagmin 1 C2A domain appeared to be the major interaction partner for 
stonin 2, if single C2 domains were offered. This is in agreement with our observation that a 
synaptotagmin 1 C2B deletion construct was internalized in an AP-2/stonin 2-dependent 
manner in fibroblasts. By contrast, a synaptotagmin 1 C2A domain deleted protein remained 
at the plasma membrane. Deleting the C2B domain reduced internalization efficiency when 
compared to its native full-length counterpart. This might be explained by the fact that the C2 
domains exhibit synergistic effects with respect to binding to stonin 2. AP-2 primarily 
associated with the C2B domain and did not exhibit any cooperative effects for the C2 
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domains. Both interactions, stonin 2 – synaptotagmin 1 and AP-2 – synaptotagmin 1, 
appeared to be mediated via patches of basic amino acid residues within the C2 domains. A 
basic peptide derived from the β4-strand of the C2B domain was sufficient to associate with 
stonin 2 and AP-2 in affinity chromatography experiments. We were able to abolish AP-2 
binding and substantially reduce stonin 2 binding to synaptotagmin 1 by mutating basic 
residues within the C2 domains. The experimental data and a structural model provided by 
Dr. Gerd Krause suggest a β-strand interaction mechanism between stonin 2 and the 
synaptotagmin 1 C2A domain.  
 
5.2.1 The Stonin 2 KYE Site is Required for Direct Interaction with 
Synaptotagmin 1 and for Stonin 2 Endocytic Function 
Apart from established endocytic signals, such as the YxxΦ or the acidic dileucine signal, 
basic peptide motifs have recently gained more attention as endocytic sorting signals (Grass et 
al., 2004; Kittler et al., 2005; Kastning et al., submitted). Whereas the AP-2µ binding site for 
YxxΦ motifs is structurally solved (Owen and Evans, 1998), not much is known about the 
binding interface between basic endocytosis motifs and µ2. However, there is indication that 
the µ2 subdomain B is required, and residues Y344 and K354 might contribute to this 
interaction (Haucke et al., 2000). Our collaborators, the group of Professor Wolfram Saenger 
(Institute for Chemistry – Crystallography, FU Berlin) succeeded in co-crystallizing µ2 with a 
basic peptide motif derived from the GABAA-receptor β3-subunit. Their data indicate that a 
basic patch comprising residues K343, Y344, and E348 (among others) are involved in 
mediating the interaction between µ2 and basic peptide motifs.  
We and others (Martina et al., 2001; Walther et al., 2001) have shown that the stonin 2 – 
synaptotagmin 1 interaction is mediated by the stonin 2 µHD. In addition, we have shown that 
both interactions, AP-2 – synaptotagmin 1 and stonin 2 – synaptotagmin 1, are at least 
partially dependent on basic residues in synaptotagmin 1. We decided to perform site-directed 
mutagenesis on stonin 2 on the basis of homology considerations between AP-2µ and the 
stonin 2 µHD. Mutating residues KYE783-785 within stonin 2 to alanines resulted in 
complete loss of interaction between stonin 2 and synaptotagmin 1 as shown by GST pull 
down and co-immunoprecipitation experiments. These data indicate that one or all of these 
residues are involved in the association with synaptotagmin 1. Similar results were seen for 
the Y784R mutation, however, not for Y784F or Y784A mutations, indicating that direct 
interaction of the aromatic side chain of residue Y784 is not required. This is in agreement 
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with the molecular model of the stonin 2 – C2A interaction, which assigns higher priority for 
stonin 2 residues K783 and E785 with respect to synaptotagmin 1 interaction. We imagine 
that introduction of a charged residue (arginine) at the Y784 position might affect the 
neighboring charged residues, i.e., the lysine residue 783 and glutamate residue 785, and 
inhibit their function. One concern is that mutating residues 783-785 in stonin 2 (δKYE) 
could result in a structurally malfunctional protein. We have several indications that argue 
against this possibility. First, both proteins, wild-type and δKYE mutant stonin 2, are 
expressed in fibroblasts, astrocytes, and neurons. We would expect protein degradation in the 
case of mis-folded proteins. Second, stonin 2 δKYE and Y784R mutants loose the ability to 
associate with synaptotagmin 1 in co-immunoprecipitation experiments, however, retain AP-2 
binding activity. And third, we probed for structural integrity of the δKYE and Y784R 
mutants by limited proteolytic digest, and did not observe significant differences in the 
proteolytic pattern between wild-type and mutant stonin 2 using two different proteases. 
Therefore we believe that we succeeded in identification of stonin 2 residues important for 
mediating or coordinating synaptotagmin 1 interaction. The direct binding contributions of 
each of the identified residues remains to be determined. The data obtained by molecular 
modeling of the stonin 2 – C2A interaction by Dr. Gerd Krause (Leibnitz Institut für 
Molekulare Pharmakologie, Berlin) argue for a direct interaction between residues K783 and 
E785 within stonin 2 with residues Q209 and K213 of synaptotagmin 1. We have analyzed 
stonin 2 δKYE and Y784R mutants in astrocytes and neurons. Stonin 2 wild-type exhibits a 
characteristic squiggle-like localization at the plasmalemma in astrocytes where it co-localizes 
with AP-2 (Diril, 2005). We did not find stonin 2 mutants in squiggle-like structures, but in 
finer dots. AP-2 partially co-localized with the stonin 2 mutant protein in these pit-like 
structures. We therefore believe that the KYE site might not only mediate interaction with 
synaptotagmin 1, but might also be required for recruiting stonin 2 to yet unidentified 
structures in astrocytes. This argues for additional unknown interaction partners of stonin 2 in 
astrocytes. Overexpression of stonin 2 in neurons showed that wild-type stonin 2 co-localizes 
with synaptotagmin 1 in SV clusters, whereas stonin 2 mutants were uniformly expressed in 
neurites and soma and did not significantly co-localize with synaptotagmin 1. Synaptotagmin 
1 localization was not noticeably altered. We conclude that the direct stonin 2 – 
synaptotagmin 1 interaction is necessary for localizing stonin 2 to synapses. Conversely, data 
obtained in Drosophila stoned B mutants indicated that stoned B is required for proper 
synaptic localization of synaptotagmin 1 (Fergestad et al., 1999; Fergestad and Broadie, 
2001). Since examined neurons express endogenous stonin 2 it is expected that they retain the 
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ability to localize synaptotagmin 1 to synapses, even in the presence of overexpressed mutant 
stonin 2. However, the lack of a dominant-negative effect of stonin 2 synaptotagmin 1-
binding mutants in the described experiment in combination with our finding that 
synaptotagmin 1 is localized to synapses in stonin 2-/- neurons, may argue against a role for 
stonin 2 in synaptic targeting of synaptotagmin 1 in mammalian small central synapses.  
Furthermore, we found that mutnat stonin 2 deficient in synaptotagmin 1 binding cannot be 
recruited to the plasma membrane and instead remains in the cytosol. In addition, stonin 2 
δKYE and Y784R mutant proteins fail to facilitate synaptotagmin 1 internalization in 
fibroblasts. Since these mutants retain the ability to interact with AP-2, we conclude that the 
loss of stonin 2 function is a direct consequence of loss of interaction between stonin 2 and 
synaptotagmin 1. Thus, the direct association between synaptotagmin 1 and stonin 2 is a pre-
requisite for AP-2/stonin 2-dependent synaptotagmin 1 internalization in fibroblasts. Future 
experiments must reveal whether this is also true for synaptotagmin 1 internalization in 
neurons. 
              
5.2.2 Stonin 2 and AP-2 Bind Directly to Synaptotagmin 1 Probably via 
Different Mechanisms 
Both stonin 2 (this thesis work) and AP-2 (Haucke et al., 2000) bind directly to 
synaptotagmin 1 in vitro. This was shown by GST pull down experiments using purified and 
in vitro translated proteins. While stonin 2 facilitated AP-2-dependent synaptotagmin 1 
endocytosis in fibroblasts, AP-2 alone was not sufficient for this process. To gain more 
insight into the molecular mechanisms of synaptotagmin 1 internalization we decided to 
elucidate the molecular characteristics of the interactions between stonin 2, AP-2, and 
synaptotagmin 1. We were able to show by GST pull down and co-immunoprecipitation 
experiments that stonin 2 primarily interacted with the synaptotagmin 1 C2A domain, 
whereas AP-2 mainly associated with the C2B domain, if single C2 domains were offered. It 
should be pointed out that AP-2 was also able to bind to C2A and stonin 2 to C2B, however, 
much less efficiently. These molecular findings were in agreement with our observation that a 
synaptotagmin 1 C2B deletion mutant was readily internalized in a stonin 2/AP-2-dependent 
manner in fibroblasts, albeit with somewhat reduced efficiency when compared to the wild-
type protein. Deleting the C2A domain resulted in retention of synaptotagmin 1 at the plasma 
membrane. This indicates that the stonin 2 – synaptotagmin 1 interaction is more important 
for stonin 2/AP-2-dependent synaptotagmin 1 internalization in fibroblasts than the 
Discussion  165 
 
association of AP-2 with synaptotagmin 1. This was expected, since AP-2 alone was not able 
to mediate efficient synaptotagmin 1 endocytosis in fibroblasts. Furthermore, synaptotagmin 1 
lacking the C2B domain was able to recruit stonin 2 to the plasma membrane, whereas a 
synaptotagmin 1 C2A deletion mutant was unable to relocalize stonin 2 from the cytosol. 
Affinity chromatography experiments showed that basic peptides derived from the C2B 
domain reduced binding of synaptotagmin 1 to stonin 2 or AP-2, suggesting a role for basic 
residues in both interactions. The AP-2 binding site within the C2B domain was shown to lie 
within a patch of basic amino acids. Lysines 326 and 327 have been postulated to be involved 
in AP-2 binding (Chapman et al., 1998). Our data confirmed the contribution of 
synaptotagmin 1 basic residues in AP-2 binding. We found that mutating lysine residues 326 
and 327 did not abolish AP-2 binding as indicated before by others (Jarousse and Kelly, 
2001a; Haucke et al., 2000). Mutation of at least six basic residues in the vicinity of lysines 
326 and 327 was necessary to completely eliminate AP-2 binding. Stonin 2, which exhibited a 
comparably low binding affinity for the isolated C2B domain, was also unable to bind to the 
mutated C2B domain. We conclude that a conserved basic site within C2B is involved in its 
association with both AP-2 and stonin 2. We could show that this basic stretch is not only 
required but also sufficient to interact with AP-2 and stonin 2, since a GST-fused C2B peptide 
(GKRLKKKKTTIKK) was able to associate with AP-2 or stonin 2. This fits well with the 
common interaction principle in clathrin-mediated endocytosis where many interactions 
between cargo and adaptor or accessory proteins are mediated via short peptide motifs (Traub, 
2003; McPherson and Ritter, 2006). In theory the basic stretch derived from the C2B domain 
would qualify as endocytic signal. Other proteins such as the GABAA receptor β3 subunit 
(Kittler et al., 2005), or the GluR2 subunit of the AMPA receptor (Kastning et al., submitted) 
also have been shown to associate with AP-2 via stretches of basic amino acid residues. Grass 
et al. (2004) could show that a chimeric protein composed of the extracellular and 
transmembrane domain of the T cell surface glycoprotein CD4 and the synaptotagmin 1 C2B-
derived basic peptide was readily internalized upon multimerization. This indicates that the 
C2B-derived basic peptide can serve as an internalization signal. In addition, mutation of 
aforesaid basic residues in the C2B domain diminished synaptotagmin 1 endocytosis in PC12 
cells (Jarousse and Kelly, 2001a; Grass et al., 2004). In contrast to these findings, we were not 
able to affect AP-2/stonin 2-dependent synaptotagmin 1 internalization in fibroblasts by 
mutating the basic stretch in the C2B domain to alanines or glutamates. We were not 
surprised by this data since we have seen that deleting the entire C2B domain was not 
abolishing synaptotagmin 1 internalization in our assay, though we could observe a reduction 
166  Discussion 
 
in internalization efficiency. This is in line with data obtained by Poskanzer et al. (2006) who 
found that mutating basic residues in the C2B domain affected only vesicle size but not 
endocytic rate and that a synaptotagmin 1 C2B deletion mutant did not efficiently recycle at 
the Drosophila neuromuscular junction (NMJ). Furthermore Llinas et al. (2004) provided 
evidence for a role of the C2B domain in SV endocytosis by observing that blocking the C2B 
domain by injection of anti-C2B antibodies into the squid giant synapse resulted in 
stmulation-dependent SV depletion. Synaptotagmin endocytosis at neuronal synapses is 
probably not an isolated event, but is integrated in the temporally and spatially regulated 
mechanism of synaptic vesicle recycling. It would thus be interesting to investigate the effects 
of deleting the synaptotagmin 1 C2B domain or expressing AP-2 binding-deficient mutants in 
small central synapses. Such experiments are currently in progress, and are carried out 
together with the group of Dr. Jürgen Klingauf.      
We tried to delineate the binding sites within the C2A domain for both AP-2 and stonin 2 
based on our knowledge gained from C2B interactions. AP-2 and stonin 2 bind to 
synaptotagmin 1 C2A, albeit stonin 2 with much greater efficiency when compared to AP-2. 
Given the overall similarity of the stonin 2 µHD and AP-2µ, we rationalized that C2A 
interactions might also be mediated via basic residues. Aligning the C2 domains showed that 
the C2A domain carries a homologous stretch of basic amino acid residues similar to those 
found in the C2B domain. Mutating these residues resulted in loss of AP-2 interaction and 
substantially reduced stonin 2 binding, indicating that stonin 2 and AP-2 interact with 
synaptotagmin 1 C2A, at least partially, via overlapping sites. Mutation of up to six basic 
residues in combination did not completely eliminate C2A – stonin 2 interaction, suggesting 
that additional residues may be involved. At the moment we do not have experimental 
information regarding the nature of these residues. A molecular model of the stonin 2 – C2A 
interaction suggests residue Q209 as one candidate based on the identified synaptotagmin 1 
binding residues in stonin 2 (see above). This will be investigated in future experiments. In 
contrast to results obtained with a C2B domain-derived peptide, a basic peptide derived from 
the C2A domain was not able to associate with either AP-2 or stonin 2 in GST pull down 
experiments. This might reflect different modes of interaction between C2A - AP-2/stonin 2 
when compared to the C2B - AP-2/stonin 2 interaction. This also might suggest a dependence 
on tertiary structural elements within C2A.  
Since our experiments using the individual C2 domains showed that stonin 2 predominantly 
bound to the C2A domain, whereas AP-2 associated with C2B, we hypothesized that a GST-
fused C2AB construct mutated in the C2A domain would specifically purify AP-2, while 
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stonin 2 should be largely absent from the affinity purified material. We were surprised to see 
that the C2A mutation in the C2AB context did not affect stonin 2 binding. In co-
immunoprecipitation experiments employing full-length synaptotagmin 1 proteins, C2B 
domain mutations resulted in decreased stonin 2 binding, whereas mutating the C2A domain 
was without effect in this assay. We conclude that stonin 2 has the ability to efficiently 
associate with the C2B domain if both C2 domains are offered in combination. Since 
mutation of the basic residues in the C2B domain decrease the stonin 2 – synaptotagmin 1 
interaction in a full-length context, this interaction is  probably, at least partially, mediated via 
the basic amino acid stretch located within the β4-strand of C2B. In addition, the cooperative 
effect does not appear to be dependent on the stonin 2 binding site in C2A, since mutation of 
C2A residues that substantially reduced stonin 2 – C2A association if C2A was offered alone, 
had no effect in the full-length context. It is thus possible that combined C2 domains provide 
a new three-dimensional interaction surface, offering an additional binding pocket for stonin 
2. Our observation that the synaptotagmin 1 C2B deletion construct was less efficiently 
endocytosed than the full-length protein fits well with the fact that the C2AB construct 
exhibited a higher affinity for stonin 2 binding than the C2A domain alone. Our findings 
appear very similar to the observations made by Bai et al. (2002) for interaction between 
synaptotagmin 1 and phosphatidyl-serine (PS) containing liposomes, at least in three aspects. 
First, they found that C2A alone was able to associate with PS containing liposomes, whereas 
C2B was not. Second, offering the C2B domain in a C2AB context enabled the C2B domain 
to penetrate PS containing liposomal membranes. Third, in the context of C2AB elimination 
of the membrane penetration ability of C2A did not alter C2B binding to liposomes. Other 
groups have found that the C2 domains, in particular C2B, bind target molecules differently in 
the presence of the C2A domain and that mutations within a construct containing the two 
domains are not additive (Wang et al., 2003; Tucker et al., 2004; Herrick et al., 2006). What 
might be the functional relevance of this synergistic effect? We hypothesize that cooperativity 
between tandemly repeated protein domains provides a new level of protein – protein 
interaction regulation. In this case not only binding partners of C2B might modulate 
interaction activities with other proteins, but also binding partners of the C2A could influence 
the selection of interaction partners for the C2B domain. This might be necessary for 
temporally and spatially regulating the synaptic vesicle cycle and appears to be especially 
important for a protein that functions at the lynchpin of SV exo- and endocytosis, such as 
synaptotagmin 1. In contrast to the stonin 2 – synaptotagmin 1 interaction we did not observe 
a cooperative effect between the C2 domains with respect to AP-2 binding. Mutating the 
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major AP-2 binding site within the C2B domain in a C2AB context resulted in a drastic 
reduction of binding efficiency. The residual binding capacity was eliminated when we 
mutated the C2A in addition to the C2B domain. If our hypothesis were correct that 
cooperativity between protein domains offers a mechanism for fine-tuning protein – protein 
interactions, we would assume that the synaptotagmin 1 – AP-2 interaction does not require 
such a complex regulation mechanism. For AP-2/stonin 2-dependent synaptotagmin 1 
internalization this might actually be true, since we did not observe association of AP-2 with 
synaptotagmin 1 in fibroblasts. Nonetheless, the situation in neurons is certainly more 
complex, and AP-2 might serve different functions in this setting.    
 
5.2.3 Stonin 2: a Synaptotagmin 1-Specific Endocytic Sorting Adaptor 
We could show that upon co-expression of stonin 2 synaptotagmin 1 was internalized in an 
AP-2-dependent manner and sorted to a peri-nuclear endocytic compartment in fibroblasts 
(Diril et al., 2006; see this thesis work). Co-immunoprecipitation experiments revealed that 
stonin 2 serves as linker between synaptotagmin 1 and AP-2 in vivo, and therefore connects a 
specific cargo protein to the clathrin endocytic machinery. By this stonin 2 qualifies as 
clathrin-associated sorting protein or CLASP (Traub, 2005). Most of the proteins classified as 
CLASPs, such as ARH, Dab2 (mediating specific internalization of LDL receptor family 
members), or β-arrestins (specific for G protein-coupled receptors) carry an intrinsic clathrin 
binding activity. It has been shown that at least some of these alternate endocytic adaptors can 
function in the absence of AP-2, whereas clathrin is required (Motley et al., 2003). Stonin 2 
does not directly associate with clathrin. This might be the reason, why stonin 2-mediated 
synaptotagmin 1 internalization in fibroblasts is strictly AP-2-dependent. Mutating the AP-2 
binding sites in stonin 2 abolished the ability of stonin 2 to mediate AP-2 – synaptotagmin 1 
binding in vivo and synaptotagmin 1 internalization. In addition, AP-2 knock down by siRNA 
also blocked stonin 2-mediated synaptotagmin 1 endocytosis (Diril et al., 2006). Our data 
suggest that synaptotagmin 1 endocytosis in fibroblasts requires two adaptors, stonin 2 and 
AP-2, with their binding sites located to different domains within synaptotagmin 1. Stonin 2 
appeared to associate directly and predominantly with the C2A domain of synaptotagmin 1. 
As discussed before additional interaction interfaces might contribute to the interaction if both 
C2 domains act in tandem. Stonin 2 in this scenario couples AP-2 to the SV protein 
synaptotagmin 1, whereas AP-2 is required for connecting the stonin 2/synaptotagmin 1 
complex to the clathrin machinery. The use of two different binding sites within 
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synaptotagmin 1 for stonin 2 and AP-2 may prevent binding competition between the two 
adaptors, although it is unclear whether AP-2 directly associates with synaptotagmin 1 in 
fibroblasts. While we cannot exclude that it does, our notion is that direct binding of AP-2 to 
synaptotagmin 1 is not required for its endocytosis. We draw this conclusion based on two 
observations. First, deleting the major AP-2 interaction interface, the C2B domain, does not 
abolish AP2/stonin 2-mediated synaptotagmin 1 endocytosis. Second, we have identified 
basic residues in the C2A domain that are responsible for C2A - AP-2 binding. Mutating these 
residues in a C2B deletion context essentially abolished AP-2 binding, but did not affect AP-
2/stonin 2-dependent endocytosis.    
Synaptotagmin is not endogenously expressed in fibroblasts. Therefore, we studied the effects 
of overexpressing an AP-2 binding-deficient dominant-negative stonin 2 mutant on 
synaptotagmin 1 internalization in primary hippocampal neurons. These experiments were 
performed by the group of Dr. Jürgen Klingauf (Max-Planck-Institute for Biophysical 
Chemistry, Göttingen). Overexpression of a dominant-negative stonin 2 mutant resulted in 
increased synaptotagmin 1 levels at the plasma membrane, indicating an endocytic defect. 
Similar results were obtained in neurons derived from stonin 2 knock out mice (unpublished 
data). While synaptotagmin 1 internalization was strictly dependent on stonin 2 in fibroblasts, 
primary hippocampal stonin 2-/- neurons were able to partially compensate for the lack of 
stonin 2. The question arises how compensation for loss of stonin 2 is achieved in vivo. 
Synaptotagmin 1 is mis-localized and degraded in Drosophila stoned B mutants (Fergestad et 
al., 1999). The animals were paralyzed at the non-permissive temperature due to severe 
neurotransmission defects (Fergestad and Broadie, 2001). Stoned B evolutionary segregated 
into two mammalian orthologs: stonin 1 and 2. It might be possible that stonin 1 partially 
compensates for stonin 2 function in stonin 2-/- animals. Some preliminary observations may 
argue against this hypothesis. First, we were unable to detect synaptotagmin 1 binding to 
stonin 1. Second, overexpressed stonin 1 did not localize to synapses in primary hippocampal 
neurons, and third, stonin 1 was unable to facilitate synaptotagmin 1 internalization in 
fibroblasts. Nonetheless, stonin 1 is the most homologous protein to stonin 2, and therefore 
one possible candidate for compensating lack of stonin 2. To test this hypothesis we decided 
to create a stonin 1 knock out mouse line, which is currently at the state of microinjecting 
embryonic stem (ES) cells into mouse blastocysts. Alternatively, AP-2 might partially 
compensate for the lack of stonin 2 in the knock out mice, although AP-2 is not sufficient to 
mediate efficient synaptotagmin 1 internalization in fibroblasts. However, different AP-2 α-
adaptin splice variants are expressed in neurons, which may execute neuron-specific functions 
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(Ball et al., 1995). We intend to clarify this question by the following experimental setup. We 
have observed that a significantly higher fraction of synaptotagmin 1 fused to the pH-sensitive 
GFP pHluorin is stranded at the plasma membrane in neurons derived from stonin 2-/- mice as 
compared to wild-type neurons. If stonin 1 compensates for stonin 2 function in stonin 2-/- 
animals, we would expect that a synaptotagmin 1 C2B deletion construct is equally well 
internalized in stonin 2-/- and wild-type neurons (that is under the assumption that stonin 1 and 
2 would interact primarily with the C2A domain). In the case of compensation via AP-2 a 
synaptotagmin 1 C2B deletion mutant should only be internalized in neurons derived from 
wild-type but not stonin 2-/- animals, since the major interaction site for AP-2 lies within the 
C2B domain. The mild stonin 2-/- phenotype regarding synaptotagmin 1 internalization in 
neurons could also be interpreted as evidence for different synaptotagmin 1 internalization 
mechanisms in neurons versus fibroblasts. In neurons, endocytic cycling of synaptotagmin 1 
might be coupled to retrieval of other SV proteins. According to one current hypothesis  
synaptic vesicle proteins may remain pre-assembled or clustered for internalization at the 
plasma membrane (Willig et al., 2006), possibly by cholesterol-rich microdomains 
(Michaelson et al., 1983; Jia et al., 2006), and endocytosed as an entity. This scenario would 
alleviate the need for specific endocytic signals and adaptor proteins for each single SV 
protein. One signal recruiting the endocytic machinery, probably the clathrin machinery (see 
this work), would be enough to efficiently internalize all required SV proteins (Bennett et al., 
1992; Jia et al., 2006). It would make sense to provide several signals and adaptors as back-up 
or alternative for such a vital mechanism as SV endocytosis. This could explain why 
synaptotagmin 1 is still efficiently endocytosed without stonin 2 in neurons, but not in 
fibroblasts. Why such a mechanism would be functional at mammalian CNS synapses, but not 
at the Drosophila NMJ remains unexplained.  
      
5.2.4 The Mysteries of Synaptotagmin 1 Endocytosis    
Two questions remain to be answered with respect to synaptotagmin 1 internalization. First, 
what is the precise mechanistic role of the endocytic adaptors AP-2 and stonin 2 for 
synaptotagmin 1 recycling? As described above, it is possible that AP-2 may act as a linker 
between stonin 2 and clathrin during SV retrieval and that direct recognition and sorting of 
synaptotagmin 1 by AP-2 is not required. This scenario would impose a stringent  
requirement for a synaptotagmin 1-specific adaptor that connects it to the clathrin endocytic 
machinery. We believe that one such adaptor protein is stonin 2. The question remains why 
Discussion  171 
 
AP-2 is able to directly associate with synaptotagmin 1, but this interaction remains 
insufficient for driving endocytosis in fibroblasts. One possibility could be that the interaction 
between AP-2 and synaptotagmin 1 is under tight regulatory control, e.g., by other binding 
partners or post-translational modifications. For instance, the AP-2 binding site of 
synaptotagmin 1 is also implicated in PIP2 binding. Conversly, the putative synaptotagmin 1 
interaction site within AP-2 also overlaps with the PIP2 binding site within its µ2 subunit.  
Therefore the AP-2 – synaptotagmin 1 interaction could be inhibited in the presence of PIP2. 
Stonin 2 could serve as mediator, disrupting the synaptotagmin 1 – PIP2 interaction, and 
enabling AP-2 to connect to its target. Our data showing that stonin 2 is required to bridge the 
interaction between AP-2 and synaptotagmin 1 in fibroblasts argues in favor of this 
possibility. Local PIP2 turnover might also regulate the AP-2 – synaptotagmin 1 interaction in 
vivo. We hypothesize that the use of two adaptors acting in tandem could serve to add 
specificity to the retrieval process. AP-2 is a ubiquitous endocytic sorting adaptor, which may 
not be sufficient to fulfill the strict requirements regarding spatial and temporal regulation of 
SV endocytosis. Our observation that stonin 2 and synaptotagmin 1 exhibit a rather complex 
mode of interaction and our hypothesis that this type of interaction might offer the 
opportunity for fine-tuning regulatory processes would be in line with this scenario. 
            
Second, what is the endocytic sorting signal within synaptotagmin 1? We and others 
(Jarousse and Kelly, 2001a; Poskanzer et al., 2006) have shown that the AP-2 binding site 
within synaptotagmin 1 might not represent an endocytic signal in the context of the full-
length synaptotagmin 1. Mutating these residues did not result in retention of synaptotagmin 1 
at the plasma membrane in fibroblasts. So far we lack experimental evidence that this holds 
also true at chemical synapses in neurons. Nonetheless, transplanting the AP-2 binding 
sequence on to a reporter protein is sufficient to target the chimera for internalization in 
fibroblasts (Grass et al., 2004). Jarousse et al. (2003) showed by transplantation experiments 
that a putative signal for internalization in PC12 cells lies within the 29 carboxy-terminal 
amino acids of synaptotagmin 1. They identified a WHxL motif within the C2B domain to be 
required for endocytosis. Our own data reported here clearly show that the WHxL motif is not 
required for AP-2/stonin 2-dependent synaptotagmin 1 internalization in fibroblasts. A 
sequence similar to this motif is present in the C2A domain. Mutating both WxxL motifs in 
full-length as well as C2B deletion constructs did not abolish AP-2/stonin 2-dependent 
synaptotagmin 1 endocytosis. Also combining these mutations with the AP-2 binding-
deficient synaptotagmin 1 mutant did not affect endocytosis. From these data we conclude 
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that neither the basic AP-2 binding peptide nor the WHxL motif are strictly required for AP-
2/stonin 2-dependent synaptotagmin 1 internalization in fibroblasts. Han et al. (2004) 
suggested that intra-lumenal N-glycosylation might play a role in mediating synaptotagmin 1 
internalization. We could show that a C2A domain deletion mutant, which is most likely 
properly N-glycosylated, was not endocytosed in fibroblasts. In addition, we have mutated the 
glycosylation sites within synaptotagmin 1 (data not shown) and did not observe any 
endocytic defects, therefore, we consider a role for N-glycosylation in synaptotagmin 
endocytosis as unlikely. Blagoveshchenskaya et al. (1999) suggested that about 20% of 
synaptotagmin 1 molecules travel through an endocytic compartment before reaching their 
final SV destination. This pathway is dependent on AP-3 and a di-hydrophobic signal (ML) in 
the carboxy-terminal part of synaptotagmin 1. Again, this signal appeared to be dispensable 
for synaptotagmin 1 internalization. We cannot exclude that any of the above mentioned 
motifs exert regulatory or sorting functions upon internalization initiation by another motif or 
domain. This signal remains to be identified, but most likely involves basic residues within 
the C2 domains. If our conclusion is correct that stonin 2 represents the synaptotagmin 1 
specific endocytic adaptor, the actual stonin 2 binding site, or at least parts of it, should be 
identical to the synaptotagmin 1 endocytic sorting signal. We have shown that the stonin 2 – 
synaptotagmin 1 interaction is mediated by a complex mechanism including synergistic 
effects between the C2 domains. We therefore believe that we are dealing with a so far 
unknown signal, extending beyond a simple peptide motif. Further mutagenesis studies are 
needed to unequivocally answer this question.      
 
5.3 GIT1: A Novel Stonin 2 Interacting Protein  
We found that stonin 2 functions as endocytic sorting adaptor for the SV protein 
synaptotagmin 1. Interaction with the known stonin 2 binding partners intersectin and eps15 is 
not required for AP-2/stonin 2-dependent synaptotagmin 1 internalization in fibroblasts. We 
do not know whether these interactions might exert regulatory functions in neurons. In 
addition, we found stonin 2 expressed in characteristic squiggle-like structures in astroglial 
cells. We believe that in these cells stonin 2 exerts a different function apart from 
synaptotagmin  internalization, since stonin 2 does not bind to synaptotagmin IV, the claimed 
predominant synaptotagmin isoform in astrocytes. To gain additional insights into putative 
novel stonin 2 functions, we set out to identify new interaction partners. We succeeded to 
isolate the G protein-coupled receptor kinase interacting protein 1 (GIT1) by large scale anti-
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stonin 2 immunoprecipitation from brain. We believe that we identified a novel, direct 
binding partner of stonin 2 on the basis of following data. First, stonin 2 and GIT1 could be 
co-immunoprecipitated from brain and co-transfected fibroblasts. We excluded the possibility 
for GIT1 cross-reactivity of the stonin 2 antibodies by using anti-HA and anti-FLAG tag 
antibodies for co-immunoprecipitation experiments from transfected fibroblasts. Second, we 
were able to affinity purify stonin 2 from transfected fibroblasts using GST-fused GIT1 fusion 
proteins. Third, we could show that stonin 2 synthesized by coupled transcription / translation 
in vitro was able to bind to GST-fused GIT1, indicating a direct association of these proteins. 
Our data show that an amino-terminal stonin 2 fragment (amino acids 1-555) was sufficient to 
associate with GIT1 in co-immunoprecipitation experiments. We also found that the stonin 
homology domain (SHD: amino acids 411 – 553) did not bind to GIT1 (data not shown). 
Therefore, we hypothesize that at least one binding site for GIT1 is located within the amino-
terminal 411 amino acids of stonin 2. This is in line with our observation that AP-2 and GIT1 
binding to stonin 2 appear to be competitive. Mutating the AP-2 binding sites within stonin 2 
increased the efficiency of the co-immunoprecipitation between stonin 2 and GIT1. These 
data show that GIT1 binding is not mediated by the AP-2 binding WVxF motifs, instead GIT1 
may associate with residues in spatial proximity.  
Both stonin 2 and GIT 1 are largely localized to the cytosol when ectopically expressed in 
fibroblasts. GIT1 is also contained within paxillin-positive protein complexes in the cytosol 
(Manabe et al., 2002). In addition, stonin 2 and GIT1 colocalize in membrane ruffle-like 
structures in fibroblasts. This could indicate a cooperation function of stonin 2 and GIT1 in 
cell motility.  
GIT family proteins are multifunctional scaffolds, with a complex domain structure and many 
binding partners (reviewed in Hoefen and Berk, 2006). They appear to have important 
functions in the control of cytoskeletal dynamics during cell spreading and migration, and 
membrane trafficking between the plasma membrane and recycling endosomal structures. A 
selection of GIT interacting proteins and the functional relevance of these interactions are 
summarized in Figure 5-1.  
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The GIT protein family comprises two isoforms GIT1 and GIT2, of which GIT2 is expressed 
in more than 10 splice variants (Premont et al., 2000). Since GIT1 and GIT2 are highly 
homologous, we believe that there might be the possibility that stonin 2 also interacts with 
other GIT isoforms or splice variants. This will be investigated in future experiments. The 
most homologous protein to stonin 2 is stonin 1, which may also associate with GIT1. 
Altogether, we believe that we have identified a novel stonin 2 interacting protein, GIT1, 
which directly associates with stonin 2 in vitro and in living cells. The functional significance 
of the stonin 2 - GIT1 interaction remains to be investigated. Stonin 2 specifically associated 
with the ARF-GAP domain of GIT1 in affinity purification experiments. We speculate that 
stonin 2 might regulate the ARF-GAP activity of GIT1. This question may be approached by 
the following experimental setups. First, the effects of GIT1 or a GIT1/stonin 2 complex on  
 
Figure 5-1: GIT1 domain structure and selection of GIT1 protein interactions and functions 
The full-length GIT1 protein has an amino-terminal ARF GTPase-activating protein (ARF-GAP) 
domain, three ankyrin (ANK) repeats, a Spa2-homology domain (SHD), a coiled-coil (CC) domain 
including a putative leucine zipper (represented by the blue stripe), and a paxillin-binding site (PBS). 
Major signaling pathways include (A) agonist (Ag)-receptor (GPCR) endocytosis; (B) angiotensin-II 
(AngII)-stimulated PLCγ activation and Ca2+ mobilization; (C) scaffolding MEK1 activation in response 
to TRK activation; (D) cytoskeletal regulation through PAK and Rho-family GTPases; and (E) focal 
complex assembly and disassembly. G, heterotrimeric G proteins; GRK, GPCR kinase; GPCR, G-
protein-coupled receptor; IP3, inositol(1,4,5)-trisphosphate; P, phosphorylation; TKR, tyrosine kinase 
receptor. Taken from Hoefen and Berk, 2006. 
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the nucleotide status of ADP-ribosylation factor 6 (ARF6) will be investigated. We will 
benefit from a GST-fused GGA1 (Golgi localized, gamma-adaptin ear containing, ARF-
binding) protein construct that selectively binds GTP bound ARF6. Second, Radhakrishna 
and Donaldson (1998) have identified an ARF6-dependent membrane recycling pathway. 
Membrane proteins such as the interleukin-2 (IL-2) receptor α subunit (Tac), class I molecules 
of the major histocompatibility complex (MHC-I), β1-integrin, CD1a, plakoglobin, and 
cadherins appear to be internalized via an ARF6-dependent pathway (Radhakrishna and 
Donaldson, 1997; Sugita et al., 1999; Brown et al., 2001). We intend to study internalization 
of these proteins in cells overexpressing or lacking GIT1 or stonin 2.  
In neuronal cells GIT1 is localized to synapses and is found at both presynaptic as well as 
postsynaptic sites (Kim et al., 2003; Ko et al., 2003a and 2003b; Zhang et al., 2003). Since we 
find a synaptic localization for stonin 2 it is tempting to hypothesize that the stonin 2 – GIT1 
interaction is functionally relevant in neurons. Our data that stonin 2 and GIT1 can be co-
immunoprecipitated from brain supports this hypothesis. In the brain GIT1 interacts with the 
presynaptic neuronal proteins piccolo and scribble, perhaps organizing the cytomatrix at the 
active zone (CAZ) (Kim et al., 2003; Audebert et al., 2004). It would be interesting to assess 
whether stonin 2 is also found within the CAZ, where it may interact with GIT1 as well as 
with other factors. A complex between GIT1, piccolo, and stonin 2 could be imagined, since 
piccolo contains C2 domains, and it has been shown that stonin 2 can associate with these 
domains (see this thesis work).        
 
In summary, we have identified GIT1 as a novel direct stonin 2 interaction partner. We found 
evidence that stonin 2 associates specifically with the ARF-GAP domain of GIT1, suggesting 
a regulatory function of stonin 2 on the GAP activity of GIT1. It will be an exciting challenge 
for the future to assign functional significance to the stonin 2 – GIT1 interaction in GIT1 
regulated processes.   
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6 Summary and Conclusions 
Synaptic transmission requires efficient mechanisms to recycle synaptic vesicles (SV) in order 
to sustain neurotransmitter release during repeated stimulation. While it is known that clathrin 
plays an important role in SV retrieval, the existence of an alternative clathrin-independent 
pathway, frequently referred to as kiss-and-run, is controversially discussed. In this thesis 
work we aimed at elucidating the molecular mechanisms of fast and slow components of SV 
retrieval in small central synapses of the hippocampus. We developed amphiphysin-derived 
dominant-negative tools targeting key molecules of the clathrin machinery: (i) dynamin and 
(ii) AP-2/clathrin. We characterized the dominant-negative protein domains biochemically 
and found that both domains were potent inhibitors of clathrin-mediated endocytosis (CME) 
in fibroblasts. Ultra-structural analyses of synaptic boutons expressing the dominant-negative 
domains displayed minor differences in the total number of SVs, and unaltered numbers of 
docked and exocytosis-competent vesicles under resting conditions. Inhibiting CME in 
primary hippocampal neurons under strong stimulation conditions resulted in severe reduction 
of the total recycling vesicle pool size, and slowed endocytosis kinetics. The fast and slow 
modes of SV retrieval were equally affected. We conclude that the observed effects, reduction 
in total recycling vesicle pool size and endocytic rate, are a direct consequence of endocytic 
defects caused by inhibiting CME. Therefore, we believe that the majority of SVs are 
internalized via a clathrin-dependent pathway. We further reason that the observed kinetically 
different endocytic modes are molecularly identical. However, it was noticeable that recycling 
of the readily releasable pool under mild stimulation conditions was not affected by 
perturbing CME. Therefore, we cannot exclude a clathrin-independent pathway of vesicle 
recycling for a minor fraction of the SV pool under mild stimulation conditions.  
The synaptic vesicle membrane protein synaptotagmin 1 has been shown to play a major role 
in SV endocytosis. The molecular mechanisms by which synaptotagmin 1 participates in SV 
recycling are poorly understood. It has been shown, that the endocytic adaptor AP-2 interacts 
with synaptotagmin 1. However, AP-2 is not sufficient to internalize ectopically expressed 
synaptotagmin 1 from the plasma membrane in fibroblasts. We have identified stonin 2 as a 
synaptotagmin 1-specific endocytic sorting adaptor. Synaptotagmin 1 internalization in 
fibroblasts is dependent on both AP-2 and stonin 2. Considering the key function of 
synaptotagmin 1 in the process of SV recycling, we wanted to molecularly dissect the stonin 2 
– synaptotagmin 1 interaction. We found that the interaction is mediated by the µ-homology 
domain of stonin 2 and both C2 domains of synaptotagmin 1. Site-directed mutagenesis 
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revealed that AP-2/stonin 2-mediated synaptotagmin 1 internalization is dependent on direct 
interaction between stonin 2 and synaptotagmin 1, and that residues KYE783-785 are 
essential for binding of synaptotagmin 1, and stonin 2 endocytic function. This interpretation 
is based on the following observations. First, mutating residues KYE783-785 to alanines 
abolished the direct interaction between stonin 2 and synaptotagmin 1 shown by affinity 
chromatography experiments employing GST-fused synaptotagmin 1 incubated with wild-
type or mutant versions of stonin 2 present in cell extracts, synthesized by coupled 
transcription / translation in vitro, or purified from stably transfected HEK293 cells. Second, 
stonin 2 mutated within the KYE site could not be recruited to the plasma membrane in 
synaptotagmin 1 overexpressing fibroblasts. Third, the stonin 2 KYE mutant was not able to 
internalize synaptotagmin 1 in fibroblasts. Fourth, while overexpressed wild-type stonin 2 
was concentrated at synapses in primary hippocampal neurons, the stonin 2 KYE mutant lost 
this ability. We also confirmed the structural integrity of the stonin 2 KYE mutant by limited 
proteolysis. Finally, while the stonin 2 KYE mutant lost the ability to associate with 
synaptotagmin 1, it retained its AP-2 binding activity. Based on these observations we 
conclude that the KYE site within the stonin 2 µHD is directly involved in synaptotagmin 1 
interaction. The stonin 2 µHD predominantly associates with the C2A domain of 
synaptotagmin 1, in contrast to AP-2 which predominantly interacts with C2B. Molecular 
modeling and experimental data suggest a β-strand interaction between residues within the 
µHD of stonin 2 and C2A. Surprisingly, the C2 domains exhibit synergistic effects with 
respect to stonin 2 binding. The stonin 2 – synaptotagmin 1 as well as the AP-2 – 
synaptotagmin 1 interaction appeared to be mediated via basic residues in C2A and C2B. 
Mutating these residues abolished AP-2 and substantially reduced stonin 2 binding to 
synaptotagmin 1 in GST pull down and co-immunoprecipitation experiments. However, AP-
2/stonin 2-dependent synaptotagmin 1 internalization was not affected by mutating these basic 
residues. Our data indicate that the synaptotagmin 1 internalization signal might not be a 
simple peptide motif, but rather a complex interaction site that involves cooperativity between 
the two C2 domains. It will be interesting to analyze synaptotagmin 1 internalization in 
neurons and to assess the importance of the KYE site in synaptotagmin 1 internalization 
during SV exo/endocytosis.  
In order to gain further insights into stonin 2 function we set out to find novel interaction 
partners. We identified the G protein-coupled receptor kinase interacting protein 1 (GIT1) as a 
novel stonin 2 binding protein by large scale co-immunoprecipitation from rat brain. The 
interaction was confirmed by affinity chromatography and co-immunoprecipitation 
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experiments from cell extracts. Our data indicate that the stonin 2 – GIT1 interaction is direct 
and mediated by the amino-terminal ARF-GAP domain of GIT1. The amino-terminal 411 
amino acids of stonin 2 were sufficient to associate with GIT1. Assignment of functional 
relevance to the stonin 2 – GIT1 interaction will be an exciting endeavor for the future.  
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Appendix 
A) List of Primers 
(numbers given correspond to amino acid residues; r: rat; h: human; Syt1: synaptotagmin 1; 
Stn2: stonin 2; F: forward; R: reverse) 
 primer sequence used for 
construct 
1 BamHI-Syt1-F GATCGGATCCATGGTGAGTGCCAGTCATCC rSyt1 







































































26 C2A,K244S-R CACGGTGTTCATAGGAACTGAGAACTCTCC rSyt1,K244S 

































































































































































































87 Stn2,Y784F-F AACTCTGGGAACTGCCAAGTTCGAGCATGC hStn2,F784F 





















































104 EcoRI-GIT-GAP-F GATCGAATTCATGTCCCGAAAGGGGCCG hGIT1-ArfGAP, 
GIT1 






















113 GIT1-500-F TTCTTCCACCCAGAGAAGGG hGIT1 Seq 
114 GIT1-1000-F GGGGCGACAAAAGCTGGC hGIT1 Seq 
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B) List of Abbreviations 
2-ME  2-mercaptoethanol 
A  adensosine 
aa   amino acid 
AAK  adaptor associated kinase 
ADP  adenosine diphosphate 
Amp   ampicillin 
AMPA  α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid 
AmpR   ampicillin resistance 
ANTH  AP180 amino-terminal homology 
ARF   ADP-ribosylation factor 
AP   action potential 
AP   adaptor protein (or assembly polypeptide) 
AP  alkaline phosphatase 
APS   ammonium persulfate 
ATP   adenosine triphosphate 
BCA  bicinchoninic acid 
BCIP   5-bromo-4-chloro-3-indolyl-phosphate 
BFA   Brefeldin A 
BSA   bovine serum albumin 
bp   base pairs 
C  cytosine 
CAZ  cytomatrix assembled at the active zone 
CCV   clathrin-coated vesicle 
CCP   clathrin-coated pit 
CD  cluster of differentiation 
cDNA   copy-DNA 
CFP  cyan fluorescence protein 
CIP  calf intestine alkaline phosphatase 
CLAP  clathrin and AP-2 
CME  clathrin-mediated endocytosis 
CMV  cytomegalo virus 
CNS  central nervous system 
CLASP  clathrin associated sorting protein 
CT  carboxy-terminal 
Da   Dalton 
DAPI  diamidophenylindole 
DAS  dihyrdoxyacetone synathase 
dH2O   destilled water 
ddH2O   bidestilled water 
DIC  differential interference contrast 
DIV  days in vitro 
DMEM  Dulbecco’s Minimal Essential Medium 
DMSO   dimethylsulfoxid 
DNA   deoxyribonucleic acid 
DNase  deoxyribonuclease 
dNTP   deoxynucleosidtriphosphate 
Dox  doxycycline 
DSS  disuccinimidyl suberate 
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DTT   dithiothreitol 
E. coli   Escherichia coli 
EDTA   ethylenediaminetetraacetic acid 
EE  early endosome 
EGF  epidermal growth factor  
EGTA ethyleneglycol-bis(2-aminoethylether)-N,N,N′,N′-
tetraacetic acid 
EH  eps15 homology 
EHSH  EH domain and SH3 domain containing protein 
EM   electron microscopy 
ENaC  epithelial sodium channel 
ENTH  epsin amino-terminal homology 
EPS  epidermal growth factor receptor pathway substrate 
ER   endoplasmic reticulum 
ES  embryonic stem (cells) 
ESE  EH domain and SH3 domain regulator of endocytosis 
et al.  and others (et alii) 
FCS  fetal calf serum 
Fig.   figure 
FL  full-length 
FMD  formate dehydrogenase 
g  gram 
g  acceleration of gravity 
G  guanosine 
GABA  γ-aminobutyric acid 
GAK  cycline G associated kinase 
GαM-AP  goat anti-mouse conjugated alkaline phosphatase 
GαM-HRP  goat anti-mouse conjugated horse radish peroxidase 
GAP  GTPase activating protein 
GED  GTPase enhancing domain 
GEF   GTP exchange factor 
GFP   green fluorescent protein 
GGA Golgi localized, gamma-adaptin eat containing, ARF-
binding 
GIT  G protein-coupled receptor kinase interacting protein 
GPCR  G protein-coupled receptor 
GRK  G protein-coupled receptor kinase 
GSDB  goat serum dilution buffer 
GST  glutathione S-transferase 
GTP  guanosine triphosphate 
h  hour 
HA  hemagglutinin 
HEPES  4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid 
HIP  Huntingtin-interacting protein 
HIP1R  HIP1-related 
His6  6x Histidine tag 
HRP  horse radish peroxidase 
Hsc70  heat shock cognate protein 70 
IPTG  isopropyl-β-D-thiogalactopyranoside 
IRES  internal ribosomal entry site 
kb   kilo bases 
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Kan   kanamycin 
KanR   kanamycin resistance 
l   liter 
LB  Luria-Bertani 
m  milli 
µ  micro 
M   molar 
mAmp  milliampere 
MAP2  microtubule associated protein 2 
mbar   millibar 
MES   2-(N-morpholino)ethansulfonic acid 
µHD  µ-homology domain 
min   minute 
MOX  methanol oxidase 
mRNA   messenger RNA 
MVB   multivesicular body 
MW  molecular weight 
n   nano 
NCBI  National Center of Biotechnology Information 
ND  not determined 
NMJ  neuromuscular junction 
NMR  nuclear magnetic resonance 
NPF  asparagine proline phenylalanine 
NSF  N-ethylmaleimide-sensitive factor 
NT  amino-terminal 
OD   optical density 
o/n   overnight 
ORF  open reading frame 
PAGE   polyacrylamide gel-electrophoresis 
PBS   phosphate buffered saline 
PBS-T   phosphate buffered saline with 0.05% (v/v) Tween-20 
PCR   polymerase chain reaction 
PDB  protein data base 
PFA  paraformaldehyde 
pH  preponderance of hydrogen ions 
PH  pleckstrin homology  
PIP2  phosphatidylinositol (4,5)-bisphosphate 
PIPKI  phosphatidylinositol (4)-phosphate 5-kinase I 
PM   plasma membrane 
PNK  polynucleotide kinase 
PRD  proline-rich domain (region) 
PSF  point spread function 
PTB  phosphotyrosine binding 
PtdIns(4,5)P2  phosphatidylinositol (4,5)-bisphosphate 
RE  restriction enzyme 
RNA   ribonucleic acid 
RNAi  RNA interference 
RNase  ribonuclease 
rpm   rounds per minute 
RT   room temperature 
SDS   sodium dodecyl sulfate 
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sec   seconds 
SFV  semliki forest virus 
SHD  spa2-homology domain 
SHD  stonin-homology domain 
siRNA  short interfering RNA 
SNAP  soluble NSF attachment protein 
SNARE  soluble NSF attachment protein receptor 
SV   synaptic vesicle 
Syt  synaptotagmin 
T  thymidine 
Taq  Thermus aquaticus 
TBE   Tris/boronacid/EDTA-buffer 
TBS  Tris buffered saline 
TE  Tris-EDTA 
TEMED   N,N,N’,N’-tetramethylenediamin 
Tet  tetracycline 
Tf  transferrin 
TGN   trans-Golgi network 
Tm  melting temperature 
TMD  transmembrane domain 
Tris   Tris-(hydroxymethyl)-aminoethan 
Triton® X-100  octylphenol ethylene oxide condensate 
UIM  ubiquitin-interacting motif 
UV  ultraviolet 
(v/v)   volume per volume 
VAMP  vesicle associated membrane protein 
vol  volume 
W   Watt 
WB  Western blot 
WT  wild-type 
(w/v)   weight per volume 
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